syndrome	score	normalized_score
PRIMARY ANGIITIS OF THE CENTRAL NERVOUS SYSTEM	1.00537634	100.0
HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA	1.0	99.46524104595498
CHIARI MALFORMATION TYPE II	1.0	99.46524104595498
DYSTROPHIC EPIDERMOLYSIS BULLOSA	1.0	99.46524104595498
CLUSTER HEADACHE, FAMILIAL	0.5277778	52.49554609570383
TRIGEMINAL NEURALGIA	0.5	49.73262052297749
PITUITARY DERMOID AND EPIDERMOID CYSTS	0.35	34.812834366084246
SHEEHAN SYNDROME	0.25747768	25.610079505153266
PITUITARY DEFICIENCY DUE TO RATHKE CLEFT CYSTS	0.25	24.866310261488746
PITUITARY APOPLEXY	0.25	24.866310261488746
NEUROENDOCRINE NEOPLASM OF APPENDIX	0.22857143000000002	22.73491238116863
PUDENDAL NEURALGIA	0.22857143000000002	22.73491238116863
ADVANCED SLEEP PHASE SYNDROME, FAMILIAL, 2; FASPS2	0.20424821999999998	20.315598435507244
CRYPTOSPORIDIOSIS	0.2	19.893048209191
PORPHYRIA, ACUTE HEPATIC	0.2	19.893048209191
CONGENITAL SUCRASE-ISOMALTASE DEFICIENCY	0.2	19.893048209191
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 6	0.19444430000000001	19.340449169511988
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 5	0.19444430000000001	19.340449169511988
MIGRAINE, FAMILIAL TYPICAL, SUSCEPTIBILITY TO, 2	0.19444430000000001	19.340449169511988
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 11	0.19444430000000001	19.340449169511988
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 10	0.19444430000000001	19.340449169511988
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 1	0.19444430000000001	19.340449169511988
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 3	0.19444430000000001	19.340449169511988
VITAMIN D-DEPENDENT RICKETS, TYPE 2B, WITH NORMAL VITAMIN D RECEPTOR	0.166667	16.57757332940618
RARE CIRCULATORY SYSTEM DISEASE	0.166667	16.57757332940618
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 17	0.166667	16.57757332940618
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA, AUTOSOMAL DOMINANT	0.166667	16.57757332940618
OSGOOD-SCHLATTER DISEASE	0.166667	16.57757332940618
SINDING-LARSEN-JOHANSSON DISEASE	0.166667	16.57757332940618
FAMILIAL ALZHEIMER-LIKE PRION DISEASE	0.15477308999999997	15.394542704277283
PSEUDOHYPOPARATHYROIDISM TYPE 1C	0.14848739	14.769334038634726
PSEUDOHYPOPARATHYROIDISM TYPE 1A	0.14848739	14.769334038634726
PSEUDOHYPOPARATHYROIDISM TYPE 1B	0.14458114	14.380797940798965
PSEUDOHYPOPARATHYROIDISM TYPE 2	0.14285699999999998	14.209305940101991
AUTOIMMUNE HYPOPARATHYROIDISM	0.14285699999999998	14.209305940101991
FAMILIAL ISOLATED HYPERPARATHYROIDISM	0.14285699999999998	14.209305940101991
MYOPATHIC EHLERS-DANLOS SYNDROME	0.13580247	13.507625413186073
GABRIELE-DE VRIES SYNDROME	0.13046448	12.976680951135174
X-LINKED FEMALE RESTRICTED FACIAL DYSMORPHISM-SHORT STATURE-CHOANAL ATRESIA-INTELLECTUAL DISABILITY	0.12919328	12.850240736717556
INTELLECTUAL DISABILITY-BALDING-PATELLA LUXATION-ACROMICRIA SYNDROME	0.12869004	12.800185848813591
MACROCEPHALY/MEGALENCEPHALY SYNDROME, AUTOSOMAL RECESSIVE	0.12746914	12.678748736020584
CONTRACTURAL ARACHNODACTYLY, CONGENITAL	0.12746914	12.678748736020584
PRIETO X-LINKED MENTAL RETARDATION SYNDROME; PRS	0.12598912	12.531538189967751
X-LINKED INTELLECTUAL DISABILITY-DYSMORPHISM-CEREBRAL ATROPHY SYNDROME	0.12598912	12.531538189967751
HEREDITARY PHEOCHROMOCYTOMA-PARAGANGLIOMA	0.125	12.433155130744373
NON-FUNCTIONING PARAGANGLIOMA	0.125	12.433155130744373
SPORADIC PHEOCHROMOCYTOMA/SECRETING PARAGANGLIOMA	0.125	12.433155130744373
MIGRAINE WITHOUT AURA, SUSCEPTIBILITY TO, 4	0.11111099999999999	11.051682397857105
PAROXYSMAL HEMICRANIA	0.10980392	10.921673370590758
CARNEY COMPLEX	0.10813008	10.755184471518398
PARAGANGLIOMAS 1	0.1	9.9465241045955
PARAGANGLIOMAS 3	0.1	9.9465241045955
ARNOLD-CHIARI MALFORMATION TYPE I	0.1	9.9465241045955
PARAGANGLIOMAS 4	0.1	9.9465241045955
MIGRAINE, FAMILIAL HEMIPLEGIC, 2; FHM2	0.08333330000000001	8.288766771654881
MIGRAINE, FAMILIAL HEMIPLEGIC, 3	0.08333330000000001	8.288766771654881
EPILEPSY, FAMILIAL TEMPORAL LOBE, 4	0.08333330000000001	8.288766771654881
7Q11.23 MICRODUPLICATION SYNDROME	0.05111507999999999	5.084173753283273
16P13.2 MICRODELETION SYNDROME	0.04951004	4.924528062794873
DISTAL 16P11.2 MICRODELETION SYNDROME	0.048586449999999996	4.83266296081724
MICROGNATHIA-RECURRENT INFECTIONS-BEHAVIORAL ABNORMALITIES-MILD INTELLECTUAL DISABILITY SYNDROME	0.04670422999999999	4.645447494815722
ADNP SYNDROME	0.04473049999999999	4.449129964606089
WILLIAMS-BEUREN SYNDROME; WBS	0.044078099999999995	4.384238841347708
INTELLECTUAL DISABILITY-MICROCEPHALY-STRABISMUS-BEHAVIORAL ABNORMALITIES SYNDROME	0.04219049	4.196487257696954
SIALURIA	0.03978693	3.9574165829285377
INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME DUE TO SETD5 HAPLOINSUFFICIENCY	0.039069559999999996	3.886063202959401
EARLY-ONSET PROGRESSIVE DIFFUSE BRAIN ATROPHY-MICROCEPHALY-MUSCLE WEAKNESS-OPTIC ATROPHY SYNDROME	0.038530999999999996	3.832495202741691
ALACRIMIA-CHOREOATHETOSIS-LIVER DYSFUNCTION SYNDROME	0.03774513	3.754328453760907
EPENDYMOMA	0.03758172	3.7380748387215874
SUBEPENDYMOMA	0.03758172	3.7380748387215874
CURRY-JONES SYNDROME	0.03754188	3.7341121435183164
INTELLECTUAL DISABILITY-STRABISMUS SYNDROME	0.0375014	3.7300857905607763
X-LINKED INTELLECTUAL DISABILITY, NASCIMENTO TYPE	0.0375014	3.7300857905607763
16P12.1P12.3 TRIPLICATION SYNDROME	0.03734542	3.714571202262428
MALONYL-COA DECARBOXYLASE DEFICIENCY	0.037115459999999996	3.6916981754315
TUFTED ANGIOMA	0.03625238	3.6058517151895577
HOLMES-GANG SYNDROME	0.035815099999999996	3.562357554584982
WILLIAMS-BEUREN REGION DUPLICATION SYNDROME	0.034876279999999996	3.468977596986219
TURNPENNY-FRY SYNDROME; TPFS	0.034876279999999996	3.468977596986219
PITT-HOPKINS-LIKE SYNDROME	0.03482598	3.4639744953616076
MENTAL RETARDATION, X-LINKED, SYNDROMIC 33	0.03433392	3.415031628852535
PUERTO RICAN INFANT HYPOTONIA SYNDROME	0.03397235	3.379067981647549
PARATHYROID CARCINOMA	0.03394777	3.37662312602264
HYPERPARATHYROIDISM-JAW TUMOR SYNDROME	0.03394777	3.37662312602264
PRIMARY PARATHYROID HYPERPLASIA	0.03394777	3.37662312602264
ANAL SPHINCTER DYSPLASIA; ASDP	0.032983229999999995	3.2806849224241734
300270 ADRENOMYODYSTROPHY	0.032983229999999995	3.2806849224241734
SEVERE INTELLECTUAL DISABILITY-POOR LANGUAGE-STRABISMUS-GRIMACING FACE-LONG FINGERS SYNDROME	0.03212506	3.195326836515767
RAMOS-ARROYO SYNDROME	0.03212506	3.195326836515767
VERY LONG CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.031684050000000005	3.151461670562091
EPIDERMAL NEVUS SYNDROME	0.031467840000000004	3.129956290795545
MARFANOID HABITUS-AUTOSOMAL RECESSIVE INTELLECTUAL DISABILITY SYNDROME	0.03130345	3.11360519982
QAZI-MARKOUIZOS SYNDROME	0.030400919999999998	3.023834835818794
PERIPHERAL PRIMITIVE NEUROECTODERMAL TUMOR	0.03037634	3.021389980193885
FAMILIAL HYPOCALCIURIC HYPERCALCEMIA	0.03037634	3.021389980193885
RETINAL CAPILLARY MALFORMATION	0.03024694	3.0085191780025378
YUAN-HAREL-LUPSKI SYNDROME; YUHAL	0.0294118	2.925451776595419
VARIANT ABETA2M AMYLOIDOSIS	0.0294118	2.925451776595419
PMP22-RAI1 CONTIGUOUS GENE DUPLICATION SYNDROME	0.0294118	2.925451776595419
HEREDITARY LATE-ONSET PARKINSON DISEASE	0.0294118	2.925451776595419
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SEIZURES, AND DISTAL LIMB ANOMALIES	0.0294118	2.925451776595419
CURRARINO SYNDROME	0.0294118	2.925451776595419
EARLY-ONSET SEIZURES-DISTAL LIMB ANOMALIES-FACIAL DYSMORPHISM-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.0294118	2.925451776595419
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 47	0.0294118	2.925451776595419
AL AMYLOIDOSIS	0.0294118	2.925451776595419
CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG	0.02876692	2.8613086319497034
SOMATOSTATINOMA	0.028571430000000002	2.84186417197763
FAMILIAL GLUCOCORTICOID DEFICIENCY	0.028571430000000002	2.84186417197763
GRFOMA	0.028571430000000002	2.84186417197763
PPOMA	0.028571430000000002	2.84186417197763
GLUCAGONOMA	0.028571430000000002	2.84186417197763
ANAPLASTIC THYROID CARCINOMA	0.027777800000000002	2.7629255727263287
OROMANDIBULAR DYSTONIA	0.027777800000000002	2.7629255727263287
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2A2A	0.027777800000000002	2.7629255727263287
THYROID LYMPHOMA	0.027777800000000002	2.7629255727263287
ACATALASEMIA	0.027777800000000002	2.7629255727263287
HEREDITARY PAINFUL CALLOSITIES	0.027777800000000002	2.7629255727263287
OSTEOSARCOMA	0.027777800000000002	2.7629255727263287
BUERGER DISEASE	0.027777800000000002	2.7629255727263287
CHARCOT-MARIE-TOOTH DISEASE-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.027777800000000002	2.7629255727263287
AMYOTROPHIC LATERAL SCLEROSIS	0.027777800000000002	2.7629255727263287
AUTOSOMAL DOMINANT OPTIC ATROPHY AND CATARACT	0.027777800000000002	2.7629255727263287
FIBULAR HEMIMELIA	0.027777800000000002	2.7629255727263287
LEUKOCYTE ADHESION DEFICIENCY, TYPE III	0.027777800000000002	2.7629255727263287
VULVOVAGINAL GINGIVAL SYNDROME	0.027777800000000002	2.7629255727263287
PRIMARY HYPEROXALURIA TYPE 3	0.027777800000000002	2.7629255727263287
INTERSTITIAL CYSTITIS	0.027777800000000002	2.7629255727263287
EPITHELIAL RECURRENT EROSION DYSTROPHY	0.027777800000000002	2.7629255727263287
EPISODIC PAIN SYNDROME, FAMILIAL, 3	0.027777800000000002	2.7629255727263287
AUTOSOMAL SPASTIC PARAPLEGIA TYPE 72	0.027777800000000002	2.7629255727263287
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2W	0.027777800000000002	2.7629255727263287
O'SULLIVAN-MCLEOD SYNDROME	0.027777800000000002	2.7629255727263287
POEMS SYNDROME	0.027777800000000002	2.7629255727263287
INFANTILE DIGITAL FIBROMATOSIS	0.027777800000000002	2.7629255727263287
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 27	0.027777800000000002	2.7629255727263287
SPINOCEREBELLAR ATAXIA TYPE 43	0.027777800000000002	2.7629255727263287
COENZYME Q10 DEFICIENCY, PRIMARY, 8; COQ10D8	0.027777800000000002	2.7629255727263287
KYPHOSCOLIOSIS-LATERAL TONGUE ATROPHY-HEREDITARY SPASTIC PARAPLEGIA SYNDROME	0.027777800000000002	2.7629255727263287
DESANTO-SHINAWI SYNDROME	0.027724730000000003	2.75764695238402
WIEDEMANN-RAUTENSTRAUCH SYNDROME	0.025298010000000003	2.51627266263298
MULTIPLE ENDOCRINE NEOPLASIA TYPE 1	0.025	2.486631026148875
MERCURY POISONING	0.025	2.486631026148875
TIGLIC ACIDEMIA	0.025	2.486631026148875
ASHERMAN SYNDROME	0.025	2.486631026148875
RECURRENT ACUTE PANCREATITIS	0.025	2.486631026148875
JEJUNAL NEUROENDOCRINE TUMOR	0.025	2.486631026148875
VIPOMA	0.025	2.486631026148875
ILEAL NEUROENDOCRINE TUMOR	0.025	2.486631026148875
GANGLIONEUROMA	0.025	2.486631026148875
GALLBLADDER NEUROENDOCRINE TUMOR	0.025	2.486631026148875
PRIMARY HEPATIC NEUROENDOCRINE CARCINOMA	0.025	2.486631026148875
HYPERLIPOPROTEINEMIA, TYPE I	0.025	2.486631026148875
SANDHOFF DISEASE	0.025	2.486631026148875
ADENOCARCINOMA OF OVARY	0.025	2.486631026148875
CARCINOID SYNDROME	0.025	2.486631026148875
ANGIOEDEMA, HEREDITARY, TYPE III	0.025	2.486631026148875
ZOLLINGER-ELLISON SYNDROME	0.025	2.486631026148875
ESTROGEN RESISTANCE SYNDROME	0.025	2.486631026148875
VISCERAL NEUROPATHY, FAMILIAL, AUTOSOMAL RECESSIVE	0.025	2.486631026148875
NEUROENDOCRINE TUMOR OF STOMACH	0.025	2.486631026148875
MULTIPLE ENDOCRINE NEOPLASIA TYPE 4	0.025	2.486631026148875
DUODENAL NEUROENDOCRINE TUMOR	0.025	2.486631026148875
SPINOCEREBELLAR ATAXIA TYPE 25	0.025	2.486631026148875
FAMILIAL CHYLOMICRONEMIA SYNDROME	0.025	2.486631026148875
DEVELOPMENTAL DELAY, INTELLECTUAL DISABILITY, OBESITY, AND DYSMORPHIC FEATURES; DIDOD	0.02406952	2.3940806086604347
MELAS	0.023961180000000002	2.383304544445516
OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME; OCNDS	0.0237347	2.360777656653428
SMITH-MAGENIS SYNDROME	0.0235009	2.337522683296884
WAC-RELATED FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY-BEHAVIORAL ABNORMALITIES SYNDROME	0.0235009	2.337522683296884
CORNELIA DE LANGE SYNDROME	0.02343746	2.3312126084049285
LYNCH SYNDROME	0.022972060000000002	2.2849214852221413
FAMILIAL COLORECTAL CANCER TYPE X	0.022972060000000002	2.2849214852221413
PRADER-WILLI SYNDROME; PWS	0.02285981	2.2737565119147325
DISTAL MONOSOMY 10Q	0.02278859	2.2666725974474398
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME	0.02263042	2.2509401802712006
ROLANDIC EPILEPSY	0.02172001	2.160386030170553
PANCREATIC TRIACYLGLYCEROL LIPASE DEFICIENCY	0.02137363	2.1259332599770553
CHROMOSOME 17Q11.2 DELETION SYNDROME, 1.4-MB	0.02123854	2.112496500564157
BARDET-BIEDL SYNDROME 1; BBS1	0.02095708	2.0845010138193625
ENDOCARDIAL FIBROELASTOSIS	0.02093144	2.081950725038944
ERYTHERMALGIA, PRIMARY	0.02081283	2.0701531527984836
CONGENITAL LABIOSCROTAL AGENESIS-CEREBELLAR MALFORMATION-CORNEAL DYSTROPHY-FACIAL DYSMORPHISM SYNDROME	0.020695039999999998	2.05843714205568
CLASSICAL EHLERS-DANLOS SYNDROME	0.02067642	2.0565850992674046
22Q11.2 DELETION SYNDROME	0.02038289	2.0273890670631856
RING CHROMOSOME 12 SYNDROME	0.0202947	2.018617227455343
CRANIOFACIAL DYSMORPHISM, SKELETAL ANOMALIES, AND MENTAL RETARDATION SYNDROME	0.02016327	2.0055445108246728
RERE-RELATED NEURODEVELOPMENTAL SYNDROME	0.020098239999999996	1.999076286199454
OPTIC ATROPHY-INTELLECTUAL DISABILITY SYNDROME	0.020098239999999996	1.999076286199454
RUBINSTEIN-TAYBI SYNDROME 1; RSTS1	0.020034839999999998	1.9927701899171406
NEUROFIBROMATOSIS TYPE 1	0.01976157	1.9655893234965127
RIDDLE SYNDROME	0.019650220000000003	1.9545138689060462
WILLIAMS SYNDROME	0.01954353	1.9439019223388527
CYCLIC VOMITING SYNDROME	0.019400630000000002	1.929688339393386
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 20	0.01934549	1.924203826002112
X-LINKED INTELLECTUAL DISABILITY-GLOBAL DEVELOPMENT DELAY-FACIAL DYSMORPHISM-SACRAL CAUDAL REMNANT SYNDROME	0.01934006	1.9236637297432322
MARFAN SYNDROME; MFS	0.01927705	1.917396424904927
VASCULAR EHLERS-DANLOS SYNDROME	0.019196400000000002	1.9093745532145707
CORNELIA DE LANGE SYNDROME 5; CDLS5	0.018688820000000002	1.8588879861644647
NEURODEVELOPMENTAL DISORDER WITH COARSE FACIES AND MILD DISTAL SKELETAL ABNORMALITIES; NEDCFSA	0.01853205	1.8432948203256903
TEMPLE SYNDROME	0.01846083	1.8362109058583973
FG SYNDROME TYPE 1	0.018428390000000003	1.8329842534388667
JACOBSEN SYNDROME	0.018428390000000003	1.8329842534388667
SCHAAF-YANG SYNDROME; SHFYNG	0.0184214	1.8322889914039555
TURNER SYNDROME DUE TO STRUCTURAL X CHROMOSOME ANOMALIES	0.01829148	1.819366467287265
TURNER SYNDROME	0.01829148	1.819366467287265
MONOSOMY X	0.01829148	1.819366467287265
MOSAIC MONOSOMY X	0.01829148	1.819366467287265
ADULT-ONSET CHRONIC PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL MYOPATHY	0.018278500000000003	1.8180754084584887
CINCA SYNDROME	0.01820728	1.8109914939911955
SHORT ULNA-DYSMORPHISM-HYPOTONIA-INTELLECTUAL DISABILITY SYNDROME	0.01818558	1.8088330982604983
HYPOGONADOTROPIC HYPOGONADISM-SEVERE MICROCEPHALY-SENSORINEURAL HEARING LOSS-DYSMORPHISM SYNDROME	0.01803995	1.7943479752069755
CHROMOSOME 1P36 DELETION SYNDROME	0.01803642	1.7939968629060836
CORNELIA DE LANGE SYNDROME 1	0.0176997	1.7605049269410893
CORNELIA DE LANGE SYNDROME 3	0.0176997	1.7605049269410893
TUMOR NECROSIS FACTOR RECEPTOR 1 ASSOCIATED PERIODIC SYNDROME	0.017507580000000002	1.7413956648313407
RHEUMATIC FEVER	0.017507580000000002	1.7413956648313407
DUPLICATION/INVERSION 15Q11	0.01739971	1.7306663492797132
NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE; NEDMIAL	0.01739971	1.7306663492797132
MENTAL RETARDATION, AUTOSOMAL DOMINANT 57; MRD57	0.01736924	1.7276356433850435
CREATINE DEFICIENCY SYNDROME, X-LINKED	0.01736924	1.7276356433850435
X-LINKED ADRENOLEUKODYSTROPHY	0.01729243	1.7199957182203036
CLEFT PALATE, PSYCHOMOTOR RETARDATION, AND DISTINCTIVE FACIAL FEATURES	0.0172811	1.7188687770392528
CEREBRAL ANGIOPATHY, DYSPHORIC	0.0172414	1.7149200069697286
GLUTATHIONE SYNTHETASE DEFICIENCY	0.0172414	1.7149200069697286
NOVELTY SEEKING PERSONALITY TRAIT	0.0172414	1.7149200069697286
CARDIAC ARRHYTHMIA	0.0172414	1.7149200069697286
DIASTEMATOMYELIA	0.0172414	1.7149200069697286
COCHLEOSACCULAR DEGENERATION OF THE INNER EAR WITH PROGRESSIVE CATARACTS	0.0172414	1.7149200069697286
ARTHROGRYPOSIS MULTIPLEX CONGENITA WITH WHISTLING FACE	0.0172414	1.7149200069697286
MOTION SICKNESS	0.0172414	1.7149200069697286
CONGENITAL TRACHEAL STENOSIS	0.0172414	1.7149200069697286
NEUROVISCERAL STORAGE DISEASE WITH CURVILINEAR BODIES	0.0172414	1.7149200069697286
MEDIAN-ULNAR NERVE COMMUNICATIONS	0.0172414	1.7149200069697286
SPASTIC PSEUDOSCLEROSIS	0.0172414	1.7149200069697286
600416 MUSCULAR DYSTROPHY, SCAPULOHUMERAL	0.0172414	1.7149200069697286
CEREBRAL SCLEROSIS SIMILAR TO PELIZAEUS-MERZBACHER DISEASE	0.0172414	1.7149200069697286
HYPEREOSINOPHILIC SYNDROME, IDIOPATHIC	0.0172414	1.7149200069697286
223300 DISSEMINATED SCLEROSIS WITH NARCOLEPSY	0.0172414	1.7149200069697286
601668 SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH ABNORMAL DENTITION; SEMDAD	0.0172414	1.7149200069697286
TRANSSEXUALITY	0.0172414	1.7149200069697286
DISCRIMINATION, TWO-POINT, REDUCTION IN	0.0172414	1.7149200069697286
MERALGIA PARAESTHETICA, FAMILIAL	0.0172414	1.7149200069697286
CERVICAL RIB	0.0172414	1.7149200069697286
269800 SENILE PLAQUE FORMATION	0.0172414	1.7149200069697286
%600511 SCHIZOPHRENIA 3; SCZD3;;SCHIZOPHRENIA SUSCEPTIBILITY LOCUS, CHROMOSOME 6-RELATED	0.0172414	1.7149200069697286
SPATIAL VISUALIZATION, APTITUDE FOR	0.0172414	1.7149200069697286
THUMBS, CONGENITAL CLASPED	0.0172414	1.7149200069697286
%160700 MYOPIA 2, AUTOSOMAL DOMINANT; MYP2	0.0172414	1.7149200069697286
PERONEAL NERVE, ACCESSORY DEEP	0.0172414	1.7149200069697286
TRICARBOXYLIC ACID CYCLE, DEFECT OF	0.0172414	1.7149200069697286
ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE	0.0172414	1.7149200069697286
ASPARAGUS, SPECIFIC SMELL HYPERSENSITIVITY	0.0172414	1.7149200069697286
TRICHORHINOPHALANGEAL SYNDROME, TYPE III; TRPS3	0.0172414	1.7149200069697286
JUMPING FRENCHMAN OF MAINE	0.0172414	1.7149200069697286
190400 TRIGEMINAL NEURALGIA;;TIC DOULOUREUX	0.0172414	1.7149200069697286
%609939 SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 6; SLEB6	0.0172414	1.7149200069697286
MOSAIC TRISOMY 15	0.0172414	1.7149200069697286
MODIFIER, X-LINKED, FOR NEUROFUNCTIONAL DEFECTS	0.0172414	1.7149200069697286
SICKLE CELL ANEMIA	0.0172414	1.7149200069697286
VESTIBULOCOCHLEAR DYSFUNCTION, PROGRESSIVE	0.0172414	1.7149200069697286
POLYCYSTIC LIVER DISEASE 1 WITH OR WITHOUT KIDNEY CYSTS; PCLD1	0.0172414	1.7149200069697286
COGNITIVE FUNCTION 1, SOCIAL	0.0172414	1.7149200069697286
INTRINSIC FACTOR AND R BINDER, COMBINED CONGENITAL DEFICIENCY OF	0.0172414	1.7149200069697286
ALCOHOL DEPENDENCE	0.0172414	1.7149200069697286
141405 HEMIFACIAL SPASM, FAMILIAL	0.0172414	1.7149200069697286
304950 DYGGVE-MELCHIOR-CLAUSEN SYNDROME, X-LINKED	0.0172414	1.7149200069697286
THROMBOPHILIA, HEREDITARY, DUE TO PROTEIN C DEFICIENCY, AUTOSOMALDOMINANT	0.0172414	1.7149200069697286
PALMOMENTAL REFLEX	0.0172414	1.7149200069697286
ANDROSTENONE, ABILITY TO SMELL	0.0172414	1.7149200069697286
GRANULOMAS, CONGENITAL CEREBRAL	0.0172414	1.7149200069697286
MYOPATHY, CONGENITAL	0.0172414	1.7149200069697286
RHEUMATOID ARTHRITIS	0.0172414	1.7149200069697286
206600 ANHIDROSIS, FAMILIAL GENERALIZED, WITH ABNORMAL OR ABSENT SWEAT GLANDS	0.0172414	1.7149200069697286
LICHTENSTEIN SYNDROME	0.01719646	1.7104500390371233
CARDIOFACIOCUTANEOUS SYNDROME 1; CFC1	0.017157190000000003	1.706544039021249
DIGEORGE SYNDROME; DGS	0.01681146	1.6721559212344306
MIDFACE HYPOPLASIA, HEARING IMPAIRMENT, ELLIPTOCYTOSIS, AND NEPHROCALCINOSIS; MFHIEN	0.016807910000000002	1.6718028196287178
KLEEFSTRA SYNDROME DUE TO 9Q34 MICRODELETION	0.01672332	1.66338905488864
ACHALASIA-MICROCEPHALY SYNDROME	0.01660466	1.651586509386127
AUTISM SPECTRUM DISORDER DUE TO AUTS2 DEFICIENCY	0.01659525	1.6506505414678845
SCLEROSTEOSIS 1; SOST1	0.01656418	1.6475601564285867
CHROMOSOME 15Q13.3 MICRODELETION SYNDROME	0.01650711	1.6418836751220938
NON-RHIZOMELIC CHONDRODYSPLASIA PUNCTATA	0.01649296	1.6404762419612937
KABUKI SYNDROME 1	0.016463409999999998	1.6375370440883859
RIN2 SYNDROME	0.016463409999999998	1.6375370440883859
INTELLECTUAL DISABILITY-SEIZURES-HYPOPHOSPHATASIA-OPHTHALMIC-SKELETAL ANOMALIES SYNDROME	0.01643286	1.634498380974432
HEMORRHAGIC FEVER-RENAL SYNDROME	0.01640529	1.631756124278795
MARFAN SYNDROME	0.01626695	1.6179961028324974
MITOCHONDRIAL DNA DEPLETION SYNDROME 7 (HEPATOCEREBRAL TYPE)	0.01625553	1.6168602097797529
MONOSOMY 18Q	0.01621665	1.612993001207886
JABERI-ELAHI SYNDROME; JABELS	0.01621665	1.612993001207886
FACIAL DYSMORPHISM-MACROCEPHALY-MYOPIA-DANDY-WALKER MALFORMATION SYNDROME	0.01597556	1.5890129262441168
ZIMMERMANN-LABAND SYNDROME 1	0.01597556	1.5890129262441168
XYLT1-CDG	0.01597556	1.5890129262441168
SILVER-RUSSELL SYNDROME	0.01588104	1.579611471660453
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND SPEECH AND WALKING IMPAIRMENT; NEDSSWI	0.01566483	1.5581060918939074
PRADER-WILLI SYNDROME	0.015606130000000001	1.5522674822445097
RAJAB INTERSTITIAL LUNG DISEASE WITH BRAIN CALCIFICATIONS; RILDBC	0.01551799	1.5435006158987192
BONE MARROW FAILURE SYNDROME 3; BMFS3	0.01548163	1.5398840597342882
COGNITIVE IMPAIRMENT-COARSE FACIES-HEART DEFECTS-OBESITY-PULMONARY INVOLVEMENT-SHORT STATURE-SKELETAL DYSPLASIA SYNDROME	0.01532316	1.5241218029857357
SPINOCEREBELLAR ATAXIA TYPE 36	0.015268400000000001	1.5186750863860592
RABIES	0.015268400000000001	1.5186750863860592
NORRIE DISEASE	0.015268400000000001	1.5186750863860592
ACROMEGALY	0.015180260000000001	1.509908220040269
SOMATOMAMMOTROPINOMA	0.015180260000000001	1.509908220040269
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 12; MGR12	0.015180260000000001	1.509908220040269
PDE4D HAPLOINSUFFICIENCY SYNDROME	0.015094090000000001	1.5013373002193389
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IL; CDG1L	0.014877880000000001	1.479831920452793
AHDC1-RELATED INTELLECTUAL DISABILITY-OBSTRUCTIVE SLEEP APNEA-MILD DYSMORPHISM SYNDROME	0.014877880000000001	1.479831920452793
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPES I AND III	0.01485497	1.47755317178043
BLEPHAROPHIMOSIS-PTOSIS-ESOTROPIA-SYNDACTYLY-SHORT STATURE SYNDROME	0.01484004	1.476068155731614
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME	0.01484004	1.476068155731614
1P21.3 MICRODELETION SYNDROME	0.01470872	1.463006380277459
15Q OVERGROWTH SYNDROME	0.01469879	1.4620186904338728
MENTAL RETARDATION, X-LINKED 21	0.01469879	1.4620186904338728
SMITH-LEMLI-OPITZ SYNDROME; SLOS	0.014688050000000001	1.4609504337450392
GLOBAL DEVELOPMENTAL DELAY-VISUAL ANOMALIES-PROGRESSIVE CEREBELLAR ATROPHY-TRUNCAL HYPOTONIA SYNDROME	0.01463376	1.4555504658086544
PRADER-WILLI-LIKE SYNDROME	0.014515150000000001	1.4437528935681936
%300861 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHUDLEY-SCHWARTZ TYPE; MRXSCS;;MENTAL RETARDATION, X-LINKED, WITH SEIZURES, HYPOGAMMAGLOBULINEMIA,AND GAIT DISTURBANCE	0.01449554	1.4418023801912825
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 35	0.01449554	1.4418023801912825
CLASSICAL-LIKE EHLERS-DANLOS SYNDROME TYPE 2	0.01449251	1.4415010005109132
COFFIN-SIRIS SYNDROME 6; CSS6	0.01445009	1.4372816849857437
EMANUEL SYNDROME	0.01444393	1.4366689791009006
49,XXXXY SYNDROME	0.014218310000000001	1.4142276314161124
ACROOSTEOLYSIS DOMINANT TYPE	0.01421094	1.4134945725896038
9P13 MICRODELETION SYNDROME	0.01393906	1.3864519628540293
MALIGNANT ATROPHIC PAPULOSIS	0.013936150000000001	1.386162519002586
VIRAL HEMORRHAGIC FEVER	0.013936150000000001	1.386162519002586
BEHÇET DISEASE	0.013936150000000001	1.386162519002586
KAWASAKI DISEASE	0.013936150000000001	1.386162519002586
IMMUNOGLOBULIN A VASCULITIS	0.013936150000000001	1.386162519002586
HYPERIMMUNOGLOBULINEMIA D WITH PERIODIC FEVER	0.013936150000000001	1.386162519002586
LEGIONELLOSIS	0.013936150000000001	1.386162519002586
PFAPA SYNDROME	0.013936150000000001	1.386162519002586
48,XXXY SYNDROME	0.01393128	1.385678123278692
48,XXYY SYNDROME	0.01393128	1.385678123278692
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 36; MRT36	0.013888760000000002	1.381448861229418
DISTAL 22Q11.2 MICRODELETION SYNDROME	0.01386784	1.3793680483867363
BLEPHAROPHIMOSIS WITH PTOSIS, SYNDACTYLY, AND SHORT STATURE	0.013850920000000001	1.377685096508239
KLEEFSTRA SYNDROME	0.01384314	1.3769112569329014
RADIOULNAR SYNOSTOSIS-MICROCEPHALY-SCOLIOSIS SYNDROME	0.0137797	1.370601182040946
NEURODEVELOPMENTAL DISORDER WITH MOVEMENT ABNORMALITIES, ABNORMAL GAIT, AND AUTISTIC FEATURES; NEDMAGA	0.013770150000000002	1.3696512889889574
IDIOPATHIC INTRACRANIAL HYPERTENSION	0.01371017	1.3636853638310207
KAGAMI-OGATA SYNDROME	0.013698930000000002	1.3625673745216642
INTELLECTUAL DISABILITY-CRANIOFACIAL DYSMORPHISM-CRYPTORCHIDISM SYNDROME	0.01362693	1.3554058771663555
HOLOPROSENCEPHALY	0.01362693	1.3554058771663555
CARDIOFACIOCUTANEOUS SYNDROME	0.01358576	1.3513108931924935
11Q22.2Q22.3 MICRODELETION SYNDROME	0.01356401	1.349147524199744
SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.01351573	1.3443453423620453
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, GENEVIEVE TYPE; SEMDG	0.01350642	1.3434193209679075
MUCOPOLYSACCHARIDOSIS TYPE IIIA	0.01350642	1.3434193209679075
ALAZAMI-YUAN SYNDROME	0.01350642	1.3434193209679075
MUCOPOLYSACCHARIDOSIS TYPE IIIB	0.01350642	1.3434193209679075
MUCOPOLYSACCHARIDOSIS-PLUS SYNDROME; MPSPS	0.01350642	1.3434193209679075
CEREBELLAR, OCULAR, CRANIOFACIAL, AND GENITAL SYNDROME; COFG	0.01350642	1.3434193209679075
CORNELIA DE LANGE SYNDROME 2; CDLS2	0.01350642	1.3434193209679075
TBCK-RELATED INTELLECTUAL DISABILITY SYNDROME	0.01350642	1.3434193209679075
AMAUROSIS CONGENITA, CONE-ROD TYPE, WITH CONGENITAL HYPERTRICHOSIS	0.01350642	1.3434193209679075
GLUTARYL-COA DEHYDROGENASE DEFICIENCY	0.013493960000000001	1.342179984064475
HYPERMOBILE EHLERS-DANLOS SYNDROME	0.013375350000000001	1.3303824118240142
AUTOSOMAL DOMINANT PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.013375350000000001	1.3303824118240142
TALL STATURE-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.0132287	1.3157958342246248
WAARDENBURG-SHAH SYNDROME	0.013080000000000001	1.3010053528810914
TYPHOID	0.01308	1.3010053528810912
GITELMAN SYNDROME	0.01308	1.3010053528810912
TURCOT SYNDROME WITH POLYPOSIS	0.01308	1.3010053528810912
MOWAT-WILSON SYNDROME; MOWS	0.01303513	1.2965423475153595
MENTAL RETARDATION, AUTOSOMAL DOMINANT 58; MRD58	0.01301249	1.2942904544580789
11P15.4 MICRODUPLICATION SYNDROME	0.01297263	1.2903257699499873
AXIAL MESODERMAL DYSPLASIA SPECTRUM	0.01296391	1.2894584330480665
TRISOMY X	0.01290521	1.2836198233986689
47,XYY SYNDROME	0.01290521	1.2836198233986689
LEGIUS SYNDROME	0.01290521	1.2836198233986689
MACROCEPHALY-INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER-SMALL THORAX SYNDROME	0.01285491	1.2786167217740574
ADIPOSIS DOLOROSA	0.01285402	1.2785281977095264
PROXIMAL 16P11.2 MICRODELETION SYNDROME	0.01282899	1.2760385827261462
12Q14 MICRODELETION SYNDROME	0.01281707	1.2748529570528784
TEMTAMY PREAXIAL BRACHYDACTYLY SYNDROME	0.01281707	1.2748529570528784
SAY-BARBER-MILLER SYNDROME	0.01280924	1.2740741442154886
19P13.12 MICRODELETION SYNDROME	0.01274085	1.2672717163803555
BRAIN MALFORMATIONS-MUSCULOSKELETAL ABNORMALITIES-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	0.012667860000000001	1.2600117484364115
X-LINKED INTELLECTUAL DISABILITY, BROOKS TYPE	0.012667860000000001	1.2600117484364115
MENTAL RETARDATION, X-LINKED, SYNDROMIC, TURNER TYPE; MRXST	0.012667860000000001	1.2600117484364115
%300612 BROOKS-WISNIEWSKI-BROWN SYNDROME;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, BROOKS-WISNIEWSKI-BROWN TYPE;MRXSBWB	0.012667860000000001	1.2600117484364115
STICKLER SYNDROME, TYPE II	0.01252661	1.2459622831386703
SAETHRE-CHOTZEN SYNDROME	0.012517180000000001	1.2450243259156069
PITT-HOPKINS SYNDROME	0.01249218	1.2425376948894582
SCHUURS-HOEIJMAKERS SYNDROME; SHMS	0.01240603	1.233968764373349
INTELLECTUAL DISABILITY-OBESITY-PROGNATHISM-EYE AND SKIN ANOMALIES SYNDROME	0.01238083	1.231462240298991
SPASTIC PARAPLEGIA, INTELLECTUAL DISABILITY, NYSTAGMUS, AND OBESITY; SINO	0.01238083	1.231462240298991
%606772 MENTAL RETARDATION, OBESITY, MANDIBULAR PROGNATHISM, AND EYE AND SKINANOMALIES;;MOMES SYNDROME	0.01238083	1.231462240298991
19P13.13 MICRODELETION SYNDROME	0.012309970000000002	1.2244141333184748
TEMPLE SYNDROME	0.01230961	1.224378325831698
CONGENITAL ANALBUMINEMIA	0.01230961	1.224378325831698
BECKWITH-WIEDEMANN SYNDROME	0.01230961	1.224378325831698
BRAIN SMALL VESSEL DISEASE 1 WITH OR WITHOUT OCULAR ANOMALIES; BSVD1	0.01227306	1.2207428712714685
MICROCEPHALY-FACIAL DYSMORPHISM-OCULAR ANOMALIES-MULTIPLE CONGENITAL ANOMALIES SYNDROME	0.01227306	1.2207428712714685
OVARIAN HYPERSTIMULATION SYNDROME	0.012262309999999998	1.2196736199302243
OVARIAN FIBROTHECOMA	0.012262309999999998	1.2196736199302243
GONADOBLASTOMA	0.012262309999999998	1.2196736199302243
134780 FEMORAL-FACIAL SYNDROME; FFS;;FEMORAL HYPOPLASIA-UNUSUAL FACIES SYNDROME; FHUFS	0.012164620000000001	1.209956860532445
UNILATERAL POLYMICROGYRIA	0.012164620000000001	1.209956860532445
PEROXISOME BIOGENESIS DISORDER 2B; PBD2B	0.012164620000000001	1.209956860532445
3-PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY, INFANTILE/JUVENILE FORM	0.012164620000000001	1.209956860532445
PSYCHOMOTOR DELAY DUE TO S-ADENOSYLHOMOCYSTEINE HYDROLASE DEFICIENCY	0.012164620000000001	1.209956860532445
ACITRETIN/ETRETINATE EMBRYOPATHY	0.0120934	1.2028729460651522
WITTEVEEN-KOLK SYNDROME	0.012083990000000001	1.2019369781469098
MIDFACE HYPOPLASIA, OBESITY, DEVELOPMENTAL DELAY, AND NEONATAL HYPOTONIA	0.012082	1.2017390423172283
ACRODYSOSTOSIS WITH MULTIPLE HORMONE RESISTANCE	0.012082	1.2017390423172283
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 2; IHPRF2	0.012046010000000001	1.1981592882919845
HYPOTONIA-SPEECH IMPAIRMENT-SEVERE COGNITIVE DELAY SYNDROME	0.012046010000000001	1.1981592882919845
DDOST-CDG	0.012046010000000001	1.1981592882919845
LUSCAN-LUMISH SYNDROME; LLS	0.01203633	1.1971964647586593
CLASSIC CONGENITAL ADRENAL HYPERPLASIA DUE TO 21-HYDROXYLASE DEFICIENCY	0.01203633	1.1971964647586593
POLYCYSTIC OVARY SYNDROME 1	0.01203633	1.1971964647586593
CORTISONE REDUCTASE DEFICIENCY 1; CORTRD1	0.01203633	1.1971964647586593
PITUITARY ADENOMA 4, ACTH-SECRETING; PITA4	0.01203633	1.1971964647586593
SLC35A2-CDG	0.01202337	1.195907395234704
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 1; DSMA1	0.01197479	1.1910753738246915
BARTTER SYNDROME, TYPE 1, ANTENATAL	0.01197479	1.1910753738246915
BARTTER SYNDROME, ANTENATAL, TYPE 2	0.01197479	1.1910753738246915
CEREBELLAR ATROPHY, VISUAL IMPAIRMENT, AND PSYCHOMOTOR RETARDATION; CAVIPMR	0.01193284	1.1869028069628136
TRICHOTHIODYSTROPHY	0.01193284	1.1869028069628136
PMM2-CDG	0.01193284	1.1869028069628136
TUBEROUS SCLEROSIS COMPLEX	0.01191609	1.1852367641752939
MARDEN-WALKER SYNDROME	0.01191609	1.1852367641752939
SPASTIC PARAPLEGIA TYPE 7	0.01191609	1.1852367641752939
DISTAL 7Q11.23 MICRODELETION SYNDROME	0.01191609	1.1852367641752939
TUBEROUS SCLEROSIS 2; TSC2	0.01191609	1.1852367641752939
NIEMANN-PICK DISEASE TYPE B	0.01191609	1.1852367641752939
TUBEROUS SCLEROSIS-1	0.01191609	1.1852367641752939
HYPERINSULINISM-HYPERAMMONEMIA SYNDROME	0.01191609	1.1852367641752939
EARLY-ONSET SCHIZOPHRENIA	0.01191609	1.1852367641752939
LOWE OCULOCEREBRORENAL SYNDROME	0.01190476	1.1841098229942433
CONGENITAL HYPOTONIA, EPILEPSY, DEVELOPMENTAL DELAY, AND DIGITAL ANOMALIES; CHEDDA	0.01190476	1.1841098229942433
CRANIOFACIAL DYSPLASIA-SHORT STATURE-ECTODERMAL ANOMALIES-INTELLECTUAL DISABILITY SYNDROME	0.011867780000000001	1.180431598380364
8P INVERTED DUPLICATION/DELETION SYNDROME	0.01182994	1.176667833659185
MENTAL RETARDATION, AUTOSOMAL DOMINANT 29; MRD29	0.01182994	1.176667833659185
EPISODIC ATAXIA TYPE 1	0.01182795	1.1764698978295034
MULTICENTRIC OSTEOLYSIS-NODULOSIS-ARTHROPATHY SPECTRUM	0.01182012	1.1756910849921136
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 1; CDGF1	0.01182012	1.1756910849921136
PLAA-ASSOCIATED NEURODEVELOPMENTAL DISORDER	0.01182012	1.1756910849921136
SHPRINTZEN-GOLDBERG CRANIOSYNOSTOSIS SYNDROME; SGS	0.01179159	1.1728533416650724
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIA	0.01179159	1.1728533416650724
HOLOPROSENCEPHALY 5; HPE5	0.011779640000000001	1.1716647320345732
SPASTIC TETRAPLEGIA-THIN CORPUS CALLOSUM-PROGRESSIVE POSTNATAL MICROCEPHALY SYNDROME	0.011779640000000001	1.1716647320345732
228560 FIBROMATOSIS, GINGIVAL, WITH DISTINCTIVE FACIES	0.011779640000000001	1.1716647320345732
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 4; CGL4	0.01170151	1.1638935127516528
HYPOTONIA, HYPERVENTILATION, IMPAIRED INTELLECTUAL DEVELOPMENT, DYSAUTONOMIA, EPILEPSY, AND EYE ABNORMALITIES; HIDEA	0.011670960000000001	1.160854849637699
DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL IMPAIRMENT AND BEHAVIORAL ABNORMALITIES; DDVIBA	0.011670960000000001	1.160854849637699
ALAGILLE SYNDROME 1; ALGS1	0.01163401	1.1571796089810509
DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM SYNDROME DUE TO MED13L DEFICIENCY	0.01163401	1.1571796089810509
GROWTH DELAY DUE TO INSULIN-LIKE GROWTH FACTOR TYPE 1 DEFICIENCY	0.01162366	1.1561501437362252
BOHRING-OPITZ SYNDROME	0.011588339999999999	1.1526370314224819
MALAN OVERGROWTH SYNDROME	0.011528060000000001	1.146641266692232
SHORT STATURE-BRACHYDACTYLY-OBESITY-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.01134698	1.1286301008436304
MYHRE SYNDROME	0.01134698	1.1286301008436304
JOUBERT SYNDROME 2	0.011187840000000001	1.1128012023835772
MOEBIUS SYNDROME; MBS	0.011187840000000001	1.1128012023835772
XIA-GIBBS SYNDROME	0.011187840000000001	1.1128012023835772
MULTIPLE JOINT DISLOCATIONS, SHORT STATURE, AND CRANIOFACIAL DYSMORPHISM WITH OR WITHOUT CONGENITAL HEART DEFECTS	0.011187840000000001	1.1128012023835772
COSTELLO SYNDROME; CSTLO	0.01111662	1.1057172879162842
GAUCHER DISEASE, PERINATAL LETHAL	0.01111662	1.1057172879162842
FIBULO-ULNAR HYPOPLASIA-RENAL ANOMALIES SYNDROME	0.01111662	1.1057172879162842
X-LINKED NON-SYNDROMIC INTELLECTUAL DISABILITY	0.01109487	1.1035539189235346
2Q37 MICRODELETION SYNDROME	0.01109487	1.1035539189235346
OKAMOTO SYNDROME	0.01104659	1.098751737085836
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IB	0.01104659	1.098751737085836
CRANIOFACIOFRONTODIGITAL SYNDROME	0.01104659	1.098751737085836
NOONAN SYNDROME-LIKE DISORDER WITH OR WITHOUT JUVENILE MYELOMONOCYTIC LEUKEMIA	0.01104659	1.098751737085836
GAPO SYNDROME; GAPOS	0.01104659	1.098751737085836
NOONAN SYNDROME 7; NS7	0.01104659	1.098751737085836
PARTIAL DELETION OF THE SHORT ARM OF CHROMOSOME 7	0.01100673	1.0947870525777441
HYPEREKPLEXIA 2; HKPX2	0.01094372	1.0885197477394386
OCULAR ANOMALIES-AXONAL NEUROPATHY-DEVELOPMENTAL DELAY SYNDROME	0.01094372	1.0885197477394386
HAREL-YOON SYNDROME; HAYOS	0.01094372	1.0885197477394386
PONTOCEREBELLAR HYPOPLASIA, TYPE 8	0.01094372	1.0885197477394386
INTELLECTUAL DISABILITY-CARDIAC ANOMALIES-SHORT STATURE-JOINT LAXITY SYNDROME	0.01094372	1.0885197477394386
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 35; COXPD35	0.01094372	1.0885197477394386
HERMANSKY-PUDLAK SYNDROME 8; HPS8	0.01094372	1.0885197477394386
PROGRESSIVE BIFOCAL CHORIORETINAL ATROPHY	0.01094372	1.0885197477394386
MENTAL RETARDATION, X-LINKED, SYNDROMIC, 35; MRXS35	0.0108725	1.0814358332721457
HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME	0.01084334	1.0785354268432457
FRONTOMETAPHYSEAL DYSPLASIA 2; FMD2	0.01084334	1.0785354268432457
STOCCO DOS SANTOS X-LINKED MENTAL RETARDATION SYNDROME; SDSX	0.01084334	1.0785354268432457
MENTAL RETARDATION, AUTOSOMAL DOMINANT 44; MRD44	0.010840820000000001	1.07828477443581
GLOBAL DEVELOPMENTAL DELAY-OSTEOPENIA-ECTODERMAL DEFECT SYNDROME	0.010840820000000001	1.07828477443581
17Q21.31 MICRODUPLICATION SYNDROME	0.010840820000000001	1.07828477443581
COHEN SYNDROME	0.01080247	1.0744702824416974
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME DUE TO FKBP22 DEFICIENCY	0.01080247	1.0744702824416974
BRITTLE CORNEA SYNDROME 2; BCS2	0.01080247	1.0744702824416974
RETINOPATHY, PIGMENTARY, AND MENTAL RETARDATION	0.01080247	1.0744702824416974
AORTIC ANEURYSM, FAMILIAL THORACIC 10; AAT10	0.01080247	1.0744702824416974
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIA; ARCL2A	0.01080247	1.0744702824416974
CROUZON SYNDROME-ACANTHOSIS NIGRICANS SYNDROME	0.01079304	1.0735323252186342
ANEURYSM-OSTEOARTHRITIS SYNDROME	0.01079304	1.0735323252186342
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 1; EDSMC1	0.01071973	1.0662405283975551
DUBOWITZ SYNDROME	0.010646880000000001	1.0589944855873574
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA-SPONDYLO-EPIPHYSEAL DYSPLASIA SYNDROME	0.01059922	1.0542539721991069
GASTROCUTANEOUS SYNDROME	0.01055874	1.0502276192415667
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC DEFECTS AND DYSMORPHIC FACIES; IDDCDF	0.01055874	1.0502276192415667
JUVENILE POLYPOSIS OF INFANCY	0.01053553	1.0479190309968902
JUVENILE POLYPOSIS SYNDROME	0.01053553	1.0479190309968902
NON-DISTAL MONOSOMY 20Q	0.01035985	1.030444977449937
MENTAL RETARDATION, X-LINKED, SYNDROMIC 11; MRXS11	0.01035786	1.0302470416202554
MENTAL RETARDATION, AUTOSOMAL DOMINANT 49; MRD49	0.01030955	1.0254418758253254
MICROTRIPLICATION 11Q24.1	0.01027171	1.0216781111041464
KLEEFSTRA SYNDROME	0.01027171	1.0216781111041464
INTELLECTUAL DISABILITY-OBESITY-BRAIN MALFORMATIONS-FACIAL DYSMORPHISM SYNDROME	0.01027171	1.0216781111041464
FACIAL PARESIS, HEREDITARY CONGENITAL, 3; HCFP3	0.010198720000000001	1.0144181431602022
CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA; CAGSSS	0.010198720000000001	1.0144181431602022
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 3; MCAHS3	0.010198720000000001	1.0144181431602022
RADIAL RAY HYPOPLASIA WITH CHOANAL ATRESIA	0.010198720000000001	1.0144181431602022
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IA; CDG1A	0.010198720000000001	1.0144181431602022
MENTAL RETARDATION-HYPOTONIC FACIES SYNDROME, X-LINKED, 1; MRXHF1	0.01019094	1.0136443035848648
XP22.13P22.2 DUPLICATION SYNDROME	0.01014364	1.008939597683391
WILSON-TURNER SYNDROME	0.01014165	1.0087416618537095
RETINITIS PIGMENTOSA-JUVENILE CATARACT-SHORT STATURE-INTELLECTUAL DISABILITY SYNDROME	0.01014165	1.0087416618537095
SHPRINTZEN OMPHALOCELE SYNDROME	0.01014165	1.0087416618537095
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2Z	0.01014165	1.0087416618537095
MICROPHTHALMIA WITH LINEAR SKIN DEFECTS SYNDROME	0.01014165	1.0087416618537095
THOC6-RELATED DEVELOPMENTAL DELAY-MICROCEPHALY-FACIAL DYSMORPHISM SYNDROME	0.01014165	1.0087416618537095
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY AND INTELLECTUAL DISABILITY DUE TO GRIN2A MUTATION	0.01014165	1.0087416618537095
MILROY DISEASE	0.01014165	1.0087416618537095
GMS SYNDROME	0.010127500000000001	1.0073342286929092
KAGAMI-OGATA SYNDROME	0.010127500000000001	1.0073342286929092
BLOMSTRAND LETHAL CHONDRODYSPLASIA	0.010127500000000001	1.0073342286929092
ZELLWEGER SYNDROME	0.010127500000000001	1.0073342286929092
ATELOSTEOGENESIS, TYPE I; AO1	0.010127500000000001	1.0073342286929092
CHROMOSOME 16P13.3 DELETION SYNDROME	0.01006543	1.0011604211811866
ZTTK SYNDROME; ZTTKS	0.01005747	1.000368677862461
INTELLECTUAL DISABILITY-FEEDING DIFFICULTIES-DEVELOPMENTAL DELAY-MICROCEPHALY SYNDROME	0.0100555	1.0001727313376003
MACROTHROMBOCYTOPENIA-LYMPHEDEMA-DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM-CAMPTODACTYLY SYNDROME	0.0100555	1.0001727313376003
CROUZON DISEASE	0.0100555	1.0001727313376003
MCDONOUGH SYNDROME	0.0100555	1.0001727313376003
TAKENOUCHI-KOSAKI SYNDROME; TKS	0.0100555	1.0001727313376003
INTELLECTUAL DISABILITY-SEVERE SPEECH DELAY-MILD DYSMORPHISM SYNDROME	0.01002503	0.9971420254429302
RUBINSTEIN-TAYBI SYNDROME	0.01002503	0.9971420254429302
ANGELMAN SYNDROME	0.00994682	0.9893628489407261
WIEDEMANN-STEINER SYNDROME; WDSTS	0.00993689	0.9883751590971398
ARTERIAL TORTUOSITY SYNDROME	0.00990987	0.985687608284078
TETRASOMY 9P	0.00990987	0.985687608284078
MUCOPOLYSACCHARIDOSIS, TYPE VI; MPS6	0.00985422	0.9801523676198706
COFFIN-SIRIS SYNDROME 4; CSS4	0.00985422	0.9801523676198706
X-LINKED INTELLECTUAL DISABILITY, STOCCO DOS SANTOS TYPE	0.00985422	0.9801523676198706
HURLER SYNDROME	0.00985422	0.9801523676198706
HURLER-SCHEIE SYNDROME	0.00985422	0.9801523676198706
COFFIN-SIRIS SYNDROME 3; CSS3	0.00985422	0.9801523676198706
VON HIPPEL-LINDAU DISEASE	0.00980392	0.9751492659952591
EPISODIC ATAXIA TYPE 7	0.00980392	0.9751492659952591
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 5; IBGC5	0.00980392	0.9751492659952591
EPISODIC ATAXIA TYPE 6	0.00980392	0.9751492659952591
PHACE ASSOCIATION	0.00980392	0.9751492659952591
BERNARD-SOULIER SYNDROME	0.00980392	0.9751492659952591
FAMILIAL CERVICAL ARTERY DISSECTION	0.00980392	0.9751492659952591
GLUT1 DEFICIENCY SYNDROME 2; GLUT1DS2	0.00980392	0.9751492659952591
BENIGN FAMILIAL INFANTILE EPILEPSY	0.00980392	0.9751492659952591
PULMONARY ARTERIOVENOUS MALFORMATION	0.00980392	0.9751492659952591
CLASSIC HODGKIN LYMPHOMA	0.00980392	0.9751492659952591
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 7, AUTOSOMAL RECESSIVE; IBGC7	0.00980392	0.9751492659952591
SENSORY ATAXIC NEUROPATHY, DYSARTHRIA, AND OPHTHALMOPARESIS; SANDO	0.00980392	0.9751492659952591
ALPHA-METHYLACYL-COA RACEMASE DEFICIENCY; AMACRD	0.00980392	0.9751492659952591
CADASIL	0.00980392	0.9751492659952591
PERIODIC FEVER, MENSTRUAL CYCLE-DEPENDENT	0.00980392	0.9751492659952591
SNEDDON SYNDROME	0.00980392	0.9751492659952591
BLACKFAN-DIAMOND ANEMIA	0.00980392	0.9751492659952591
MITOCHONDRIAL MYOPATHY, ENCEPHALOPATHY, LACTIC ACIDOSIS, AND STROKE-LIKE EPISODES; MELAS	0.00980392	0.9751492659952591
GLYCOGEN STORAGE DISEASE DUE TO PHOSPHOGLYCERATE KINASE 1 DEFICIENCY	0.00980392	0.9751492659952591
STORMORKEN SYNDROME; STRMK	0.00980392	0.9751492659952591
FAMILIAL PAROXYSMAL ATAXIA	0.00980392	0.9751492659952591
HEREDITARY HEMORRHAGIC TELANGIECTASIA	0.00980392	0.9751492659952591
SYSTEMIC SCLEROSIS	0.00980392	0.9751492659952591
TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 4; HHT4	0.00980392	0.9751492659952591
ANGIOMATOSIS, DIFFUSE CORTICOMENINGEAL, OF DIVRY AND VAN BOGAERT	0.00980392	0.9751492659952591
AUTOSOMAL DOMINANT OPTIC ATROPHY, CLASSIC FORM	0.00980392	0.9751492659952591
PAROXYSMAL NONKINESIGENIC DYSKINESIA 2	0.00980392	0.9751492659952591
COMBINED MALONIC AND METHYLMALONIC ACIDEMIA	0.00980392	0.9751492659952591
ABETAL34V AMYLOIDOSIS	0.00980392	0.9751492659952591
WALDENSTRÖM MACROGLOBULINEMIA	0.00980392	0.9751492659952591
EPISODIC ATAXIA, TYPE 2	0.00980392	0.9751492659952591
PEROXISOME BIOGENESIS DISORDER 14B	0.00980392	0.9751492659952591
NEUROFIBROMATOSIS TYPE 2	0.00980392	0.9751492659952591
HARTNUP DISEASE	0.00980392	0.9751492659952591
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 4; IBGC4	0.00980392	0.9751492659952591
ABETA AMYLOIDOSIS, ITALIAN TYPE	0.00980392	0.9751492659952591
SENSORY ATAXIC NEUROPATHY-DYSARTHRIA-OPHTHALMOPARESIS SYNDROME	0.00980392	0.9751492659952591
KERION CELSI	0.00980392	0.9751492659952591
INFANTILE CONVULSIONS AND CHOREOATHETOSIS	0.00980392	0.9751492659952591
TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 2; HHT2	0.00980392	0.9751492659952591
ARACHNOIDITIS	0.00980392	0.9751492659952591
BENIGN PAROXYSMAL TORTICOLLIS OF INFANCY	0.00980392	0.9751492659952591
EPISODIC ATAXIA, TYPE 6	0.00980392	0.9751492659952591
EPISODIC ATAXIA WITH SLURRED SPEECH	0.00980392	0.9751492659952591
PAROXYSMAL KINESIGENIC DYSKINESIA	0.00980392	0.9751492659952591
CITRULLINEMIA TYPE I	0.00980392	0.9751492659952591
RETINAL VASCULOPATHY WITH CEREBRAL LEUKOENCEPHALOPATHY AND SYSTEMIC MANIFESTATIONS	0.00980392	0.9751492659952591
VASCULOPATHY, RETINAL, WITH CEREBRAL LEUKODYSTROPHY; RVCL	0.00980392	0.9751492659952591
DEAFNESS-LYMPHEDEMA-LEUKEMIA SYNDROME	0.00980392	0.9751492659952591
HEMIFACIAL ATROPHY, PROGRESSIVE; HFA	0.00980392	0.9751492659952591
TAKAYASU ARTERITIS	0.00980392	0.9751492659952591
ATYPICAL TERATOID RHABDOID TUMOR	0.00980392	0.9751492659952591
MICROCEPHALY WITH OR WITHOUT CHORIORETINOPATHY, LYMPHEDEMA, OR MENTAL RETARDATION; MCLMR	0.00965776	0.9606114263639822
CHOREOACANTHOCYTOSIS	0.00959671	0.9545390733981267
MENTAL RETARDATION, AUTOSOMAL DOMINANT 23; MRD23	0.009569620000000001	0.9518445600181918
BLEPHAROPHIMOSIS-EPICANTHUS INVERSUS-PTOSIS SYNDROME	0.009569620000000001	0.9518445600181918
CUTANEOUS MASTOCYTOMA	0.009508570000000001	0.9457722070523363
EBOLA HEMORRHAGIC FEVER	0.009508570000000001	0.9457722070523363
THROMBOTIC THROMBOCYTOPENIC PURPURA	0.009508570000000001	0.9457722070523363
PEDIATRIC SYSTEMIC LUPUS ERYTHEMATOSUS	0.009508570000000001	0.9457722070523363
ACQUIRED METHEMOGLOBINEMIA	0.009508570000000001	0.9457722070523363
POLYARTERITIS NODOSA, CHILDHOOD-ONSET	0.009508570000000001	0.9457722070523363
AUTOIMMUNE HEMOLYTIC ANEMIA	0.009508570000000001	0.9457722070523363
SYSTEMIC MASTOCYTOSIS	0.009508570000000001	0.9457722070523363
INDOLENT SYSTEMIC MASTOCYTOSIS	0.009508570000000001	0.9457722070523363
HELLP SYNDROME	0.009508570000000001	0.9457722070523363
CUSHING DISEASE	0.009508570000000001	0.9457722070523363
LASSA FEVER	0.009508570000000001	0.9457722070523363
CARNEY TRIAD	0.009508570000000001	0.9457722070523363
POLYCYTHEMIA VERA	0.009508570000000001	0.9457722070523363
GRANULOMATOSIS WITH POLYANGIITIS	0.009508570000000001	0.9457722070523363
RHABDOID TUMOR	0.009508570000000001	0.9457722070523363
GIANT CELL ARTERITIS	0.009508570000000001	0.9457722070523363
PLAGUE	0.009508570000000001	0.9457722070523363
PRIMARY FAMILIAL POLYCYTHEMIA	0.009508570000000001	0.9457722070523363
CUTANEOUS MASTOCYTOSIS	0.009508570000000001	0.9457722070523363
MARBURG HEMORRHAGIC FEVER	0.009508570000000001	0.9457722070523363
CRIMEAN-CONGO HEMORRHAGIC FEVER	0.009508570000000001	0.9457722070523363
PREECLAMPSIA	0.009508570000000001	0.9457722070523363
HYPER-IGD SYNDROME	0.009508570000000001	0.9457722070523363
DENGUE FEVER	0.009508570000000001	0.9457722070523363
YELLOW FEVER	0.009508570000000001	0.9457722070523363
PERINEURAL CYST	0.009508570000000001	0.9457722070523363
FAMILIAL COLD URTICARIA	0.009508570000000001	0.9457722070523363
RELAPSING FEVER	0.009508570000000001	0.9457722070523363
AMERICAN TRYPANOSOMIASIS	0.009508570000000001	0.9457722070523363
FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 2; FCAS2	0.009508570000000001	0.9457722070523363
LEPTOSPIROSIS	0.009508570000000001	0.9457722070523363
SCRUB TYPHUS	0.009508570000000001	0.9457722070523363
OROFACIODIGITAL SYNDROME VI	0.0094637	0.9413092016866043
XP21 MICRODELETION SYNDROME	0.0094637	0.9413092016866043
PYCR2-RELATED MICROCEPHALY-PROGRESSIVE LEUKOENCEPHALOPATHY	0.0094637	0.9413092016866043
CRANIOLENTICULOSUTURAL DYSPLASIA	0.0094637	0.9413092016866043
AUTOSOMAL RECESSIVE FRONTOTEMPORAL PACHYGYRIA	0.0094637	0.9413092016866043
MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 9; MCOPCB9	0.0094637	0.9413092016866043
PACHYGYRIA, FRONTOTEMPORAL	0.0094637	0.9413092016866043
OROFACIODIGITAL SYNDROME TYPE 6	0.0094637	0.9413092016866043
HYPERPHOSPHATASIA-INTELLECTUAL DISABILITY SYNDROME	0.0094637	0.9413092016866043
DIAMOND-BLACKFAN ANEMIA 1	0.00939248	0.9342252872193113
GALLOWAY-MOWAT SYNDROME	0.00939248	0.9342252872193113
YUNIS-VARON SYNDROME	0.00939248	0.9342252872193113
RESTRICTIVE DERMOPATHY, LETHAL	0.00939248	0.9342252872193113
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 1; SMABF1	0.00939248	0.9342252872193113
DISTAL MONOSOMY 17Q	0.00939248	0.9342252872193113
HOLOPROSENCEPHALY-CAUDAL DYSGENESIS SYNDROME	0.00939248	0.9342252872193113
ROBERTS SYNDROME	0.00939248	0.9342252872193113
FETAL AKINESIA DEFORMATION SEQUENCE; FADS	0.00939248	0.9342252872193113
POLYHYDRAMNIOS, MEGALENCEPHALY, AND SYMPTOMATIC EPILEPSY; PMSE	0.00939248	0.9342252872193113
INTERMEDIATE NEMALINE MYOPATHY	0.00939248	0.9342252872193113
VELO-FACIAL-SKELETAL SYNDROME	0.00939248	0.9342252872193113
KNIEST-LIKE DYSPLASIA, LETHAL	0.00939248	0.9342252872193113
RENAL TUBULAR DYSGENESIS	0.00939248	0.9342252872193113
8P23.1 MICRODELETION SYNDROME	0.00937073	0.9320619182265619
OBESITY DUE TO SIM1 DEFICIENCY	0.00937073	0.9320619182265619
IMMUNODEFICIENCY 61; IMD61	0.00937073	0.9320619182265619
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIB; ARCL2B	0.00932245	0.9272597363888632
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 2; NSLH2	0.00932245	0.9272597363888632
HYPER-IGE RECURRENT INFECTION SYNDROME, AUTOSOMAL DOMINANT	0.00932245	0.9272597363888632
601450 DISLOCATION OF HIP, CONGENITAL, WITH HYPEREXTENSIBILITY OF FINGERSAND FACIAL DYSMORPHISM;;HIP, CONGENITAL DISLOCATION OF, WITH HYPEREXTENSIBILITY OF FINGERSAND FACIAL DYSMORPHISM	0.00932245	0.9272597363888632
3MC SYNDROME 2	0.00932245	0.9272597363888632
LOEYS-DIETZ SYNDROME 5	0.00932245	0.9272597363888632
CONGENITAL HEART DEFECTS, DYSMORPHIC FACIAL FEATURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER; CHDFIDD	0.00932245	0.9272597363888632
LATERAL MENINGOCELE SYNDROME	0.00932245	0.9272597363888632
MEESTER-LOEYS SYNDROME; MRLS	0.00932245	0.9272597363888632
MAN1B1-CDG	0.00932245	0.9272597363888632
ZIMMERMANN-LABAND SYNDROME	0.00932245	0.9272597363888632
MICROCEPHALY-CORPUS CALLOSUM HYPOPLASIA-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.00932245	0.9272597363888632
MENTAL RETARDATION, AUTOSOMAL DOMINANT 36; MRD36	0.00932245	0.9272597363888632
PHELAN-MCDERMID SYNDROME	0.00932245	0.9272597363888632
X-LINKED INTELLECTUAL DISABILITY, CABEZAS TYPE	0.00928259	0.9232950518807714
MENTAL RETARDATION, X-LINKED 97; MRX97	0.00928259	0.9232950518807714
SECONDARY POLYCYTHEMIA	0.00928259	0.9232950518807714
FAMILIAL PRIMARY HYPOMAGNESEMIA WITH NORMOCALCIURIA AND NORMOCALCEMIA	0.00928259	0.9232950518807714
CRANIOPHARYNGIOMA	0.00928259	0.9232950518807714
MENINGIOMA	0.00928259	0.9232950518807714
MÜLLERIAN APLASIA AND HYPERANDROGENISM	0.00928259	0.9232950518807714
1P36 DELETION SYNDROME	0.00920182	0.9152612443614896
CHROMOSOME 6PTER-P24 DELETION SYNDROME	0.00916487	0.9115860037048417
AUTOSOMAL DOMINANT ROBINOW SYNDROME	0.00916487	0.9115860037048417
NEUROFIBROMATOSIS-NOONAN SYNDROME; NFNS	0.00916487	0.9115860037048417
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 66; MRT66	0.00915452	0.9105565384600158
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.0091192	0.9070434261462726
SPINOCEREBELLAR ATAXIA 42, EARLY-ONSET, SEVERE, WITH NEURODEVELOPMENTAL DEFICITS; SCA42ND	0.0091192	0.9070434261462726
LEIGH SYNDROME, FRENCH CANADIAN TYPE; LSFC	0.0091192	0.9070434261462726
MULTICENTRIC OSTEOLYSIS, NODULOSIS, AND ARTHROPATHY; MONA	0.0091192	0.9070434261462726
BENT BONE DYSPLASIA SYNDROME; BBDS	0.0091192	0.9070434261462726
IMMUNODEFICIENCY 49; IMD49	0.0091192	0.9070434261462726
HIRSUTISM, SKELETAL DYSPLASIA, AND MENTAL RETARDATION	0.0091192	0.9070434261462726
FRONTOMETAPHYSEAL DYSPLASIA	0.0091192	0.9070434261462726
FGFR2-RELATED BENT BONE DYSPLASIA	0.0091192	0.9070434261462726
PALLISTER-KILLIAN SYNDROME	0.00908865	0.9040047630323188
HYDROCEPHALUS-COSTOVERTEBRAL DYSPLASIA-SPRENGEL ANOMALY SYNDROME	0.00908865	0.9040047630323188
ECTODERMAL DYSPLASIA WITH MENTAL RETARDATION AND SYNDACTYLY	0.00906638	0.9017896721142254
EPILEPSY-TELANGIECTASIA	0.00906638	0.9017896721142254
WAARDENBURG SYNDROME	0.00906638	0.9017896721142254
STAG1-RELATED INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-GASTROESOPHAGEAL REFLUX SYNDROME	0.00906638	0.9017896721142254
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 68; MRT68	0.00906638	0.9017896721142254
SEVERE INTELLECTUAL DISABILITY-SHORT STATURE-BEHAVIORAL ABNORMALITIES-FACIAL DYSMORPHISM SYNDROME	0.00906638	0.9017896721142254
INTELLECTUAL DEVELOPMENTAL DISORDER WITH GASTROINTESTINAL DIFFICULTIES AND HIGH PAIN THRESHOLD	0.00903591	0.8987589662195551
OCULOCEREBRORENAL SYNDROME OF LOWE	0.00903591	0.8987589662195551
AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	0.00894777	0.8899920998737648
2Q23.1 MICRODELETION SYNDROME	0.00894777	0.8899920998737648
SMITH-MAGENIS SYNDROME; SMS	0.00894777	0.8899920998737648
SACRAL DEFECT WITH ANTERIOR MENINGOCELE	0.00894777	0.8899920998737648
CHROMOSOME 3Q13.31 DELETION SYNDROME	0.00892274	0.8875024848903845
SCHWARTZ-JAMPEL SYNDROME	0.00892274	0.8875024848903845
ICHTHYOSIS FOLLICULARIS-ALOPECIA-PHOTOPHOBIA SYNDROME	0.00892075	0.887304549060703
NEUROECTODERMAL MELANOLYSOSOMAL DISEASE	0.00892075	0.887304549060703
MICROCEPHALY-LYMPHEDEMA-CHORIORETINOPATHY SYNDROME	0.00892075	0.887304549060703
OCULOCEREBROFACIAL SYNDROME, KAUFMAN TYPE	0.00892075	0.887304549060703
5Q35 MICRODUPLICATION SYNDROME	0.00892075	0.887304549060703
OPHTHALMOPLEGIA-INTELLECTUAL DISABILITY-LINGUA SCROTALIS SYNDROME	0.00892075	0.887304549060703
17Q24.2 MICRODELETION SYNDROME	0.0088346	0.8787356185445939
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 66; EIEE66	0.0088346	0.8787356185445939
FOUNTAIN SYNDROME	0.0088346	0.8787356185445939
BOHRING-OPITZ SYNDROME	0.0088346	0.8787356185445939
KAUFMAN OCULOCEREBROFACIAL SYNDROME; KOS	0.00875383	0.8707018110253123
6Q TERMINAL DELETION SYNDROME	0.00858541	0.8539498751283524
MONOSOMY 13Q34	0.00858541	0.8539498751283524
PONTOCEREBELLAR HYPOPLASIA, TYPE 11; PCH11	0.00847458	0.8429261424632293
CONGENITAL MYASTHENIC SYNDROME	0.00847458	0.8429261424632293
MICROCEPHALY-SEIZURES-INTELLECTUAL DISABILITY-HEART DISEASE SYNDROME	0.00847458	0.8429261424632293
MENTAL RETARDATION, ANTERIOR MAXILLARY PROTRUSION, AND STRABISMUS; MRAMS	0.00847458	0.8429261424632293
BILATERAL POLYMICROGYRIA	0.00847458	0.8429261424632293
PRESYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.00847458	0.8429261424632293
X-LINKED INTELLECTUAL DISABILITY, CANTAGREL TYPE	0.00847458	0.8429261424632293
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 72; EIEE72	0.00847458	0.8429261424632293
MENTAL RETARDATION, X-LINKED 98; MRX98	0.00847458	0.8429261424632293
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-PYRAMIDAL SIGNS-NYSTAGMUS-OCULOMOTOR APRAXIA SYNDROME	0.00847458	0.8429261424632293
INTELLECTUAL DEVELOPMENTAL DISORDER WITH OR WITHOUT EPILEPSY OR CEREBELLAR ATAXIA; IDDECA	0.00847458	0.8429261424632293
SPINOCEREBELLAR ATAXIA, X-LINKED 3	0.00847458	0.8429261424632293
108450 ASYMMETRIC SHORT STATURE SYNDROME	0.00847458	0.8429261424632293
X-LINKED SPINOCEREBELLAR ATAXIA TYPE 3	0.00847458	0.8429261424632293
MICROPHTHALMIA, SYNDROMIC 13; MCOPS13	0.00847458	0.8429261424632293
X-LINKED ENDOTHELIAL CORNEAL DYSTROPHY	0.00847458	0.8429261424632293
FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 1; CFEOM1	0.00847458	0.8429261424632293
CORTICAL DYSGENESIS WITH PONTOCEREBELLAR HYPOPLASIA DUE TO TUBB3 MUTATION	0.00847458	0.8429261424632293
DUANE RETRACTION SYNDROME 1	0.00847458	0.8429261424632293
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 18	0.00847458	0.8429261424632293
GALLOWAY-MOWAT SYNDROME 2, X-LINKED; GAMOS2	0.00847458	0.8429261424632293
AUTOSOMAL RECESSIVE CONGENITAL CEREBELLAR ATAXIA DUE TO MGLUR1 DEFICIENCY	0.00847458	0.8429261424632293
MUCOEPITHELIAL DYSPLASIA, HEREDITARY	0.00847458	0.8429261424632293
RICHIERI COSTA-DA SILVA SYNDROME	0.00847458	0.8429261424632293
HEREDITARY METHEMOGLOBINEMIA	0.00847458	0.8429261424632293
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 13	0.00847458	0.8429261424632293
GAUCHER DISEASE, TYPE II	0.00847458	0.8429261424632293
ADAMS-OLIVER SYNDROME 1; AOS1	0.00847458	0.8429261424632293
ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC, WITH MYELIN DEFECT	0.00847458	0.8429261424632293
PIGMENTED PARAVENOUS CHORIORETINAL ATROPHY	0.00847458	0.8429261424632293
GENERALIZED EPILEPSY-PAROXYSMAL DYSKINESIA SYNDROME	0.00847458	0.8429261424632293
TRICHOTHIODYSTROPHY 6, NONPHOTOSENSITIVE; TTD6	0.00847458	0.8429261424632293
CRANIOFACIAL DYSSYNOSTOSIS WITH SHORT STATURE	0.00847458	0.8429261424632293
INFANTILE HYPOTONIA-OCULOMOTOR ANOMALIES-HYPERKINETIC MOVEMENTS-DEVELOPMENTAL DELAY SYNDROME	0.00847458	0.8429261424632293
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 42; EIEE42	0.00847458	0.8429261424632293
COLOBOMA, OCULAR, AUTOSOMAL RECESSIVE	0.00847458	0.8429261424632293
NEURODEVELOPMENTAL DISORDER WITH REGRESSION, ABNORMAL MOVEMENTS, LOSS OF SPEECH, AND SEIZURES; NEDAMSS	0.00847458	0.8429261424632293
RICHIERI-COSTA/GUION-ALMEIDA SYNDROME	0.00847458	0.8429261424632293
POLYMICROGYRIA, BILATERAL FRONTOPARIETAL	0.00847458	0.8429261424632293
CONGENITAL MUSCULAR DYSTROPHY, ULLRICH TYPE	0.00847458	0.8429261424632293
BLINDNESS-SCOLIOSIS-ARACHNODACTYLY SYNDROME	0.00847458	0.8429261424632293
PONTOCEREBELLAR HYPOPLASIA, TYPE 10; PCH10	0.00847458	0.8429261424632293
CHROMOSOME 5Q12 DELETION SYNDROME	0.00847458	0.8429261424632293
RING CHROMOSOME 7 SYNDROME	0.00847458	0.8429261424632293
INTELLECTUAL DISABILITY-SEIZURES-MACROCEPHALY-OBESITY SYNDROME	0.0084668	0.8421523028878917
ICHTHYOSIS-PREMATURITY SYNDROME	0.00840336	0.8358422279959363
LEUKODYSTROPHY, HYPOMYELINATING, 3; HLD3	0.00840336	0.8358422279959363
VACTERL/VATER ASSOCIATION	0.00840336	0.8358422279959363
INDOMETHACIN EMBRYOFETOPATHY	0.00840336	0.8358422279959363
PELIZAEUS-MERZBACHER DISEASE	0.00840336	0.8358422279959363
46,XY DISORDER OF SEX DEVELOPMENT-ADRENAL INSUFFICIENCY DUE TO CYP11A1 DEFICIENCY	0.00840336	0.8358422279959363
PEMPHIGOID GESTATIONIS	0.00840336	0.8358422279959363
BRONCHOPULMONARY DYSPLASIA	0.00840336	0.8358422279959363
CORNEODERMATOOSSEOUS SYNDROME	0.00840336	0.8358422279959363
DIETHYLSTILBESTROL SYNDROME	0.00840336	0.8358422279959363
INFANTILE SIALIC ACID STORAGE DISEASE	0.00840336	0.8358422279959363
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 2	0.00840336	0.8358422279959363
PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY	0.00840336	0.8358422279959363
EBSTEIN MALFORMATION	0.00840336	0.8358422279959363
BARTTER SYNDROME, TYPE 4B, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.00840336	0.8358422279959363
ROIFMAN SYNDROME; RFMN	0.00840336	0.8358422279959363
HYPOPIGMENTATION, ORGANOMEGALY, AND DELAYED MYELINATION AND DEVELOPMENT; HOD	0.00840336	0.8358422279959363
FIBULAR APLASIA-ECTRODACTYLY SYNDROME	0.00840336	0.8358422279959363
MARFAN LIPODYSTROPHY SYNDROME; MFLS	0.00840336	0.8358422279959363
SCHISIS ASSOCIATION	0.00840336	0.8358422279959363
AUTOSOMAL DOMINANT MYOPIA-MIDFACIAL RETRUSION-SENSORINEURAL HEARING LOSS-RHIZOMELIC DYSPLASIA SYNDROME	0.00840336	0.8358422279959363
OSTEOGENESIS IMPERFECTA, TYPE IIA	0.00840336	0.8358422279959363
CONGENITAL TOXOPLASMOSIS	0.00840336	0.8358422279959363
RETINOPATHY OF PREMATURITY	0.00840336	0.8358422279959363
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 2	0.00840336	0.8358422279959363
DOUBLE UTERUS-HEMIVAGINA-RENAL AGENESIS SYNDROME	0.00840336	0.8358422279959363
EPIDERMOLYSIS BULLOSA SIMPLEX WITH PYLORIC ATRESIA	0.00840336	0.8358422279959363
HYPERURICEMIA, PULMONARY HYPERTENSION, RENAL FAILURE, AND ALKALOSIS SYNDROME	0.00840336	0.8358422279959363
HYDROLETHALUS	0.00840336	0.8358422279959363
PACHYGYRIA-INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.00840336	0.8358422279959363
SPLENOGONADAL FUSION-LIMB DEFECTS-MICROGNATHIA SYNDROME	0.00840336	0.8358422279959363
AGENESIS OF THE CORPUS CALLOSUM AND CONGENITAL LYMPHEDEMA	0.00840336	0.8358422279959363
MICROFORM HOLOPROSENCEPHALY	0.00840336	0.8358422279959363
IMPERFORATE OROPHARYNX-COSTOVERTEBRAL ANOMALIES SYNDROME	0.00840336	0.8358422279959363
DIFFUSE NEONATAL HEMANGIOMATOSIS	0.00840336	0.8358422279959363
INHERITED ISOLATED ADRENAL INSUFFICIENCY DUE TO PARTIAL CYP11A1 DEFICIENCY	0.00840336	0.8358422279959363
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25; MC1DN25	0.00840336	0.8358422279959363
HEC SYNDROME	0.00840336	0.8358422279959363
PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME; PVHH	0.00840336	0.8358422279959363
CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY, 1; ICP1	0.00840336	0.8358422279959363
CONGENITAL ENTEROVIRUS INFECTION	0.00840336	0.8358422279959363
FATCO SYNDROME	0.00840336	0.8358422279959363
LOWER LIMB MALFORMATION-HYPOSPADIAS SYNDROME	0.00840336	0.8358422279959363
PEDIATRIC-ONSET GRAVES DISEASE	0.00840336	0.8358422279959363
TYSHCHENKO SYNDROME	0.00840336	0.8358422279959363
CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY 3	0.00840336	0.8358422279959363
PYRIDOXAL PHOSPHATE-RESPONSIVE SEIZURES	0.00840336	0.8358422279959363
CORNEODERMATOOSSEOUS SYNDROME	0.00840336	0.8358422279959363
VENTRICULOMEGALY WITH CYSTIC KIDNEY DISEASE; VMCKD	0.00840336	0.8358422279959363
BARTTER SYNDROME, TYPE 4A, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.00840336	0.8358422279959363
PTOSIS-VOCAL CORD PARALYSIS SYNDROME	0.00840336	0.8358422279959363
OMPHALOCELE	0.00840336	0.8358422279959363
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2; MC5DN2	0.00840336	0.8358422279959363
ADAMS-OLIVER SYNDROME	0.00840336	0.8358422279959363
BARTTER SYNDROME, TYPE 5, ANTENATAL, TRANSIENT	0.00840336	0.8358422279959363
CONGENITAL PULMONARY AIRWAY MALFORMATION	0.00840336	0.8358422279959363
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 30; MC1DN30	0.00840336	0.8358422279959363
NEMALINE MYOPATHY 10	0.00840336	0.8358422279959363
ACROFACIAL DYSOSTOSIS, CATANIA TYPE	0.00840336	0.8358422279959363
CONGENITAL HERPES SIMPLEX VIRUS INFECTION	0.00840336	0.8358422279959363
SEVERE CONGENITAL NEMALINE MYOPATHY	0.00840336	0.8358422279959363
ACROFACIAL DYSOSTOSIS 1, NAGER TYPE; AFD1	0.00840336	0.8358422279959363
PULMONARY ATRESIA-INTACT VENTRICULAR SEPTUM SYNDROME	0.00840336	0.8358422279959363
OSTEOGENESIS IMPERFECTA, TYPE XIII	0.00833333	0.8288766771654882
MENTAL RETARDATION, AUTOSOMAL DOMINANT 40; MRD40	0.00833333	0.8288766771654882
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 55; EIEE55	0.00833333	0.8288766771654882
OSTEOGENESIS IMPERFECTA, TYPE XVI; OI16	0.00833333	0.8288766771654882
INTELLECTUAL DEVELOPMENTAL DISORDER WITH PERSISTENCE OF FETAL HEMOGLOBIN	0.00833333	0.8288766771654882
MEIER-GORLIN SYNDROME 2; MGORS2	0.00833333	0.8288766771654882
15Q26 OVERGROWTH SYNDROME	0.00833333	0.8288766771654882
VESICOURETERAL REFLUX 8; VUR8	0.00833333	0.8288766771654882
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.00833333	0.8288766771654882
EHLERS-DANLOS SYNDROME, CLASSIC TYPE, 2; EDSCL2	0.00833333	0.8288766771654882
EHLERS-DANLOS SYNDROME, HYPERMOBILITY TYPE	0.00833333	0.8288766771654882
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIN	0.00833333	0.8288766771654882
MARFANOID HYPERMOBILITY SYNDROME	0.00833333	0.8288766771654882
OSTEOGENESIS IMPERFECTA, TYPE I	0.00833333	0.8288766771654882
GIANT AXONAL NEUROPATHY	0.00833333	0.8288766771654882
TRICHORHINOPHALANGEAL SYNDROME, TYPE II	0.00833333	0.8288766771654882
EHLERS-DANLOS SYNDROME, PERIODONTAL TYPE, 2; EDSPD2	0.00833333	0.8288766771654882
PERIVENTRICULAR NODULAR HETEROTOPIA	0.00833333	0.8288766771654882
MACS SYNDROME	0.00833333	0.8288766771654882
CRANIOECTODERMAL DYSPLASIA 4	0.00833333	0.8288766771654882
ODONTOCHONDRODYSPLASIA; ODCD	0.00833333	0.8288766771654882
OSTEOGENESIS IMPERFECTA, TYPE V	0.00833333	0.8288766771654882
HALLERMANN-STREIFF SYNDROME; HSS	0.00833333	0.8288766771654882
NEMALINE MYOPATHY 7; NEM7	0.00833333	0.8288766771654882
OSTEOGENESIS IMPERFECTA, TYPE XVIII; OI18	0.00833333	0.8288766771654882
WILSON DISEASE	0.00833333	0.8288766771654882
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	0.00833333	0.8288766771654882
OCULO-PALATO-CEREBRAL SYNDROME	0.00833333	0.8288766771654882
CK SYNDROME	0.00833333	0.8288766771654882
BAZEX SYNDROME; BZX	0.00833333	0.8288766771654882
EHLERS-DANLOS SYNDROME, CLASSIC-LIKE; EDSCLL	0.00833333	0.8288766771654882
NEONATAL MARFAN SYNDROME	0.00833333	0.8288766771654882
KOOLEN-DE VRIES SYNDROME; KDVS	0.00833333	0.8288766771654882
HYPER-IGE RECURRENT INFECTION SYNDROME 3, AUTOSOMAL RECESSIVE; HIES3	0.00833333	0.8288766771654882
X-LINKED MYOTUBULAR MYOPATHY-ABNORMAL GENITALIA SYNDROME	0.00833333	0.8288766771654882
CARTILAGE-HAIR HYPOPLASIA; CHH	0.00833333	0.8288766771654882
WARBURG MICRO SYNDROME 1	0.00833333	0.8288766771654882
MYASTHENIC SYNDROME, CONGENITAL, 25, PRESYNAPTIC; CMS25	0.00833333	0.8288766771654882
ABNORMAL HAIR, JOINT LAXITY, AND DEVELOPMENTAL DELAY; HJDD	0.00833333	0.8288766771654882
PIERRE ROBIN SEQUENCE WITH PECTUS EXCAVATUM AND RIB AND SCAPULAR ANOMALIES	0.00833333	0.8288766771654882
MICROPHTHALMIA WITH CYST, BILATERAL FACIAL CLEFTS, AND LIMB ANOMALIES	0.00833333	0.8288766771654882
10Q22.3Q23.3 MICRODELETION SYNDROME	0.008177740000000001	0.8134008803111482
CHARGE SYNDROME	0.008177740000000001	0.8134008803111482
16P13.11 MICRODELETION SYNDROME	0.00817575	0.8132029444814667
SKELETAL DYSPLASIA-T-CELL IMMUNODEFICIENCY-DEVELOPMENTAL DELAY SYNDROME	0.00817575	0.8132029444814667
JOUBERT SYNDROME 10	0.00813008	0.8086603669228978
RUBINSTEIN-TAYBI SYNDROME 2; RSTS2	0.00813008	0.8086603669228978
ACANTHOSIS NIGRICANS-INSULIN RESISTANCE-MUSCLE CRAMPS-ACRAL ENLARGEMENT SYNDROME	0.00813008	0.8086603669228978
46,XY SEX REVERSAL 6; SRXY6	0.00813008	0.8086603669228978
FOWLER URETHRAL SPHINCTER DYSFUNCTION SYNDROME	0.00813008	0.8086603669228978
CONGENITAL ADRENAL HYPERPLASIA DUE TO 11-BETA-HYDROXYLASE DEFICIENCY	0.00813008	0.8086603669228978
MUCOPOLYSACCHARIDOSIS, TYPE VII; MPS7	0.00813008	0.8086603669228978
NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE MICROCEPHALY, SPASTICITY, AND BRAIN ANOMALIES; NDMSBA	0.00813008	0.8086603669228978
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND CEREBELLAR ATAXIA; CCAFCA	0.00813008	0.8086603669228978
CEREBROOCULOFACIOSKELETAL SYNDROME 1	0.00813008	0.8086603669228978
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 1	0.00813008	0.8086603669228978
LEUKODYSTROPHY, HYPOMYELINATING, 17; HLD17	0.00813008	0.8086603669228978
EPILEPSY-MICROCEPHALY-SKELETAL DYSPLASIA SYNDROME	0.00813008	0.8086603669228978
RABSON-MENDENHALL SYNDROME	0.00813008	0.8086603669228978
CONGENITAL ADRENAL HYPERPLASIA DUE TO CYTOCHROME P450 OXIDOREDUCTASE DEFICIENCY	0.00813008	0.8086603669228978
PSEUDOLEPRECHAUNISM SYNDROME, PATTERSON TYPE	0.00813008	0.8086603669228978
OVARIAN DYSGENESIS 2; ODG2	0.00813008	0.8086603669228978
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIA; CDG2A	0.00813008	0.8086603669228978
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 2	0.00813008	0.8086603669228978
GLUCOCORTICOID RESISTANCE, GENERALIZED; GCCR	0.00813008	0.8086603669228978
CRANIOFACIOFRONTODIGITAL SYNDROME	0.00813008	0.8086603669228978
HYPERTRICHOSIS, CONGENITAL GENERALIZED, WITH OR WITHOUT GINGIVAL HYPERPLASIA	0.00813008	0.8086603669228978
CONGENITAL ADRENAL HYPERPLASIA DUE TO 3-BETA-HYDROXYSTEROID DEHYDROGENASE DEFICIENCY	0.00813008	0.8086603669228978
GENERALIZED GLUCOCORTICOID RESISTANCE SYNDROME	0.00813008	0.8086603669228978
SEVERE INTELLECTUAL DISABILITY-CORPUS CALLOSUM AGENESIS-FACIAL DYSMORPHISM-CEREBELLAR ATAXIA SYNDROME	0.00813008	0.8086603669228978
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 3; CGL3	0.00813008	0.8086603669228978
SPECIFIC GRANULE DEFICIENCY 2; SGD2	0.00813008	0.8086603669228978
NKX6-2-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.00813008	0.8086603669228978
BRACHYOLMIA TYPE 4 WITH MILD EPIPHYSEAL AND METAPHYSEAL CHANGES; BCYM4	0.00813008	0.8086603669228978
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 2	0.00813008	0.8086603669228978
PATTERSON PSEUDOLEPRECHAUNISM SYNDROME	0.00813008	0.8086603669228978
INSULIN-RESISTANCE SYNDROME TYPE B	0.00813008	0.8086603669228978
HYPERSECRETION OF ADRENAL ANDROGENS, FAMILIAL	0.00813008	0.8086603669228978
PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 4	0.00813008	0.8086603669228978
DYSSEGMENTAL DYSPLASIA, ROLLAND-DESBUQUOIS TYPE	0.00813008	0.8086603669228978
LISSENCEPHALY 7 WITH CEREBELLAR HYPOPLASIA; LIS7	0.00813008	0.8086603669228978
MENTAL RETARDATION, MICROCEPHALY, EPILEPSY, AND COARSE FACE	0.00813008	0.8086603669228978
FLOATING-HARBOR SYNDROME	0.00813008	0.8086603669228978
CRANIORHINY	0.00813008	0.8086603669228978
CARNEY COMPLEX, TYPE 1; CNC1	0.00813008	0.8086603669228978
DOWN SYNDROME	0.00809953	0.8056217038089439
DESBUQUOIS DYSPLASIA 1	0.00809953	0.8056217038089439
4Q21 MICRODELETION SYNDROME	0.0080896	0.8046340139653576
GINGIVAL FIBROMATOSIS-FACIAL DYSMORPHISM SYNDROME	0.0080896	0.8046340139653576
AL KAISSI SYNDROME; ALKAS	0.0080896	0.8046340139653576
CRANIODIAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT; CDD	0.0080896	0.8046340139653576
MONOSOMY 9P	0.0080896	0.8046340139653576
FONTAINE PROGEROID SYNDROME; FPS	0.0080896	0.8046340139653576
CHROMOSOME 3PTER-P25 DELETION SYNDROME	0.0080896	0.8046340139653576
BRANCHIOSKELETOGENITAL SYNDROME	0.0080896	0.8046340139653576
211910 CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE I; GCS1;;FACIOTHORACOSKELETAL SYNDROME; FTSS	0.0080896	0.8046340139653576
PERIPARTUM CARDIOMYOPATHY	0.00803848	0.7995493508430883
DEVELOPMENTAL AND SPEECH DELAY DUE TO SOX5 DEFICIENCY	0.007933619999999999	0.7891194256670094
16P11.2P12.2 MICRODUPLICATION SYNDROME	0.007933619999999999	0.7891194256670094
MYELODYSPLASIA, IMMUNODEFICIENCY, FACIAL DYSMORPHISM, SHORT STATURE,	0.00788332	0.7841163240423977
ALPORT SYNDROME	0.00784548	0.7803525593212189
CRANIOSYNOSTOSIS 2	0.00784548	0.7803525593212189
NIGHT BLINDNESS-SKELETAL ANOMALIES-DYSMORPHISM SYNDROME	0.00784548	0.7803525593212189
INTELLECTUAL DISABILITY-SEIZURES-ABNORMAL GAIT-FACIAL DYSMORPHISM SYNDROME	0.00776471	0.7723187518019372
WHITE-SUTTON SYNDROME; WHSUS	0.00776471	0.7723187518019372
HEREDITARY FRUCTOSE INTOLERANCE	0.007703659999999999	0.7662463988360816
HEREDITARY COPROPORPHYRIA	0.007703659999999999	0.7662463988360816
ACUTE INTERMITTENT PORPHYRIA	0.007703659999999999	0.7662463988360816
MITOCHONDRIAL DNA DEPLETION SYNDROME 1 (MNGIE TYPE); MTDPS1	0.007703659999999999	0.7662463988360816
FAMILIAL MEDITERRANEAN FEVER	0.007703659999999999	0.7662463988360816
MALT LYMPHOMA	0.007703659999999999	0.7662463988360816
LATE-ONSET ISOLATED ACTH DEFICIENCY	0.007703659999999999	0.7662463988360816
JUVENILE DERMATOMYOSITIS	0.007703659999999999	0.7662463988360816
ACUTE ADRENAL INSUFFICIENCY	0.007703659999999999	0.7662463988360816
PERIPHERAL DEMYELINATING NEUROPATHY-CENTRAL DYSMYELINATING LEUKODYSTROPHY-WAARDENBURG SYNDROME-HIRSCHSPRUNG DISEASE	0.007703659999999999	0.7662463988360816
PORPHYRIA VARIEGATA	0.007703659999999999	0.7662463988360816
ADDISON DISEASE	0.007703659999999999	0.7662463988360816
PRIMARY PERITONEAL CARCINOMA	0.007703659999999999	0.7662463988360816
PSEUDOMYXOMA PERITONEI	0.007703659999999999	0.7662463988360816
CAP POLYPOSIS	0.007703659999999999	0.7662463988360816
CHROMOSOME 19P13.13 DELETION SYNDROME	0.007703659999999999	0.7662463988360816
MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE); MTDPS4B	0.007703659999999999	0.7662463988360816
INFANT BOTULISM	0.007703659999999999	0.7662463988360816
NEUROENDOCRINE TUMOR OF THE RECTUM	0.007703659999999999	0.7662463988360816
NK-CELL ENTEROPATHY	0.007703659999999999	0.7662463988360816
BOTULISM	0.007703659999999999	0.7662463988360816
IGG4-RELATED RETROPERITONEAL FIBROSIS	0.007703659999999999	0.7662463988360816
NEUROENDOCRINE TUMOR OF ANAL CANAL	0.007703659999999999	0.7662463988360816
POLYMYOSITIS	0.007703659999999999	0.7662463988360816
PORPHYRIA VARIEGATA	0.007703659999999999	0.7662463988360816
VISCERAL MYOPATHY; VSCM	0.007703659999999999	0.7662463988360816
PORPHYRIA	0.007703659999999999	0.7662463988360816
HIRSCHSPRUNG DISEASE	0.007703659999999999	0.7662463988360816
PERITONEAL CYSTIC MESOTHELIOMA	0.007703659999999999	0.7662463988360816
FOODBORNE BOTULISM	0.007703659999999999	0.7662463988360816
MULTIPLE ENDOCRINE NEOPLASIA TYPE 2	0.007703659999999999	0.7662463988360816
PORPHYRIA DUE TO ALA DEHYDRATASE DEFICIENCY	0.007703659999999999	0.7662463988360816
GITELMAN SYNDROME	0.007703659999999999	0.7662463988360816
MENTAL RETARDATION, X-LINKED 91; MRX91	0.00759629	0.7555668159049775
X-LINKED INTELLECTUAL DISABILITY, STEVENSON TYPE	0.00759629	0.7555668159049775
SEPTO-OPTIC DYSPLASIA SPECTRUM	0.0074776800000000004	0.7437692436645168
THYROTOXIC PERIODIC PARALYSIS	0.0074776800000000004	0.7437692436645168
13Q12.3 MICRODELETION SYNDROME	0.0074776800000000004	0.7437692436645168
ADIPOSIS DOLOROSA	0.0074776800000000004	0.7437692436645168
TETRASOMY X	0.00744073	0.7400940030078687
NEUROFIBROMATOSIS, TYPE I	0.00744073	0.7400940030078687
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.00744073	0.7400940030078687
CHROMOSOME 22Q11.2 DUPLICATION SYNDROME	0.00744073	0.7400940030078687
ANDERSEN CARDIODYSRHYTHMIC PERIODIC PARALYSIS	0.00744073	0.7400940030078687
CHROMOSOME 10Q26 DELETION SYNDROME	0.00744073	0.7400940030078687
BARAITSER-WINTER CEREBROFRONTOFACIAL SYNDROME	0.00744073	0.7400940030078687
NEUROFIBROMATOSIS-NOONAN SYNDROME	0.00744073	0.7400940030078687
HYPERTELORISM-MICROTIA-FACIAL CLEFTING SYNDROME	0.00744073	0.7400940030078687
ALAGILLE SYNDROME	0.00744073	0.7400940030078687
TALL STATURE-INTELLECTUAL DISABILITY-RENAL ANOMALIES SYNDROME	0.00744073	0.7400940030078687
GOLDBERG-SHPRINTZEN MEGACOLON SYNDROME	0.00744073	0.7400940030078687
TRISOMY 8Q	0.00744073	0.7400940030078687
OROFACIODIGITAL SYNDROME TYPE 4	0.00744073	0.7400940030078687
SPASTIC PARAPLEGIA-SEVERE DEVELOPMENTAL DELAY-EPILEPSY SYNDROME	0.0073645099999999995	0.732512762335346
6Q16 MICRODELETION SYNDROME	0.0073645099999999995	0.732512762335346
MENTAL RETARDATION, AUTOSOMAL DOMINANT 43; MRD43	0.00726147	0.7222638638979708
NEURODEVELOPMENTAL DISORDER WITH SPASTICITY AND POOR GROWTH; NEDSG	0.00726147	0.7222638638979708
UROFACIAL SYNDROME	0.00726147	0.7222638638979708
NIJMEGEN BREAKAGE SYNDROME	0.00718862	0.7150178210877729
CHROMOSOME 2P16.1-P15 DELETION SYNDROME	0.00718862	0.7150178210877729
NEURODEVELOPMENTAL DISORDER, X-LINKED, WITH CRANIOFACIAL ABNORMALITIES; NEDXCF	0.00718862	0.7150178210877729
3P25.3 MICRODELETION SYNDROME	0.00718862	0.7150178210877729
OSTEOPENIA-MYOPIA-HEARING LOSS-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.0071483	0.7110073825688
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 2; LSDMCA2	0.0071483	0.7110073825688
FETAL TRIMETHADIONE SYNDROME	0.00710048	0.7062509547419825
CAMPTODACTYLY SYNDROME, GUADALAJARA TYPE 1	0.00710048	0.7062509547419825
TRANSALDOLASE DEFICIENCY	0.00710048	0.7062509547419825
DESBUQUOIS DYSPLASIA 2; DBQD2	0.00710048	0.7062509547419825
MARSHALL-SMITH SYNDROME; MRSHSS	0.00710048	0.7062509547419825
GERMAN SYNDROME	0.00710048	0.7062509547419825
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 7; MC3DN7	0.00710048	0.7062509547419825
BARATELA-SCOTT SYNDROME	0.00710048	0.7062509547419825
ALPHA-THALASSEMIA-X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.00702969	0.6992098103283394
MUSCULOCONTRACTURAL EHLERS-DANLOS SYNDROME	0.00702969	0.6992098103283394
CRANIOSYNOSTOSIS-HYDROCEPHALUS-ARNOLD-CHIARI MALFORMATION TYPE I-RADIOULNAR SYNOSTOSIS SYNDROME	0.00661951	0.6584111577561096
RAPID-ONSET CHILDHOOD OBESITY-HYPOTHALAMIC DYSFUNCTION-HYPOVENTILATION-AUTONOMIC DYSREGULATION SYNDROME	0.00661951	0.6584111577561096
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, CHROMOSOME 16-RELATED	0.00661951	0.6584111577561096
HERMANSKY-PUDLAK SYNDROME	0.00660137	0.6566068582835358
SHUKLA-VERNON SYNDROME; SHUVER	0.0064536	0.6419088796141751
17P11.2 MICRODUPLICATION SYNDROME	0.0064536	0.6419088796141751
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 70; MRT70	0.0064536	0.6419088796141751
SMITH-LEMLI-OPITZ SYNDROME	0.0064536	0.6419088796141751
CHROMOSOME 15Q11.2 DELETION SYNDROME	0.0064536	0.6419088796141751
AARSKOG-SCOTT SYNDROME	0.0064536	0.6419088796141751
MUENKE SYNDROME	0.0064536	0.6419088796141751
15Q24 MICRODELETION SYNDROME	0.0064536	0.6419088796141751
1Q21.1 MICRODUPLICATION SYNDROME	0.0064536	0.6419088796141751
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT ANOMALIES OF THE BRAIN, EYE, OR HEART; NEDBEH	0.0064536	0.6419088796141751
CHROMOSOME 15Q25 DELETION SYNDROME	0.0064536	0.6419088796141751
22Q11.2 MICRODUPLICATION SYNDROME	0.0064536	0.6419088796141751
DISTAL MONOSOMY 15Q	0.0064536	0.6419088796141751
PROXIMAL 16P11.2 MICRODUPLICATION SYNDROME	0.0064536	0.6419088796141751
DISTAL 22Q11.2 MICRODUPLICATION SYNDROME	0.0064536	0.6419088796141751
301950 BRANCHIAL ARCH SYNDROME, X-LINKED;;MANDIBULOFACIAL DYSOSTOSIS, TORIELLO TYPE	0.00645161	0.6417109437844937
SHWACHMAN-DIAMOND SYNDROME 1; SDS1	0.00645161	0.6417109437844937
FETAL ALCOHOL SYNDROME	0.00645161	0.6417109437844937
WALKER-WARBURG SYNDROME	0.00645161	0.6417109437844937
ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.00645161	0.6417109437844937
FRAXE INTELLECTUAL DISABILITY	0.00645161	0.6417109437844937
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 15	0.00645161	0.6417109437844937
X-LINKED INTELLECTUAL DISABILITY DUE TO GRIA3 MUTATIONS	0.00645161	0.6417109437844937
ROLANDIC EPILEPSY-SPEECH DYSPRAXIA SYNDROME	0.00645161	0.6417109437844937
X-LINKED EPILEPSY-LEARNING DISABILITIES-BEHAVIOR DISORDERS SYNDROME	0.00645161	0.6417109437844937
MUCOLIPIDOSIS III ALPHA/BETA	0.00645161	0.6417109437844937
WISKOTT-ALDRICH SYNDROME	0.00645161	0.6417109437844937
HSD10 DISEASE	0.00645161	0.6417109437844937
LISSENCEPHALY, X-LINKED, 2	0.00645161	0.6417109437844937
MIETENS SYNDROME	0.00645161	0.6417109437844937
ISOLATED CLEFT LIP	0.00645161	0.6417109437844937
CHROMOSOME XQ27.3-Q28 DUPLICATION SYNDROME	0.00645161	0.6417109437844937
OCCIPITAL HORN SYNDROME	0.00645161	0.6417109437844937
CLEFT LIP WITH OR WITHOUT CLEFT PALATE	0.00645161	0.6417109437844937
BRANCHIOGENIC DEAFNESS SYNDROME	0.00645161	0.6417109437844937
MICROCEPHALY-CLEFT PALATE-ABNORMAL RETINAL PIGMENTATION SYNDROME	0.00645161	0.6417109437844937
EAR-PATELLA-SHORT STATURE SYNDROME	0.00645161	0.6417109437844937
AUTOSOMAL DOMINANT POPLITEAL PTERYGIUM SYNDROME	0.00645161	0.6417109437844937
MUSICAL PERFECT PITCH	0.00645161	0.6417109437844937
CONGENITAL INSENSITIVITY TO PAIN WITH SEVERE INTELLECTUAL DISABILITY	0.00645161	0.6417109437844937
PERLMAN SYNDROME	0.00645161	0.6417109437844937
HISTIDINEMIA	0.00645161	0.6417109437844937
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.00645161	0.6417109437844937
CHILDHOOD APRAXIA OF SPEECH	0.00645161	0.6417109437844937
FEINGOLD SYNDROME 1; FGLDS1	0.00645161	0.6417109437844937
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, SBBYS TYPE	0.00645161	0.6417109437844937
MICROPHTHALMIA, SYNDROMIC 3	0.00645161	0.6417109437844937
SOLITARY MEDIAN MAXILLARY CENTRAL INCISOR; SMMCI	0.00645161	0.6417109437844937
GRANGE SYNDROME	0.00645161	0.6417109437844937
ULNA HYPOPLASIA-INTELLECTUAL DISABILITY SYNDROME	0.00645161	0.6417109437844937
612917 GIACHETI SYNDROME;;MARFANOID HABITUS AND SPECIFIC LANGUAGE AND LEARNING DISABILITIES	0.00645161	0.6417109437844937
OSTEOPATHIA STRIATA-CRANIAL SCLEROSIS SYNDROME	0.00645161	0.6417109437844937
HYPERTRICHOSIS CUBITI	0.00645161	0.6417109437844937
FAMILIAL CONGENITAL MIRROR MOVEMENTS	0.00645161	0.6417109437844937
LATHOSTEROLOSIS	0.00645161	0.6417109437844937
COENZYME Q10 DEFICIENCY, PRIMARY, 1; COQ10D1	0.00645161	0.6417109437844937
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 17; GPIBD17	0.00645161	0.6417109437844937
MARINESCO-SJÖGREN SYNDROME	0.00645161	0.6417109437844937
BLOOM SYNDROME	0.00645161	0.6417109437844937
AUTOSOMAL RECESSIVE AXONAL NEUROPATHY WITH NEUROMYOTONIA	0.00645161	0.6417109437844937
SPEECH DEVELOPMENT, DELAYED, WITH FACIAL ASYMMETRY, STRABISMUS, ANDTRANSVERSE EARLOBE CREASE	0.00645161	0.6417109437844937
SPASTIC PARAPLEGIA 9A, AUTOSOMAL DOMINANT; SPG9A	0.00645161	0.6417109437844937
PAROXYSMAL EXERTION-INDUCED DYSKINESIA	0.00645161	0.6417109437844937
FILIPPI SYNDROME	0.00645161	0.6417109437844937
INTELLECTUAL DISABILITY-MUSCLE WEAKNESS-SHORT STATURE-FACIAL DYSMORPHISM SYNDROME	0.00645161	0.6417109437844937
INTELLECTUAL DISABILITY-SPARSE HAIR-BRACHYDACTYLY SYNDROME	0.00645161	0.6417109437844937
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 32	0.00645161	0.6417109437844937
MICROBRACHYCEPHALY-PTOSIS-CLEFT LIP SYNDROME	0.00645161	0.6417109437844937
INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-HAND ANOMALIES SYNDROME	0.00645161	0.6417109437844937
POMT2-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R14	0.00645161	0.6417109437844937
VELOCARDIOFACIAL SYNDROME	0.00645161	0.6417109437844937
SPORADIC INFANTILE BILATERAL STRIATAL NECROSIS	0.00645161	0.6417109437844937
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 7	0.00645161	0.6417109437844937
DUCHENNE MUSCULAR DYSTROPHY	0.00645161	0.6417109437844937
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.00645161	0.6417109437844937
THUMB DEFORMITY-ALOPECIA-PIGMENTATION ANOMALY SYNDROME	0.00645161	0.6417109437844937
MYOPATHY WITH EXTRAPYRAMIDAL SIGNS	0.00645161	0.6417109437844937
RING CHROMOSOME 13 SYNDROME	0.006403300000000001	0.6369057779895637
D-BIFUNCTIONAL PROTEIN DEFICIENCY	0.006403300000000001	0.6369057779895637
PROLIDASE DEFICIENCY	0.006403300000000001	0.6369057779895637
ROIFMAN-CHITAYAT SYNDROME	0.006403300000000001	0.6369057779895637
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, FADEN-ALKURAYA TYPE; SEMDFA	0.006403300000000001	0.6369057779895637
METHYLMALONATE SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.006403300000000001	0.6369057779895637
FATTY ACYL-COA REDUCTASE 1 DEFICIENCY	0.006403300000000001	0.6369057779895637
FANCONI ANEMIA, COMPLEMENTATION GROUP L	0.006403300000000001	0.6369057779895637
LEPRECHAUNISM	0.006403300000000001	0.6369057779895637
EARLY-ONSET EPILEPSY-INTELLECTUAL DISABILITY-BRAIN ANOMALIES SYNDROME	0.006403300000000001	0.6369057779895637
NOONAN SYNDROME 5; NS5	0.006403300000000001	0.6369057779895637
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 38; COXPD38	0.0064033	0.6369057779895636
COHEN SYNDROME	0.00637539	0.634129703111971
RETINAL DYSTROPHY AND OBESITY; RDOB	0.00637539	0.634129703111971
MEHMO SYNDROME; MEHMO	0.00637539	0.634129703111971
BARDET-BIEDL SYNDROME 21; BBS21	0.00637539	0.634129703111971
SPASTIC PARAPLEGIA AND PSYCHOMOTOR RETARDATION WITH OR WITHOUT SEIZURES	0.00637539	0.634129703111971
WAARDENBURG SYNDROME, TYPE 1; WS1	0.00636546	0.6331420132683846
WHITE MATTER HYPOPLASIA-CORPUS CALLOSUM AGENESIS-INTELLECTUAL DISABILITY SYNDROME	0.00636546	0.6331420132683846
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 13; MRT13	0.00636546	0.6331420132683846
OSTEOSCLEROSIS-DEVELOPMENTAL DELAY-CRANIOSYNOSTOSIS SYNDROME	0.00636546	0.6331420132683846
KBG SYNDROME	0.00636546	0.6331420132683846
INTELLECTUAL DISABILITY-BRACHYDACTYLY-PIERRE ROBIN SYNDROME	0.00636546	0.6331420132683846
X-LINKED INTELLECTUAL DISABILITY-HYPOGAMMAGLOBULINEMIA-PROGRESSIVE NEUROLOGICAL DETERIORATION SYNDROME	0.00636546	0.6331420132683846
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 61; MRT61	0.00636546	0.6331420132683846
X-LINKED INTELLECTUAL DISABILITY, SNYDER TYPE	0.00636546	0.6331420132683846
ELSAHY-WATERS SYNDROME; ESWS	0.00636546	0.6331420132683846
14Q24.1Q24.3 MICRODELETION SYNDROME	0.00636546	0.6331420132683846
PALATAL ANOMALIES-WIDELY SPACED TEETH-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.00636546	0.6331420132683846
ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.00636546	0.6331420132683846
BRACHYTELEPHALANGY-DYSMORPHISM-KALLMANN SYNDROME	0.00636546	0.6331420132683846
2Q31.1 MICRODELETION SYNDROME	0.00636546	0.6331420132683846
WIEDEMANN-STEINER SYNDROME	0.00636546	0.6331420132683846
TRICHOHEPATONEURODEVELOPMENTAL SYNDROME; THNS	0.00636546	0.6331420132683846
SEVERE FEEDING DIFFICULTIES-FAILURE TO THRIVE-MICROCEPHALY DUE TO ASXL3 DEFICIENCY SYNDROME	0.00636546	0.6331420132683846
HYPOTONIA, ATAXIA, AND DELAYED DEVELOPMENT SYNDROME; HADDS	0.00636546	0.6331420132683846
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 5	0.00636546	0.6331420132683846
MCDONOUGH SYNDROME	0.00636546	0.6331420132683846
20P13 MICRODELETION SYNDROME	0.00636546	0.6331420132683846
MICROCEPHALY 4, PRIMARY, AUTOSOMAL RECESSIVE; MCPH4	0.00636546	0.6331420132683846
DEAFNESS WITH LABYRINTHINE APLASIA, MICROTIA, AND MICRODONTIA	0.00636546	0.6331420132683846
OSTEOPATHIA STRIATA WITH CRANIAL SCLEROSIS	0.00636546	0.6331420132683846
CEREBROFACIOTHORACIC DYSPLASIA	0.00636546	0.6331420132683846
MANDIBULOFACIAL DYSOSTOSIS WITH MACROBLEPHARON AND MACROSTOMIA	0.00636546	0.6331420132683846
1Q44 MICRODELETION SYNDROME	0.00636546	0.6331420132683846
BOSMA ARHINIA MICROPHTHALMIA SYNDROME	0.00636546	0.6331420132683846
TEMPLE-BARAITSER SYNDROME	0.006284690000000001	0.625108205749103
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX	0.006284690000000001	0.625108205749103
COFFIN-SIRIS SYNDROME 7; CSS7	0.006284690000000001	0.625108205749103
TRISOMY 8P	0.00628469	0.6251082057491029
BEAULIEU-BOYCOTT-INNES SYNDROME; BBIS	0.00615918	0.612624323345425
DYRK1A-RELATED INTELLECTUAL DISABILITY SYNDROME	0.00615918	0.612624323345425
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 15; GPIBD15	0.00615918	0.612624323345425
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE SPASTIC DIPLEGIA SYNDROME	0.00615918	0.612624323345425
EMANUEL SYNDROME	0.00604057	0.6008267511049644
19P13.3 MICRODUPLICATION SYNDROME	0.00604057	0.6008267511049644
PITT-HOPKINS SYNDROME	0.00604057	0.6008267511049644
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 6	0.00585637	0.5825052537042994
SHORT STATURE, BRACHYDACTYLY, INTELLECTUAL DEVELOPMENTAL DISABILITY, AND SEIZURES; SBIDDS	0.00563039	0.5600280985327345
ACHONDROPLASIA	0.00563039	0.5600280985327345
CHROMOSOME 2Q37 DELETION SYNDROME	0.00563039	0.5600280985327345
MACROCEPHALY/AUTISM SYNDROME	0.00563039	0.5600280985327345
ACRODYSOSTOSIS 2 WITH OR WITHOUT HORMONE RESISTANCE	0.00563039	0.5600280985327345
CHUDLEY-LOWRY-HOAR SYNDROME	0.00563039	0.5600280985327345
MICROCEPHALY 20, PRIMARY, AUTOSOMAL RECESSIVE; MCPH20	0.00546448	0.5435258203908001
TRISOMY 18P	0.00546448	0.5435258203908001
HYPERPHENYLALANINEMIA, MILD, NON-BH4-DEFICIENT; HPANBH4	0.00546448	0.5435258203908001
MENTAL RETARDATION, AUTOSOMAL DOMINANT 56; MRD56	0.00546448	0.5435258203908001
X-LINKED INTELLECTUAL DISABILITY, VAN ESCH TYPE	0.00546448	0.5435258203908001
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT SEIZURES AND GAIT ABNORMALITIES; NEDSGA	0.00546448	0.5435258203908001
PERIVENTRICULAR NODULAR HETEROTOPIA 8; PVNH8	0.00546448	0.5435258203908001
MENTAL RETARDATION, AUTOSOMAL DOMINANT 45; MRD45	0.00546448	0.5435258203908001
FAMILIAL INFANTILE MYOCLONIC EPILEPSY	0.00546448	0.5435258203908001
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA SYNDROME	0.00546448	0.5435258203908001
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 56; EIEE56	0.00546448	0.5435258203908001
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND STRUCTURAL BRAIN ANOMALIES; NEDMIBA	0.00546448	0.5435258203908001
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 71; MRT71	0.00546448	0.5435258203908001
MICROCEPHALY 25, PRIMARY, AUTOSOMAL RECESSIVE; MCPH25	0.00546448	0.5435258203908001
INCONTINENTIA PIGMENTI	0.00546448	0.5435258203908001
RECESSIVE X-LINKED ICHTHYOSIS	0.00546448	0.5435258203908001
LANGUAGE DELAY AND ATTENTION DEFICIT-HYPERACTIVITY DISORDER/COGNITIVE IMPAIRMENT WITH OR WITHOUT CARDIAC ARRHYTHMIA; LADCI	0.00546448	0.5435258203908001
UNDETERMINED EARLY-ONSET EPILEPTIC ENCEPHALOPATHY	0.00546448	0.5435258203908001
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 2; MRT2	0.00546448	0.5435258203908001
2Q32Q33 MICRODELETION SYNDROME	0.00546448	0.5435258203908001
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.00546448	0.5435258203908001
CHROMOSOME 22Q13 DUPLICATION SYNDROME	0.00546448	0.5435258203908001
%164220 SCHILBACH-ROTT SYNDROME;;OCULAR HYPOTELORISM, SUBMUCOSAL CLEFT PALATE, AND HYPOSPADIAS;;CLEFT PALATE, HYPOTELORISM, AND HYPOSPADIAS;;BLEPHAROFACIOSKELETAL SYNDROME; BRSS	0.00546448	0.5435258203908001
MOHR-TRANEBJAERG SYNDROME	0.00546448	0.5435258203908001
15Q11Q13 MICRODUPLICATION SYNDROME	0.00546448	0.5435258203908001
PANDAS	0.00546448	0.5435258203908001
AUTISM, SUSCEPTIBILITY TO, X-LINKED 4	0.00546448	0.5435258203908001
SHORT STATURE, DEVELOPMENTAL DELAY, AND CONGENITAL HEART DEFECTS	0.00546448	0.5435258203908001
MICROCEPHALY 5, PRIMARY, AUTOSOMAL RECESSIVE	0.00546448	0.5435258203908001
LANDAU-KLEFFNER SYNDROME	0.00546448	0.5435258203908001
FRAGILE X SYNDROME	0.00546448	0.5435258203908001
FAMILIAL MALE-LIMITED PRECOCIOUS PUBERTY	0.00546448	0.5435258203908001
DISTAL XQ28 MICRODUPLICATION SYNDROME	0.00546448	0.5435258203908001
STURGE-WEBER SYNDROME	0.00546448	0.5435258203908001
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPE II	0.00546448	0.5435258203908001
COGNITIVE IMPAIRMENT WITH OR WITHOUT CEREBELLAR ATAXIA; CIAT	0.00546448	0.5435258203908001
ADRENOLEUKODYSTROPHY	0.00546448	0.5435258203908001
DISTAL 7Q11.23 MICRODUPLICATION SYNDROME	0.00546448	0.5435258203908001
16P13.11 MICRODUPLICATION SYNDROME	0.00546448	0.5435258203908001
CLASSIC PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.00546448	0.5435258203908001
1Q21.1 MICRODELETION SYNDROME	0.00546448	0.5435258203908001
ATTENTION DEFICIT-HYPERACTIVITY DISORDER	0.00546448	0.5435258203908001
PHENYLKETONURIA	0.00546448	0.5435258203908001
2P15P16.1 MICRODELETION SYNDROME	0.00546448	0.5435258203908001
CHILDHOOD ABSENCE EPILEPSY	0.00546448	0.5435258203908001
8Q12 MICRODUPLICATION SYNDROME	0.00546448	0.5435258203908001
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HOUGE TYPE; MRXSHG	0.00546448	0.5435258203908001
MYOCLONIC EPILEPSY OF INFANCY	0.00546448	0.5435258203908001
SYNDROMIC RECESSIVE X-LINKED ICHTHYOSIS	0.00546448	0.5435258203908001
X-LINKED INTELLECTUAL DISABILITY WITH MARFANOID HABITUS	0.00546448	0.5435258203908001
POLYMICROGYRIA DUE TO TUBB2B MUTATION	0.00546448	0.5435258203908001
SPINOCEREBELLAR ATAXIA 14	0.00546448	0.5435258203908001
TRANSKETOLASE DEFICIENCY	0.00546448	0.5435258203908001
15Q13.3 MICRODELETION SYNDROME	0.00546448	0.5435258203908001
CLASSIC PHENYLKETONURIA	0.00546448	0.5435258203908001
THYROID HORMONE RESISTANCE, GENERALIZED, AUTOSOMAL DOMINANT	0.00546448	0.5435258203908001
2-AMINOADIPIC 2-OXOADIPIC ACIDURIA; AMOXAD	0.00546448	0.5435258203908001
3Q29 MICRODELETION SYNDROME	0.00546448	0.5435258203908001
MICROTIA	0.00546448	0.5435258203908001
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, SEIZURES, AND ABSENT LANGUAGE; NDHSAL	0.00541418	0.5385227187661886
JOUBERT SYNDROME 35; JBTS35	0.00541418	0.5385227187661886
MULTIPLE ACYL-COA DEHYDROGENASE DEFICIENCY; MADD	0.00541418	0.5385227187661886
MENTAL RETARDATION, AUTOSOMAL DOMINANT 27	0.00541418	0.5385227187661886
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 64; EIEE64	0.00541418	0.5385227187661886
ABETA AMYLOIDOSIS, DUTCH TYPE	0.00537634	0.5347589540450097
CONGENITAL DYSERYTHROPOIETIC ANEMIA TYPE III	0.00537634	0.5347589540450097
17Q12 MICRODUPLICATION SYNDROME	0.00537634	0.5347589540450097
BENIGN ADULT FAMILIAL MYOCLONIC EPILEPSY	0.00537634	0.5347589540450097
PITUICYTOMA	0.00537634	0.5347589540450097
FAMILIAL HYPERALDOSTERONISM TYPE III	0.00537634	0.5347589540450097
MIDDLE EAR NEUROENDOCRINE TUMOR	0.00537634	0.5347589540450097
MYXOPAPILLARY EPENDYMOMA	0.00537634	0.5347589540450097
SOLAR URTICARIA	0.00537634	0.5347589540450097
DISORDER OF SEX DEVELOPMENT-INTELLECTUAL DISABILITY SYNDROME	0.00537634	0.5347589540450097
BENIGN OCCIPITAL EPILEPSY	0.00537634	0.5347589540450097
INSULIN-LIKE GROWTH FACTOR I, RESISTANCE TO; IGF1RES	0.00537634	0.5347589540450097
SIDERIUS X-LINKED MENTAL RETARDATION SYNDROME; MRXSSD	0.00537634	0.5347589540450097
PINEOBLASTOMA	0.00537634	0.5347589540450097
GANGLIOCYTOMA	0.00537634	0.5347589540450097
NON-DISTAL MONOSOMY 10Q	0.00537634	0.5347589540450097
ENCEPHALITIS LETHARGICA	0.00537634	0.5347589540450097
SUSAC SYNDROME	0.00537634	0.5347589540450097
FACIAL DYSMORPHISM, HYPERTRICHOSIS, EPILEPSY, INTELLECTUAL/DEVELOPMENTAL DELAY, AND GINGIVAL OVERGROWTH SYNDROME; FHEIG	0.00537634	0.5347589540450097
HEMANGIOBLASTOMA	0.00537634	0.5347589540450097
BRUNNER SYNDROME; BRNRS	0.00537634	0.5347589540450097
MENTAL RETARDATION, X-LINKED 73	0.00537634	0.5347589540450097
X-LINKED INTELLECTUAL DISABILITY, SIDERIUS TYPE	0.00537634	0.5347589540450097
NON-DISTAL TRISOMY 13Q	0.00537634	0.5347589540450097
PAPILLARY TUMOR OF THE PINEAL REGION	0.00537634	0.5347589540450097
PINEOCYTOMA	0.00537634	0.5347589540450097
SEVERE HEMOPHILIA A	0.00537634	0.5347589540450097
URUGUAY FACIOCARDIOMUSCULOSKELETAL SYNDROME; FCMSU	0.00537634	0.5347589540450097
STEROID-RESPONSIVE ENCEPHALOPATHY ASSOCIATED WITH AUTOIMMUNE THYROIDITIS	0.00537634	0.5347589540450097
CAMURATI-ENGELMANN DISEASE	0.00537634	0.5347589540450097
AMAUROSIS-HYPERTRICHOSIS SYNDROME	0.00537634	0.5347589540450097
PIEBALDISM	0.00537634	0.5347589540450097
RECESSIVE MITOCHONDRIAL ATAXIA SYNDROME	0.00537634	0.5347589540450097
LYME DISEASE	0.00537634	0.5347589540450097
FEBRILE INFECTION-RELATED EPILEPSY SYNDROME	0.00537634	0.5347589540450097
HYPERAMMONEMIA DUE TO N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.00537634	0.5347589540450097
L1 SYNDROME	0.00537634	0.5347589540450097
ACUTE RESPIRATORY CORONAVIRUS INFECTION	0.00537634	0.5347589540450097
BRACHYDACTYLY-PREAXIAL HALLUX VARUS SYNDROME	0.00537634	0.5347589540450097
GLUTAMATE MONOSODIUM SENSITIVITY	0.00537634	0.5347589540450097
PARIETAL FORAMINA	0.00537634	0.5347589540450097
ADULT-ONSET NON-INSULINOMA PERSISTENT HYPERINSULINEMIC HYPOGLYCEMIA	0.00537634	0.5347589540450097
INTELLECTUAL DISABILITY-CATARACTS-CALCIFIED PINNAE-MYOPATHY SYNDROME	0.00537634	0.5347589540450097
POSTORGASMIC ILLNESS SYNDROME	0.00537634	0.5347589540450097
THYMIC TUMOR	0.00537634	0.5347589540450097
STEVENS-JOHNSON SYNDROME/TOXIC EPIDERMAL NECROLYSIS SPECTRUM	0.00537634	0.5347589540450097
ADENOHYPOPHYSITIS	0.00537634	0.5347589540450097
PANHYPOPHYSITIS	0.00537634	0.5347589540450097
RECESSIVE INTELLECTUAL DISABILITY-MOTOR DYSFUNCTION-MULTIPLE JOINT CONTRACTURES SYNDROME	0.00537634	0.5347589540450097
IDIOPATHIC PANUVEITIS	0.00537634	0.5347589540450097
MONOSOMY 22	0.00537634	0.5347589540450097
TEMPI SYNDROME	0.00537634	0.5347589540450097
PITUITARY CARCINOMA	0.00537634	0.5347589540450097
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY-CORTICAL BLINDNESS-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.00537634	0.5347589540450097
SNEDDON SYNDROME	0.00537634	0.5347589540450097
MANGANESE POISONING	0.00537634	0.5347589540450097
SYDENHAM CHOREA	0.00537634	0.5347589540450097
EPISODIC ATAXIA, TYPE 1; EA1	0.00537634	0.5347589540450097
PITUITARY DEFICIENCY DUE TO EMPTY SELLA TURCICA SYNDROME	0.00537634	0.5347589540450097
HYPERTHERMIA, CUTANEOUS, WITH HEADACHES AND NAUSEA	0.00537634	0.5347589540450097
JUVENILE TEMPORAL ARTERITIS	0.00537634	0.5347589540450097
PAPILLOMA OF CHOROID PLEXUS	0.00537634	0.5347589540450097
PRIMROSE SYNDROME; PRIMS	0.00537634	0.5347589540450097
WAARDENBURG SYNDROME TYPE 1	0.00537634	0.5347589540450097
AUTOIMMUNE HEMOLYTIC ANEMIA, WARM TYPE	0.00537634	0.5347589540450097
MARSILI SYNDROME; MARSIS	0.00537634	0.5347589540450097
RAT-BITE FEVER	0.00537634	0.5347589540450097
HODGKIN LYMPHOMA	0.00537634	0.5347589540450097
PAROXYSMAL COLD HEMOGLOBINURIA	0.00537634	0.5347589540450097
BABESIOSIS	0.00537634	0.5347589540450097
DRUG-INDUCED AUTOIMMUNE HEMOLYTIC ANEMIA	0.00537634	0.5347589540450097
NOCARDIOSIS	0.00537634	0.5347589540450097
PARKES WEBER SYNDROME	0.00537634	0.5347589540450097
INTERNAL CAROTID AGENESIS	0.00537634	0.5347589540450097
POSTENCEPHALITIC PARKINSONISM	0.00537634	0.5347589540450097
METHEMOGLOBINEMIA DUE TO DEFICIENCY OF METHEMOGLOBIN REDUCTASE	0.00537634	0.5347589540450097
TSH-SECRETING PITUITARY ADENOMA	0.00537634	0.5347589540450097
PRIMARY HYPERALDOSTERONISM-SEIZURES-NEUROLOGICAL ABNORMALITIES SYNDROME	0.00537634	0.5347589540450097
FUNCTIONING GONADOTROPIC ADENOMA	0.00537634	0.5347589540450097
NON-FUNCTIONING PITUITARY ADENOMA	0.00537634	0.5347589540450097
MACULOPAPULAR CUTANEOUS MASTOCYTOSIS	0.00537634	0.5347589540450097
PROLACTINOMA	0.00537634	0.5347589540450097
HYPOCALCIURIC HYPERCALCEMIA, FAMILIAL, TYPE III	0.00537634	0.5347589540450097
GOLDBERG-SHPRINTZEN SYNDROME	0.00537634	0.5347589540450097
COLD AGGLUTININ DISEASE	0.00537634	0.5347589540450097
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 16	0.00537634	0.5347589540450097
MEDULLOBLASTOMA	0.00537634	0.5347589540450097
DEAFNESS, AUTOSOMAL DOMINANT 34, WITH OR WITHOUT INFLAMMATION; DFNA34	0.00537634	0.5347589540450097
FAMILIAL CEREBRAL CAVERNOUS MALFORMATION	0.00537634	0.5347589540450097
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME	0.00537634	0.5347589540450097
NIPAH VIRUS DISEASE	0.00537634	0.5347589540450097
FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 1	0.00537634	0.5347589540450097
NARP SYNDROME	0.00537634	0.5347589540450097
LHERMITTE-DUCLOS DISEASE	0.00537634	0.5347589540450097
HYPOSPADIAS-INTELLECTUAL DISABILITY, GOLDBLATT TYPE SYNDROME	0.00537634	0.5347589540450097
HUGHES-STOVIN SYNDROME	0.00537634	0.5347589540450097
ZLOTOGORA-OGUR SYNDROME	0.00537634	0.5347589540450097
MALARIA	0.00537634	0.5347589540450097
CENTRAL DIABETES INSIPIDUS	0.00537634	0.5347589540450097
SHORT STATURE, FACIAL DYSMORPHISM, AND SKELETAL ANOMALIES WITH OR WITHOUT CARDIAC ANOMALIES; SSFSC	0.00537634	0.5347589540450097
PRIMARY UNILATERAL ADRENAL HYPERPLASIA	0.00537634	0.5347589540450097
ADRENOCORTICAL CARCINOMA WITH PURE ALDOSTERONE HYPERSECRETION	0.00537634	0.5347589540450097
GLIOBLASTOMA	0.00537634	0.5347589540450097
HOLOPROSENCEPHALY 11	0.00537634	0.5347589540450097
CHIARI MALFORMATION TYPE I	0.00537634	0.5347589540450097
ARTERITIS, FAMILIAL GRANULOMATOUS, WITH JUVENILE POLYARTHRITIS	0.00537634	0.5347589540450097
CDKL5-RELATED EPILEPTIC ENCEPHALOPATHY	0.00537634	0.5347589540450097
EVEN-PLUS SYNDROME	0.00537634	0.5347589540450097
CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY, TYPE 2; CADASIL2	0.00537634	0.5347589540450097
EDINBURGH MALFORMATION SYNDROME	0.00537634	0.5347589540450097
HERPES SIMPLEX VIRUS ENCEPHALITIS	0.00537634	0.5347589540450097
THIAMINE-RESPONSIVE MEGALOBLASTIC ANEMIA SYNDROME	0.00537634	0.5347589540450097
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 7; IIAE7	0.00537634	0.5347589540450097
LAFORA DISEASE	0.00537634	0.5347589540450097
ZIMMERMANN-LABAND SYNDROME 2; ZLS2	0.00537634	0.5347589540450097
ISOLATED TRIGONOCEPHALY	0.00537634	0.5347589540450097
WYBURN-MASON SYNDROME	0.00537634	0.5347589540450097
9Q SUBTELOMERIC DELETION SYNDROME	0.00537634	0.5347589540450097
GINGIVAL FIBROMATOSIS-HYPERTRICHOSIS SYNDROME	0.00537634	0.5347589540450097
CRYPTOCOCCOSIS	0.00537634	0.5347589540450097
AICARDI-GOUTIÈRES SYNDROME	0.00537634	0.5347589540450097
NEUROFIBROMATOSIS, TYPE II	0.00537634	0.5347589540450097
OPTIC PATHWAY GLIOMA	0.00537634	0.5347589540450097
PRIMARY MICROCEPHALY-MILD INTELLECTUAL DISABILITY-YOUNG-ONSET DIABETES SYNDROME	0.00537634	0.5347589540450097
PAROXYSMAL DYSTONIC CHOREATHETOSIS WITH EPISODIC ATAXIA AND SPASTICITY	0.00537634	0.5347589540450097
ECTOPIC ALDOSTERONE-PRODUCING TUMOR	0.00537634	0.5347589540450097
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA; MEN2A	0.00537634	0.5347589540450097
FAMILIAL HYPERALDOSTERONISM TYPE I	0.00537634	0.5347589540450097
ENAMEL HYPOPLASIA, CATARACTS, AND AQUEDUCTAL STENOSIS	0.00537634	0.5347589540450097
OSTEOPETROSIS, AUTOSOMAL DOMINANT 1; OPTA1	0.00537634	0.5347589540450097
HYDROXYKYNURENINURIA	0.00537634	0.5347589540450097
PRIMARY CILIARY DYSKINESIA	0.00537634	0.5347589540450097
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO CWF19L1 DEFICIENCY	0.00537634	0.5347589540450097
DEAFNESS, SENSORINEURAL, WITH PERIPHERAL NEUROPATHY AND ARTERIAL DISEASE	0.00537634	0.5347589540450097
ROSAÏ-DORFMAN DISEASE	0.00537634	0.5347589540450097
CENTRAL NEUROCYTOMA	0.00537634	0.5347589540450097
FAMILIAL HYPERALDOSTERONISM TYPE II	0.00537634	0.5347589540450097
PONTIAC FEVER	0.00537634	0.5347589540450097
CEREBRAL CAVERNOUS MALFORMATIONS 2	0.00537634	0.5347589540450097
MAJEED SYNDROME	0.00537634	0.5347589540450097
CLASSIC GLUCOSE TRANSPORTER TYPE 1 DEFICIENCY SYNDROME	0.00537634	0.5347589540450097
MACROCEPHALY-SPASTIC PARAPLEGIA-DYSMORPHISM SYNDROME	0.00537634	0.5347589540450097
FAMILIAL THROMBOCYTOSIS	0.00537634	0.5347589540450097
RIFT VALLEY FEVER	0.00537634	0.5347589540450097
EPISODIC ATAXIA, TYPE 3	0.00537634	0.5347589540450097
LUJO HEMORRHAGIC FEVER	0.00537634	0.5347589540450097
XQ28 (MECP2) DUPLICATION	0.00529557	0.526725146525728
LUBS X-LINKED MENTAL RETARDATION SYNDROME; MRXSL	0.00529557	0.526725146525728
MICROCEPHALY-INTELLECTUAL DISABILITY-SENSORINEURAL HEARING LOSS-EPILEPSY-ABNORMAL MUSCLE TONE SYNDROME	0.00529557	0.526725146525728
SKRABAN-DEARDORFF SYNDROME; SKDEAS	0.00529557	0.526725146525728
C SYNDROME	0.00529557	0.526725146525728
MARSHALL SYNDROME	0.0051824	0.5154686651965572
DONNAI-BARROW SYNDROME	0.0051824	0.5154686651965572
BRANCHIOOCULOFACIAL SYNDROME	0.0051824	0.5154686651965572
SPONDYLOEPIPHYSEAL DYSPLASIA, NISHIMURA TYPE	0.0051824	0.5154686651965572
JOUBERT SYNDROME WITH JEUNE ASPHYXIATING THORACIC DYSTROPHY	0.0051824	0.5154686651965572
COHEN-GIBSON SYNDROME; COGIS	0.0051824	0.5154686651965572
GAPO SYNDROME	0.0051824	0.5154686651965572
PROTEUS SYNDROME	0.0051824	0.5154686651965572
STICKLER SYNDROME	0.0051824	0.5154686651965572
MEGALOCORNEA-MENTAL RETARDATION SYNDROME	0.0051824	0.5154686651965572
CHROMOSOME 9P DELETION SYNDROME	0.0051824	0.5154686651965572
NOONAN SYNDROME 6; NS6	0.0051824	0.5154686651965572
CHAR SYNDROME	0.0051824	0.5154686651965572
PEROXISOMAL ACYL-COA OXIDASE DEFICIENCY	0.0051824	0.5154686651965572
ATKIN-FLAITZ SYNDROME	0.00489537	0.4869191570591367
TRISOMY 5P	0.00489537	0.4869191570591367
157980 MOMO SYNDROME;;MACROSOMIA, OBESITY, MACROCEPHALY, AND OCULAR ABNORMALITIES	0.00489537	0.4869191570591367
MENTAL RETARDATION WITH LANGUAGE IMPAIRMENT AND WITH OR WITHOUT AUTISTIC FEATURES	0.00489537	0.4869191570591367
ATKIN-FLAITZ SYNDROME	0.00489537	0.4869191570591367
MULTIPLE EPIPHYSEAL DYSPLASIA, AL-GAZALI TYPE	0.00489537	0.4869191570591367
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT VARIABLE BRAIN ABNORMALITIES; NEDBA	0.00489537	0.4869191570591367
CHOPS SYNDROME; CHOPS	0.00489537	0.4869191570591367
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 2; SGBS2	0.00489537	0.4869191570591367
SYMPTOMATIC FORM OF COFFIN-LOWRY SYNDROME IN FEMALE CARRIERS	0.00489537	0.4869191570591367
MOMO SYNDROME	0.00489537	0.4869191570591367
SOTOS SYNDROME	0.00489537	0.4869191570591367
SUMMITT SYNDROME	0.00489537	0.4869191570591367
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 70; EIEE70	0.00467916	0.46541377729259076
TELO2-RELATED INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER	0.00467916	0.46541377729259076
MENTAL RETARDATION, AUTOSOMAL DOMINANT 26	0.00467916	0.46541377729259076
CONO-SPONDYLAR DYSPLASIA	0.00467916	0.46541377729259076
%312150 MULTIPLE PTERYGIUM SYNDROME, X-LINKED;;PTERYGIUM SYNDROME, MULTIPLE, X-LINKED	0.00467916	0.46541377729259076
GLYCEROL KINASE DEFICIENCY; GKD	0.00467916	0.46541377729259076
FACIAL DYSMORPHISM WITH MULTIPLE MALFORMATIONS	0.00467916	0.46541377729259076
MENTAL RETARDATION, AUTOSOMAL DOMINANT 30; MRD30	0.00467916	0.46541377729259076
INTESTINAL PSEUDOOBSTRUCTION, NEURONAL, CHRONIC IDIOPATHIC, X-LINKED	0.00467916	0.46541377729259076
SYNDROMIC DIARRHEA	0.00467916	0.46541377729259076
PONTOCEREBELLAR HYPOPLASIA, TYPE 1D; PCH1D	0.00467916	0.46541377729259076
CEREBROFACIOARTICULAR SYNDROME	0.00467916	0.46541377729259076
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIG; CDG2G	0.00467916	0.46541377729259076
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 63; EIEE63	0.00467916	0.46541377729259076
VERVERI-BRADY SYNDROME; VERBRAS	0.00467916	0.46541377729259076
7P22.1 MICRODUPLICATION SYNDROME	0.00467916	0.46541377729259076
%263630 POLYSYNDACTYLY WITH CARDIAC MALFORMATION;;BONNEAU SYNDROME	0.00467916	0.46541377729259076
49,XXXYY SYNDROME	0.00467916	0.46541377729259076
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IH; CDG1H	0.00467916	0.46541377729259076
%600325 AMINOPTERIN SYNDROME SINE AMINOPTERIN; ASSA;;PSEUDOAMINOPTERIN SYNDROME	0.00467916	0.46541377729259076
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 36; EIEE36	0.00467916	0.46541377729259076
COG1-CDG	0.00467916	0.46541377729259076
HYPERTELORISM AND OTHER FACIAL DYSMORPHISM, BRACHYDACTYLY, GENITAL ABNORMALITIES, MENTAL RETARDATION, AND RECURRENT INFLAMMATORY EPISODES	0.00467916	0.46541377729259076
ATELOSTEOGENESIS TYPE II	0.00467916	0.46541377729259076
GALLOWAY-MOWAT SYNDROME 5; GAMOS5	0.00467916	0.46541377729259076
AL-GAZALI-BAKALINOVA SYNDROME; AGBK	0.00467916	0.46541377729259076
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, KRAKOW TYPE; SEMDK	0.00456055	0.4536162050521301
SEIZURES-SCOLIOSIS-MACROCEPHALY SYNDROME	0.00456055	0.4536162050521301
AUTISM, SUSCEPTIBILITY TO, 18	0.00456055	0.4536162050521301
CEREBELLAR ATAXIA, NONPROGRESSIVE, WITH MENTAL RETARDATION; CANPMR	0.00456055	0.4536162050521301
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND THIN CORPUS CALLOSUM; PEBAT	0.00456055	0.4536162050521301
SEIZURES, SCOLIOSIS, AND MACROCEPHALY/MICROCEPHALY SYNDROME; SSMS	0.00456055	0.4536162050521301
CONGENITAL CATARACT-MICROCEPHALY-NEVUS FLAMMEUS SIMPLEX-SEVERE INTELLECTUAL DISABILITY SYNDROME	0.00456055	0.4536162050521301
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 6; CHNG6	0.00456055	0.4536162050521301
MOWAT-WILSON SYNDROME	0.00456055	0.4536162050521301
MENTAL RETARDATION, X-LINKED, SYNDROMIC, BAIN TYPE; MRXSB	0.00456055	0.4536162050521301
HYPERPHOSPHATASIA WITH MENTAL RETARDATION	0.00456055	0.4536162050521301
STICKLER SYNDROME, TYPE I	0.00419328	0.41708560597318217
COFFIN-SIRIS SYNDROME 1; CSS1	0.00419328	0.41708560597318217
KNOBLOCH SYNDROME	0.00419328	0.41708560597318217
KNIEST DYSPLASIA	0.00419328	0.41708560597318217
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND CORTICAL ATROPHY; NDMSCA	0.00419328	0.41708560597318217
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, CROSS TYPE	0.00419328	0.41708560597318217
VAN BOGAERT-HOZAY SYNDROME	0.00419328	0.41708560597318217
MENTAL RETARDATION, X-LINKED 99, SYNDROMIC, FEMALE-RESTRICTED	0.00419328	0.41708560597318217
ALPORT SYNDROME-INTELLECTUAL DISABILITY-MIDFACE HYPOPLASIA-ELLIPTOCYTOSIS SYNDROME	0.00419328	0.41708560597318217
IMMUNOOSSEOUS DYSPLASIA, SCHIMKE TYPE	0.00419328	0.41708560597318217
CARTILAGE-HAIR HYPOPLASIA	0.00419328	0.41708560597318217
ABLEPHARON MACROSTOMIA SYNDROME	0.00419328	0.41708560597318217
LAMB-SHAFFER SYNDROME	0.00419328	0.41708560597318217
EHLERS-DANLOS SYNDROME, TYPE VI	0.00419328	0.41708560597318217
IDIOPATHIC HYPEREOSINOPHILIC SYNDROME	0.00413223	0.41101325300732655
MITOCHONDRIAL NEUROGASTROINTESTINAL ENCEPHALOMYOPATHY	0.00413223	0.41101325300732655
ERDHEIM-CHESTER DISEASE	0.00413223	0.41101325300732655
KETAMINE-INDUCED BILIARY DILATATION	0.00413223	0.41101325300732655
AUTOIMMUNE HEPATITIS	0.00413223	0.41101325300732655
HENNEKAM-BEEMER SYNDROME	0.00413223	0.41101325300732655
GAUCHER DISEASE	0.00413223	0.41101325300732655
CASTLEMAN DISEASE	0.00413223	0.41101325300732655
POLYEMBRYOMA	0.00413223	0.41101325300732655
TETANUS	0.00413223	0.41101325300732655
KASABACH-MERRITT SYNDROME	0.00413223	0.41101325300732655
EOSINOPHILIC GASTROENTERITIS	0.00413223	0.41101325300732655
EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS	0.00413223	0.41101325300732655
PEDIATRIC HEPATOCELLULAR CARCINOMA	0.00413223	0.41101325300732655
CONGENITAL FIBRINOGEN DEFICIENCY	0.00413223	0.41101325300732655
NODULAR NON-SUPPURATIVE PANNICULITIS	0.00413223	0.41101325300732655
SYSTEMIC CAPILLARY LEAK SYNDROME	0.00413223	0.41101325300732655
WHIPPLE DISEASE	0.00413223	0.41101325300732655
FOCAL DERMAL HYPOPLASIA	0.00413223	0.41101325300732655
ISOLATED POLYCYSTIC LIVER DISEASE	0.00413223	0.41101325300732655
DUBIN-JOHNSON SYNDROME	0.00413223	0.41101325300732655
HEREDITARY ELLIPTOCYTOSIS	0.00413223	0.41101325300732655
PEUTZ-JEGHERS SYNDROME	0.00413223	0.41101325300732655
LYSOSOMAL ACID LIPASE DEFICIENCY	0.00413223	0.41101325300732655
CYCLIC NEUTROPENIA	0.00413223	0.41101325300732655
DENT DISEASE	0.00413223	0.41101325300732655
ROTOR SYNDROME	0.00413223	0.41101325300732655
TANGIER DISEASE	0.00413223	0.41101325300732655
STEVENS-JOHNSON SYNDROME	0.00413223	0.41101325300732655
HYPOCOMPLEMENTEMIC URTICARIAL VASCULITIS	0.00413223	0.41101325300732655
CONGENITAL PANCREATIC CYST	0.00413223	0.41101325300732655
CRONKHITE-CANADA SYNDROME	0.00413223	0.41101325300732655
OVARIAN FIBROMA	0.00413223	0.41101325300732655
MALIGNANT PERITONEAL MESOTHELIOMA	0.00413223	0.41101325300732655
SHORT STATURE DUE TO GHSR DEFICIENCY	0.00413223	0.41101325300732655
PRIMARY SCLEROSING CHOLANGITIS	0.00413223	0.41101325300732655
REACTIVE ARTHRITIS	0.00413223	0.41101325300732655
MÉNÉTRIER DISEASE	0.00413223	0.41101325300732655
SMALL CELL CARCINOMA OF THE BLADDER	0.00413223	0.41101325300732655
DEHYDRATED HEREDITARY STOMATOCYTOSIS	0.00413223	0.41101325300732655
MICROSPORIDIOSIS	0.00413223	0.41101325300732655
KLATSKIN TUMOR	0.00413223	0.41101325300732655
HEPATOCELLULAR CARCINOMA	0.00413223	0.41101325300732655
EPIDERMOLYSIS BULLOSA ACQUISITA	0.00413223	0.41101325300732655
HEREDITARY CHRONIC PANCREATITIS	0.00413223	0.41101325300732655
PANCREATOBLASTOMA	0.00413223	0.41101325300732655
CARNEY-STRATAKIS SYNDROME	0.00413223	0.41101325300732655
LIPOSARCOMA	0.00413223	0.41101325300732655
JUVENILE IDIOPATHIC ARTHRITIS	0.00413223	0.41101325300732655
YAO SYNDROME	0.00413223	0.41101325300732655
CHOLANGIOCARCINOMA	0.00413223	0.41101325300732655
ACQUIRED ANGIOEDEMA	0.00413223	0.41101325300732655
AGGRESSIVE SYSTEMIC MASTOCYTOSIS	0.00413223	0.41101325300732655
HEREDITARY ANGIOEDEMA	0.00413223	0.41101325300732655
IDIOPATHIC ACUTE EOSINOPHILIC PNEUMONIA	0.00413223	0.41101325300732655
MICROSCOPIC POLYANGIITIS	0.00413223	0.41101325300732655
PRIMARY INTESTINAL LYMPHANGIECTASIA	0.00413223	0.41101325300732655
CRYOGLOBULINEMIC VASCULITIS	0.00413223	0.41101325300732655
PERIODIC FEVER, FAMILIAL, AUTOSOMAL DOMINANT	0.00413223	0.41101325300732655
TROPICAL CALCIFIC PANCREATITIS	0.00413223	0.41101325300732655
OVARIAN HYPERSTIMULATION SYNDROME	0.00413223	0.41101325300732655
POLYARTERITIS NODOSA	0.00413223	0.41101325300732655
GAUCHER DISEASE TYPE 1	0.00413223	0.41101325300732655
SICKLE CELL ANEMIA	0.00413223	0.41101325300732655
FAMILIAL MEDITERRANEAN FEVER; FMF	0.00413223	0.41101325300732655
SAPHO SYNDROME	0.00413223	0.41101325300732655
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT-	0.00413223	0.41101325300732655
INFUNDIBULOPELVIC DYSGENESIS	0.00413223	0.41101325300732655
TREHALASE DEFICIENCY	0.00413223	0.41101325300732655
AUTOSOMAL DOMINANT SEVERE CONGENITAL NEUTROPENIA	0.00413223	0.41101325300732655
PRIMARY EFFUSION LYMPHOMA	0.00413223	0.41101325300732655
HEMOCHROMATOSIS, TYPE 1	0.00413223	0.41101325300732655
ANTERIOR CUTANEOUS NERVE ENTRAPMENT SYNDROME	0.00413223	0.41101325300732655
HERMANSKY-PUDLAK SYNDROME 1; HPS1	0.00413223	0.41101325300732655
TOXIC EPIDERMAL NECROLYSIS	0.00413223	0.41101325300732655
LYMPHANGIOLEIOMYOMATOSIS	0.00413223	0.41101325300732655
PLUMMER-VINSON SYNDROME	0.00413223	0.41101325300732655
CORTICOSTEROID-SENSITIVE ASEPTIC ABSCESS SYNDROME	0.00413223	0.41101325300732655
BURKITT LYMPHOMA	0.00413223	0.41101325300732655
CUSHING SYNDROME	0.00413223	0.41101325300732655
MALAKOPLAKIA	0.00413223	0.41101325300732655
SITOSTEROLEMIA	0.00413223	0.41101325300732655
CARCINOMA OF GALLBLADDER AND EXTRAHEPATIC BILIARY TRACT	0.00413223	0.41101325300732655
MUCKLE-WELLS SYNDROME	0.00413223	0.41101325300732655
CELIAC DISEASE, SUSCEPTIBILITY TO, 1; CELIAC1	0.00413223	0.41101325300732655
CONGENITAL PRIMARY MEGAURETER	0.00413223	0.41101325300732655
INFLAMMATORY BOWEL DISEASE 11	0.00413223	0.41101325300732655
LACTOSE INTOLERANCE, ADULT TYPE	0.00413223	0.41101325300732655
NEPHROBLASTOMA	0.00413223	0.41101325300732655
BENIGN RECURRENT INTRAHEPATIC CHOLESTASIS	0.00413223	0.41101325300732655
175500 POLYPOSIS, SKIN PIGMENTATION, ALOPECIA, AND FINGERNAIL CHANGES;;CRONKHITE-CANADA SYNDROME	0.00413223	0.41101325300732655
PEUTZ-JEGHERS SYNDROME	0.00413223	0.41101325300732655
COMPLEMENT HYPERACTIVATION, ANGIOPATHIC THROMBOSIS, AND PROTEIN-LOSING ENTEROPATHY; CHAPLE	0.00413223	0.41101325300732655
PANCREATITIS, HEREDITARY	0.00413223	0.41101325300732655
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 28	0.00413223	0.41101325300732655
CHYLOMICRONEMIA, FAMILIAL, DUE TO CIRCULATING INHIBITOR OF LIPOPROTEINLIPASE	0.00413223	0.41101325300732655
ACUTE PROMYELOCYTIC LEUKEMIA	0.00413223	0.41101325300732655
SCLERODERMA	0.00413223	0.41101325300732655
ALPHA-HEAVY CHAIN DISEASE	0.00413223	0.41101325300732655
NEUROENDOCRINE TUMOR OF THE COLON	0.00413223	0.41101325300732655
CELIAC ARTERY STENOSIS FROM COMPRESSION BY MEDIAN ARCUATE LIGAMENTOF DIAPHRAGM	0.00413223	0.41101325300732655
FABRY DISEASE	0.00413223	0.41101325300732655
SHIGA TOXIN-ASSOCIATED HEMOLYTIC UREMIC SYNDROME	0.00413223	0.41101325300732655
ANEMIA, NONSPHEROCYTIC HEMOLYTIC, DUE TO G6PD DEFICIENCY	0.00413223	0.41101325300732655
NEUROBLASTOMA, SUSCEPTIBILITY TO	0.00413223	0.41101325300732655
CHRONIC GRAFT VERSUS HOST DISEASE	0.00413223	0.41101325300732655
FAMILIAL PANCREATIC CARCINOMA	0.00413223	0.41101325300732655
260570 PELGER-HUET-LIKE ANOMALY AND EPISODIC FEVER WITH ABDOMINAL PAIN	0.00413223	0.41101325300732655
BUDD-CHIARI SYNDROME	0.00413223	0.41101325300732655
GCGR-RELATED HYPERGLUCAGONEMIA	0.00413223	0.41101325300732655
ADENOCARCINOMA OF THE ANAL CANAL	0.00413223	0.41101325300732655
SQUAMOUS CELL CARCINOMA OF THE ANAL CANAL	0.00413223	0.41101325300732655
AUTOSOMAL DOMINANT HYPOCALCEMIA	0.00413223	0.41101325300732655
VISCERAL MYOPATHY, FAMILIAL, WITH EXTERNAL OPHTHALMOPLEGIA	0.00413223	0.41101325300732655
MYXOID/ROUND CELL LIPOSARCOMA	0.00413223	0.41101325300732655
SYSTEMIC-ONSET JUVENILE IDIOPATHIC ARTHRITIS	0.00413223	0.41101325300732655
5-@OXOPROLINASE DEFICIENCY; OPLAHD	0.00413223	0.41101325300732655
AA AMYLOIDOSIS	0.00413223	0.41101325300732655
HEREDITARY ANGIOEDEMA TYPE 1	0.00413223	0.41101325300732655
ANGIOEDEMA, HEREDITARY, TYPE I; HAE1	0.00413223	0.41101325300732655
HEMOCHROMATOSIS TYPE 4	0.00413223	0.41101325300732655
FAMILIAL PROGRESSIVE CARDIAC CONDUCTION DEFECT	0.00413223	0.41101325300732655
GRAFT VERSUS HOST DISEASE	0.00413223	0.41101325300732655
POMT1-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R11	0.00413223	0.41101325300732655
HEREDITARY SPHEROCYTOSIS	0.00413223	0.41101325300732655
DESMOPLASTIC SMALL ROUND CELL TUMOR	0.00413223	0.41101325300732655
ADRENOCORTICAL CARCINOMA	0.00413223	0.41101325300732655
HEPATIC VENO-OCCLUSIVE DISEASE	0.00413223	0.41101325300732655
DESMOID TUMOR	0.00413223	0.41101325300732655
PAROXYSMAL NOCTURNAL HEMOGLOBINURIA	0.00413223	0.41101325300732655
ADULT-ONSET STILL DISEASE	0.00413223	0.41101325300732655
CHOLESTASIS-LYMPHEDEMA SYNDROME	0.00413223	0.41101325300732655
OBESITY-COLITIS-HYPOTHYROIDISM-CARDIAC HYPERTROPHY-DEVELOPMENTAL DELAY SYNDROME	0.00390625	0.38853609783576165
NARCOLEPSY 7; NRCLP7	0.00390625	0.38853609783576165
HYPERCHOLESTEROLEMIA DUE TO CHOLESTEROL 7ALPHA-HYDROXYLASE DEFICIENCY	0.00390625	0.38853609783576165
LEPTIN DEFICIENCY OR DYSFUNCTION	0.00390625	0.38853609783576165
CARPENTER SYNDROME	0.00390625	0.38853609783576165
HYPOGONADOTROPIC HYPOGONADISM-RETINITIS PIGMENTOSA SYNDROME	0.00390625	0.38853609783576165
LEPTIN RECEPTOR DEFICIENCY; LEPRD	0.00390625	0.38853609783576165
X-LINKED INTELLECTUAL DISABILITY, HEDERA TYPE	0.00390625	0.38853609783576165
264010 PRADER-WILLI HABITUS, OSTEOPENIA, AND CAMPTODACTYLY;;URBAN-ROGERS-MEYER SYNDROME	0.00390625	0.38853609783576165
MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 11	0.00390625	0.38853609783576165
MALE HYPERGONADOTROPIC HYPOGONADISM-INTELLECTUAL DISABILITY-SKELETAL ANOMALIES SYNDROME	0.00390625	0.38853609783576165
HYPOGONADISM-MITRAL VALVE PROLAPSE-INTELLECTUAL DISABILITY SYNDROME	0.00390625	0.38853609783576165
ACROCEPHALOSYNDACTYLY	0.00390625	0.38853609783576165
RING CHROMOSOME Y SYNDROME	0.00390625	0.38853609783576165
ANKYLOSING VERTEBRAL HYPEROSTOSIS WITH TYLOSIS	0.00390625	0.38853609783576165
HYDROCEPHALUS-OBESITY-HYPOGONADISM SYNDROME	0.00390625	0.38853609783576165
MODY	0.00390625	0.38853609783576165
269870 SHORT STATURE-OBESITY SYNDROME; SSOS	0.00390625	0.38853609783576165
PROLACTIN DEFICIENCY WITH OBESITY AND ENLARGED TESTES	0.00390625	0.38853609783576165
SEVERE EARLY-ONSET OBESITY-INSULIN RESISTANCE SYNDROME DUE TO SH2B1 DEFICIENCY	0.00390625	0.38853609783576165
HALOTHANE HEPATITIS	0.00390625	0.38853609783576165
MICRODUPLICATION XP11.22P11.23 SYNDROME	0.00390625	0.38853609783576165
OBESITY, HYPERPHAGIA, AND DEVELOPMENTAL DELAY; OBHD	0.00390625	0.38853609783576165
SUMMITT SYNDROME	0.00390625	0.38853609783576165
X-LINKED INTELLECTUAL DISABILITY, TURNER TYPE	0.00390625	0.38853609783576165
JOUBERT SYNDROME 8	0.00390625	0.38853609783576165
BORJESON-FORSSMAN-LEHMANN SYNDROME; BFLS	0.00390625	0.38853609783576165
MICROCEPHALIC PRIMORDIAL DWARFISM, DAUBER TYPE	0.00390625	0.38853609783576165
RETINITIS PIGMENTOSA-INTELLECTUAL DISABILITY-DEAFNESS-HYPOGONADISM SYNDROME	0.00390625	0.38853609783576165
PSEUDOHYPOPARATHYROIDISM, TYPE IB	0.00390625	0.38853609783576165
248100 MACROSOMIA ADIPOSA CONGENITA	0.00390625	0.38853609783576165
BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 9; BMIQ9	0.00390625	0.38853609783576165
AROMATASE DEFICIENCY	0.00390625	0.38853609783576165
RETINITIS PIGMENTOSA	0.00390625	0.38853609783576165
COLOBOMA-OBESITY-HYPOGENITALISM-MENTAL RETARDATION SYNDROME	0.00390625	0.38853609783576165
OBESITY	0.00390625	0.38853609783576165
SERTOLI CELL-ONLY SYNDROME	0.00390625	0.38853609783576165
WILSON-TURNER X-LINKED MENTAL RETARDATION SYNDROME; WTS	0.00390625	0.38853609783576165
PROPROTEIN CONVERTASE 1/3 DEFICIENCY	0.00390625	0.38853609783576165
METAPHYSEAL DYSOSTOSIS, MENTAL RETARDATION, AND CONDUCTIVE DEAFNESS	0.00390625	0.38853609783576165
SUBAORTIC STENOSIS-SHORT STATURE SYNDROME	0.00390625	0.38853609783576165
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.00390625	0.38853609783576165
BARDET-BIEDL SYNDROME 3; BBS3	0.00390625	0.38853609783576165
MALE PSEUDOHERMAPHRODITISM/MENTAL RETARDATION SYNDROME, VERLOES TYPE	0.00390625	0.38853609783576165
NARCOLEPSY TYPE 1	0.00390625	0.38853609783576165
X-LINKED INTELLECTUAL DISABILITY-PSYCHOSIS-MACROORCHIDISM SYNDROME	0.00390625	0.38853609783576165
ULNAR-MAMMARY SYNDROME	0.00390625	0.38853609783576165
CENTRAL PRECOCIOUS PUBERTY	0.00390625	0.38853609783576165
OBESITY DUE TO CONGENITAL LEPTIN DEFICIENCY	0.00390625	0.38853609783576165
X-LINKED INTELLECTUAL DISABILITY-HYPOGONADISM-ICHTHYOSIS-OBESITY-SHORT STATURE SYNDROME	0.00390625	0.38853609783576165
WAGR SYNDROME	0.00390625	0.38853609783576165
3Q29 MICRODUPLICATION SYNDROME	0.00390625	0.38853609783576165
EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.00390625	0.38853609783576165
SHOX-RELATED SHORT STATURE	0.00390625	0.38853609783576165
HYPOGONADOTROPIC HYPOGONADISM 4 WITH OR WITHOUT ANOSMIA; HH4	0.00390625	0.38853609783576165
CARCINOMA OF ESOPHAGUS	0.00390625	0.38853609783576165
X-LINKED INTELLECTUAL DISABILITY, SHASHI TYPE	0.00390625	0.38853609783576165
MEHMO SYNDROME	0.00390625	0.38853609783576165
CLARK-BARAITSER SYNDROME	0.00390625	0.38853609783576165
SYNDROMIC X-LINKED INTELLECTUAL DISABILITY 7	0.00390625	0.38853609783576165
OBESITY-HYPOVENTILATION SYNDROME	0.00390625	0.38853609783576165
CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION	0.00390625	0.38853609783576165
OBESITY, EARLY-ONSET, WITH ADRENAL INSUFFICIENCY AND RED HAIR; OBAIRH	0.00390625	0.38853609783576165
KABUKI SYNDROME	0.00390625	0.38853609783576165
LAURENCE-MOON SYNDROME	0.00390625	0.38853609783576165
BARDET-BIEDL SYNDROME 6; BBS6	0.00390625	0.38853609783576165
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 15; COXPD15	0.00390625	0.38853609783576165
HERNÁNDEZ-AGUIRRE NEGRETE SYNDROME	0.00390625	0.38853609783576165
BARDET-BIEDL SYNDROME 11; BBS11	0.00390625	0.38853609783576165
BARDET-BIEDL SYNDROME 13; BBS13	0.00390625	0.38853609783576165
SEVERE INTELLECTUAL DISABILITY-HYPOTONIA-STRABISMUS-COARSE FACE-PLANOVALGUS SYNDROME	0.00390625	0.38853609783576165
BARDET-BIEDL SYNDROME 14; BBS14	0.00390625	0.38853609783576165
BARDET-BIEDL SYNDROME	0.00390625	0.38853609783576165
BARDET-BIEDL SYNDROME 17; BBS17	0.00390625	0.38853609783576165
BARDET-BIEDL SYNDROME 18; BBS18	0.00390625	0.38853609783576165
BARDET-BIEDL SYNDROME 19; BBS19	0.00390625	0.38853609783576165
THUMB STIFFNESS-BRACHYDACTYLY-INTELLECTUAL DISABILITY SYNDROME	0.00390625	0.38853609783576165
PERIPHERAL NEUROPATHY, AUTOSOMAL RECESSIVE, WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; PNRIID	0.00390625	0.38853609783576165
AUTOSOMAL RECESSIVE EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.00390625	0.38853609783576165
AUTOSOMAL DOMINANT EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.00390625	0.38853609783576165
BETA-MERCAPTOLACTATE CYSTEINE DISULFIDURIA	0.00390625	0.38853609783576165
144800 HYPEROSTOSIS FRONTALIS INTERNA;;MORGAGNI-STEWART-MOREL SYNDROME	0.00390625	0.38853609783576165
TRIGLYCERIDE STORAGE DISEASE, TYPE II	0.00390625	0.38853609783576165
URBAN-ROGERS-MEYER SYNDROME	0.00390625	0.38853609783576165
RETINITIS PIGMENTOSA 71; RP71	0.00390625	0.38853609783576165
DISTAL MONOSOMY 12Q	0.00390625	0.38853609783576165
PSEUDOHYPOPARATHYROIDISM WITH ALBRIGHT HEREDITARY OSTEODYSTROPHY	0.00390625	0.38853609783576165
MENTAL RETARDATION, AUTOSOMAL DOMINANT 39	0.00390625	0.38853609783576165
ULNAR-MAMMARY SYNDROME; UMS	0.00390625	0.38853609783576165
SENIOR-LOKEN SYNDROME 9	0.00390625	0.38853609783576165
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 3; SEMDJL3	0.00390625	0.38853609783576165
KALLMANN SYNDROME	0.00390625	0.38853609783576165
MONOSOMY 22Q13.3	0.00390625	0.38853609783576165
BARDET-BIEDL SYNDROME 20	0.00390625	0.38853609783576165
BARDET-BIEDL SYNDROME 12; BBS12	0.00390625	0.38853609783576165
BARDET-BIEDL SYNDROME 16; BBS16	0.00390625	0.38853609783576165
BARDET-BIEDL SYNDROME 10; BBS10	0.00390625	0.38853609783576165
BARDET-BIEDL SYNDROME 5; BBS5	0.00390625	0.38853609783576165
XQ21 MICRODELETION SYNDROME	0.00390625	0.38853609783576165
SHORT-RIB THORACIC DYSPLASIA 10 WITH OR WITHOUT POLYDACTYLY; SRTD10	0.00390625	0.38853609783576165
HELSMOORTEL-VAN DER AA SYNDROME	0.00390625	0.38853609783576165
BIEMOND SYNDROME TYPE 2	0.00390625	0.38853609783576165
ADENOCARCINOMA OF THE ESOPHAGUS	0.00390625	0.38853609783576165
DYSBETALIPOPROTEINEMIA	0.00390625	0.38853609783576165
ATAXIA-OCULOMOTOR APRAXIA TYPE 4	0.00390625	0.38853609783576165
BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 19; BMIQ19	0.00390625	0.38853609783576165
OBESITY DUE TO LEPTIN RECEPTOR GENE DEFICIENCY	0.00390625	0.38853609783576165
BARDET-BIEDL SYNDROME 2	0.00390625	0.38853609783576165
BARDET-BIEDL SYNDROME 4; BBS4	0.00390625	0.38853609783576165
BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 20; BMIQ20	0.00390625	0.38853609783576165
BARDET-BIEDL SYNDROME 8; BBS8	0.00390625	0.38853609783576165
SPASTIC PARAPLEGIA-INTELLECTUAL DISABILITY-NYSTAGMUS-OBESITY SYNDROME	0.00390625	0.38853609783576165
45,X/46,XY MIXED GONADAL DYSGENESIS	0.00390625	0.38853609783576165
X-LINKED EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.00390625	0.38853609783576165
BARDET-BIEDL SYNDROME 9; BBS9	0.00390625	0.38853609783576165
BARDET-BIEDL SYNDROME 7; BBS7	0.00390625	0.38853609783576165
IRIDOGONIODYSGENESIS, TYPE 2	0.00369004	0.3670307180692158
NEURODEVELOPMENTAL DISORDER WITH ATAXIC GAIT, ABSENT SPEECH, AND DECREASED CORTICAL WHITE MATTER; NDAGSCW	0.00369004	0.3670307180692158
SÉZARY SYNDROME	0.00369004	0.3670307180692158
CARDIAC, FACIAL, AND DIGITAL ANOMALIES WITH DEVELOPMENTAL DELAY; CAFDADD	0.00369004	0.3670307180692158
AUTOSOMAL DOMINANT DEAFNESS-ONYCHODYSTROPHY SYNDROME	0.00369004	0.3670307180692158
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-MOVEMENT DISORDER SYNDROME	0.00369004	0.3670307180692158
GALLOWAY-MOWAT SYNDROME 8; GAMOS8	0.00369004	0.3670307180692158
GALLOWAY-MOWAT SYNDROME 7; GAMOS7	0.00369004	0.3670307180692158
GALLOWAY-MOWAT SYNDROME 6; GAMOS6	0.00369004	0.3670307180692158
IMMUNODEFICIENCY 55; IMD55	0.00369004	0.3670307180692158
INTRAUTERINE GROWTH RETARDATION WITH INCREASED MITOMYCIN C SENSITIVITY	0.00369004	0.3670307180692158
CONGENITAL CATARACTS, FACIAL DYSMORPHISM, AND NEUROPATHY; CCFDN	0.00369004	0.3670307180692158
BONE MARROW FAILURE SYNDROME 4; BMFS4	0.00369004	0.3670307180692158
KENNERKNECHT SYNDROME	0.00369004	0.3670307180692158
SPINOCEREBELLAR ATAXIA 47; SCA47	0.00369004	0.3670307180692158
HYDROCEPHALUS, CONGENITAL, 3, WITH BRAIN ANOMALIES; HYC3	0.00369004	0.3670307180692158
3-PHOSPHOSERINE PHOSPHATASE DEFICIENCY	0.00369004	0.3670307180692158
MANNOSIDOSIS, BETA A, LYSOSOMAL	0.00369004	0.3670307180692158
FOCAL FACIAL DERMAL DYSPLASIA TYPE I	0.00369004	0.3670307180692158
3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.00369004	0.3670307180692158
AUTOSOMAL DOMINANT INTELLECTUAL DISABILITY-CRANIOFACIAL ANOMALIES-CARDIAC DEFECTS SYNDROME	0.00369004	0.3670307180692158
ARTHROGRYPOSIS AND ECTODERMAL DYSPLASIA	0.00369004	0.3670307180692158
SYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.00369004	0.3670307180692158
FACIAL DYSMORPHISM, LENS DISLOCATION, ANTERIOR SEGMENT ABNORMALITIES, AND SPONTANEOUS FILTERING BLEBS; FDLAB	0.00369004	0.3670307180692158
MEGAEPIPHYSEAL DWARFISM	0.00369004	0.3670307180692158
601095 HARROD SYNDROME	0.00369004	0.3670307180692158
BRACHYMORPHISM-ONYCHODYSPLASIA-DYSPHALANGISM SYNDROME	0.00369004	0.3670307180692158
PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY; PDHAD	0.00369004	0.3670307180692158
CAMURATI-ENGELMANN DISEASE	0.00369004	0.3670307180692158
MENTAL RETARDATION, X-LINKED 14	0.00369004	0.3670307180692158
BETA-MANNOSIDOSIS	0.00369004	0.3670307180692158
X-LINKED MICROCEPHALY-GROWTH RETARDATION-PROGNATHISM-CRYPTORCHIDISM SYNDROME	0.00369004	0.3670307180692158
ESOPHAGEAL ATRESIA	0.00369004	0.3670307180692158
X-LINKED INTELLECTUAL DISABILITY, CILLIERS TYPE	0.00369004	0.3670307180692158
SEVERE MOTOR AND INTELLECTUAL DISABILITIES-SENSORINEURAL DEAFNESS-DYSTONIA SYNDROME	0.00369004	0.3670307180692158
OROFACIODIGITAL SYNDROME TYPE 14	0.00369004	0.3670307180692158
SSR4-CDG	0.00369004	0.3670307180692158
CUBITUS VALGUS WITH MENTAL RETARDATION AND UNUSUAL FACIES	0.00369004	0.3670307180692158
OVERGROWTH-MACROCEPHALY-FACIAL DYSMORPHISM SYNDROME	0.00369004	0.3670307180692158
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO STUB1 DEFICIENCY	0.00369004	0.3670307180692158
GLYCOGEN STORAGE DISEASE OF HEART, LETHAL CONGENITAL	0.00369004	0.3670307180692158
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO TUD DEFICIENCY	0.00369004	0.3670307180692158
RODRIGUES BLINDNESS	0.00369004	0.3670307180692158
AUTOSOMAL RECESSIVE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.00369004	0.3670307180692158
CRISS-CROSS HEART	0.00369004	0.3670307180692158
CAUDAL APPENDAGE-DEAFNESS SYNDROME	0.00369004	0.3670307180692158
DEAFNESS, DYSTONIA, AND CEREBRAL HYPOMYELINATION; DDCH	0.00369004	0.3670307180692158
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 9B	0.00369004	0.3670307180692158
PGM3-CDG	0.00369004	0.3670307180692158
BRAIN ABNORMALITIES, NEURODEGENERATION, AND DYSOSTEOSCLEROSIS; BANDDOS	0.00369004	0.3670307180692158
CEREBELLAR-FACIAL-DENTAL SYNDROME	0.00369004	0.3670307180692158
118230 CHARCOT-MARIE-TOOTH DISEASE, GUADALAJARA NEURONAL TYPE	0.00369004	0.3670307180692158
CEREBELLAR ATROPHY WITH SEIZURES AND VARIABLE DEVELOPMENTAL DELAY; CASVDD	0.00369004	0.3670307180692158
CORPUS CALLOSUM, PARTIAL AGENESIS OF, X-LINKED	0.00369004	0.3670307180692158
FREE SIALIC ACID STORAGE DISEASE	0.00369004	0.3670307180692158
O'DONNELL-LURIA-RODAN SYNDROME; ODLURO	0.00369004	0.3670307180692158
TRANSALDOLASE DEFICIENCY	0.00369004	0.3670307180692158
X-LINKED INTELLECTUAL DISABILITY-CUBITUS VALGUS-DYSMORPHISM SYNDROME	0.00369004	0.3670307180692158
HAIRY ELBOWS	0.00369004	0.3670307180692158
NEPHROSIALIDOSIS	0.00369004	0.3670307180692158
MENTAL RETARDATION, X-LINKED 102	0.00369004	0.3670307180692158
MENTAL RETARDATION, X-LINKED 100	0.00369004	0.3670307180692158
PONTOCEREBELLAR HYPOPLASIA TYPE 4	0.00369004	0.3670307180692158
BRACHYDACTYLY-SHORT STATURE-RETINITIS PIGMENTOSA SYNDROME	0.00369004	0.3670307180692158
AORTIC ARCH ANOMALY WITH PECULIAR FACIES AND MENTAL RETARDATION	0.00369004	0.3670307180692158
ADENYLOSUCCINATE LYASE DEFICIENCY	0.00369004	0.3670307180692158
MENTAL RETARDATION, AUTOSOMAL DOMINANT 48; MRD48	0.00369004	0.3670307180692158
%606242 MENTAL RETARDATION, MICROCEPHALY, GROWTH RETARDATION, JOINT CONTRACTURES,AND FACIAL DYSMORPHISM;;KONDOH SYNDROME	0.00369004	0.3670307180692158
SPASTIC PARAPLEGIA 9B, AUTOSOMAL RECESSIVE; SPG9B	0.00369004	0.3670307180692158
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 3; MCCRP3	0.00369004	0.3670307180692158
CHROMOSOME 17Q23.1-Q23.2 DELETION SYNDROME	0.00369004	0.3670307180692158
DEXTROCARDIA WITH UNUSUAL FACIES AND MICROPHTHALMIA	0.00369004	0.3670307180692158
ZECHI-CEIDE SYNDROME	0.00369004	0.3670307180692158
MICROCEPHALY-CORPUS CALLOSUM AND CEREBELLAR VERMIS HYPOPLASIA-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROM	0.00369004	0.3670307180692158
DIAMOND-BLACKFAN ANEMIA 4	0.00369004	0.3670307180692158
MENTAL RETARDATION, AUTOSOMAL DOMINANT 52; MRD52	0.00369004	0.3670307180692158
LARON SYNDROME	0.00369004	0.3670307180692158
SHORT STATURE-WEBBED NECK-HEART DISEASE SYNDROME	0.00369004	0.3670307180692158
NEPHROTIC SYNDROME, TYPE 11; NPHS11	0.00369004	0.3670307180692158
CHROMOSOME 16P13.2 DELETION SYNDROME	0.00369004	0.3670307180692158
DILATED CARDIOMYOPATHY WITH ATAXIA	0.00369004	0.3670307180692158
SRD5A3-CDG	0.00369004	0.3670307180692158
HIRSCHSPRUNG DISEASE WITH HYPOPLASTIC NAILS AND DYSMORPHIC FACIALFEATURES	0.00369004	0.3670307180692158
AUTOIMMUNE DISEASE, MULTISYSTEM, WITH FACIAL DYSMORPHISM; ADMFD	0.00369004	0.3670307180692158
ISOLATED BILIARY ATRESIA	0.00369004	0.3670307180692158
ISOLATED AGAMMAGLOBULINEMIA	0.00369004	0.3670307180692158
SAGLIKER SYNDROME	0.00369004	0.3670307180692158
HYDROCEPHALUS, CONGENITAL, 2, WITH OR WITHOUT BRAIN OR EYE ANOMALIES; HYC2	0.00369004	0.3670307180692158
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 20	0.00369004	0.3670307180692158
BRAIN-LUNG-THYROID SYNDROME	0.00369004	0.3670307180692158
OROFACIODIGITAL SYNDROME XIV; OFD14	0.00369004	0.3670307180692158
TORIELLO-LACASSIE-DROSTE SYNDROME	0.00369004	0.3670307180692158
MENTAL RETARDATION, AUTOSOMAL DOMINANT 13	0.00369004	0.3670307180692158
PSYCHOMOTOR RETARDATION, EPILEPSY, AND CRANIOFACIAL DYSMORPHISM	0.00369004	0.3670307180692158
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIJ; CDG2J	0.00369004	0.3670307180692158
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 33	0.00369004	0.3670307180692158
IMMUNODEFICIENCY BY DEFECTIVE EXPRESSION OF MHC CLASS II	0.00369004	0.3670307180692158
ALG11-CDG	0.00369004	0.3670307180692158
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY AND SEVERE EPILEPSY	0.00369004	0.3670307180692158
3-METHYLGLUTACONIC ACIDURIA WITH CATARACTS, NEUROLOGIC INVOLVEMENT, AND NEUTROPENIA; MEGCANN	0.00369004	0.3670307180692158
MATERNAL PHENYLKETONURIA	0.00369004	0.3670307180692158
SYNDROMIC MULTISYSTEM AUTOIMMUNE DISEASE DUE TO ITCH DEFICIENCY	0.00369004	0.3670307180692158
233430 GONADAL DYSGENESIS, XY TYPE, WITH ASSOCIATED ANOMALIES	0.00369004	0.3670307180692158
T-B+ SEVERE COMBINED IMMUNODEFICIENCY DUE TO JAK3 DEFICIENCY	0.00369004	0.3670307180692158
EPILEPSY, EARLY-ONSET, VITAMIN B6-DEPENDENT; EPVB6D	0.00369004	0.3670307180692158
KLEEFSTRA SYNDROME 2; KLEFS2	0.00369004	0.3670307180692158
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IG; CDG1G	0.00369004	0.3670307180692158
HYPOHIDROTIC ECTODERMAL DYSPLASIA	0.00369004	0.3670307180692158
B4GALT7-RELATED SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.00369004	0.3670307180692158
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 55	0.00369004	0.3670307180692158
608227 CRANIOFACIAL ABNORMALITIES, CATARACTS, CONGENITAL HEART DISEASE, SACRALNEURAL TUBE DEFECTS, AND GROWTH AND DEVELOPMENTAL RETARDATION	0.00369004	0.3670307180692158
608432 CRANIOSYNOSTOSIS, CALCIFICATION OF BASAL GANGLIA, AND FACIAL DYSMORPHISM	0.00369004	0.3670307180692158
HYPOSPADIAS-MENTAL RETARDATION SYNDROME	0.00369004	0.3670307180692158
ECTODERMAL DYSPLASIA-BLINDNESS SYNDROME	0.00369004	0.3670307180692158
GROWTH HORMONE INSENSITIVITY SYNDROME	0.00369004	0.3670307180692158
STRUCTURAL HEART DEFECTS AND RENAL ANOMALIES SYNDROME	0.00369004	0.3670307180692158
DENTINOGENESIS IMPERFECTA-SHORT STATURE-HEARING LOSS-INTELLECTUAL DISABILITY SYNDROME	0.00369004	0.3670307180692158
MICROCEPHALIC PRIMORDIAL DWARFISM DUE TO RTTN DEFICIENCY	0.00369004	0.3670307180692158
SPINOCEREBELLAR ATAXIA TYPE 13	0.00369004	0.3670307180692158
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIE; CDG2E	0.00369004	0.3670307180692158
610680 HOLOPROSENCEPHALY, RECURRENT INFECTIONS, AND MONOCYTOSIS	0.00369004	0.3670307180692158
LUNG DISEASE, IMMUNODEFICIENCY, AND CHROMOSOME BREAKAGE SYNDROME; LICS	0.00369004	0.3670307180692158
%236795 3-@HYDROXYISOBUTYRIC ACIDURIA	0.00369004	0.3670307180692158
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 2; COXPD2	0.00369004	0.3670307180692158
PERIVENTRICULAR NODULAR HETEROTOPIA 7; PVNH7	0.00369004	0.3670307180692158
OCHOA SYNDROME	0.00357143	0.35523314582875504
DIABETES INSIPIDUS, NEPHROGENIC, AUTOSOMAL	0.00357143	0.35523314582875504
THYROID ECTOPIA	0.00357143	0.35523314582875504
ANAL SPHINCTER MYOPATHY, INTERNAL	0.00357143	0.35523314582875504
HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1; HSCR1	0.00357143	0.35523314582875504
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB; MEN2B	0.00357143	0.35523314582875504
ATHYREOSIS	0.00357143	0.35523314582875504
ADULT-ONSET AUTOSOMAL DOMINANT LEUKODYSTROPHY	0.00357143	0.35523314582875504
PRIMARY CONGENITAL HYPOTHYROIDISM WITHOUT THYROID DEVELOPMENTAL ANOMALY	0.00357143	0.35523314582875504
HYPERPARATHYROIDISM, NEONATAL SEVERE	0.00357143	0.35523314582875504
CONGENITAL HYPOTHYROIDISM DUE TO TRANSPLACENTAL PASSAGE OF TSH-BINDING INHIBITORY ANTIBODIES	0.00357143	0.35523314582875504
FAMILIAL THYROID DYSHORMONOGENESIS	0.00357143	0.35523314582875504
THYROID HYPOPLASIA	0.00357143	0.35523314582875504
YOUNG-ONSET PARKINSON DISEASE	0.00357143	0.35523314582875504
IDIOPATHIC CONGENITAL HYPOTHYROIDISM	0.00357143	0.35523314582875504
CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL; CCHS	0.00357143	0.35523314582875504
HYPOTHYROIDISM DUE TO TSH RECEPTOR MUTATIONS	0.00357143	0.35523314582875504
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 2	0.00357143	0.35523314582875504
COMBINED PITUITARY HORMONE DEFICIENCIES, GENETIC FORMS	0.00357143	0.35523314582875504
RESISTANCE TO THYROTROPIN-RELEASING HORMONE SYNDROME	0.00357143	0.35523314582875504
NIEMANN-PICK DISEASE, TYPE A	0.00357143	0.35523314582875504
PANHYPOPITUITARISM	0.00357143	0.35523314582875504
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE III	0.00357143	0.35523314582875504
PARKINSON DISEASE, LATE-ONSET; PD	0.00357143	0.35523314582875504
RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA, GENERALIZED INTERMEDIATE	0.00357143	0.35523314582875504
ISOLATED THYROID-STIMULATING HORMONE DEFICIENCY	0.00357143	0.35523314582875504
HOLOPROSENCEPHALY 2; HPE2	0.00357143	0.35523314582875504
HYPOPHOSPHATASIA, INFANTILE	0.00357143	0.35523314582875504
SECONDARY SHORT BOWEL SYNDROME	0.00357143	0.35523314582875504
MYXEDEMA	0.00357143	0.35523314582875504
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY	0.00357143	0.35523314582875504
%193250 VOLVULUS OF MIDGUT;;INTESTINAL MALROTATION, FAMILIAL	0.00357143	0.35523314582875504
KAPUR-TORIELLO SYNDROME	0.00357143	0.35523314582875504
MULTIPLE SYSTEM ATROPHY, PARKINSONIAN TYPE	0.00357143	0.35523314582875504
THYROID HEMIAGENESIS	0.00357143	0.35523314582875504
NEUROFERRITINOPATHY	0.00357143	0.35523314582875504
RETT SYNDROME, CONGENITAL VARIANT	0.00357143	0.35523314582875504
MATERNALLY-INHERITED DIABETES AND DEAFNESS	0.00357143	0.35523314582875504
SOLITARY FIBROUS TUMOUR/HEMANGIOPERICYTOMA	0.00357143	0.35523314582875504
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IR	0.00357143	0.35523314582875504
PITT-HOPKINS-LIKE SYNDROME 2; PTHSL2	0.00357143	0.35523314582875504
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL DOMINANT; NDHMSD	0.00357143	0.35523314582875504
ALEXANDER DISEASE	0.00357143	0.35523314582875504
GASTROINTESTINAL STROMAL TUMOR	0.00357143	0.35523314582875504
SPASTIC PARAPLEGIA 44, AUTOSOMAL RECESSIVE; SPG44	0.00357143	0.35523314582875504
PARKINSONISM-DYSTONIA, INFANTILE, 1; PKDYS1	0.00357143	0.35523314582875504
NEPHROGENIC DIABETES INSIPIDUS	0.00357143	0.35523314582875504
PERMANENT CONGENITAL HYPOTHYROIDISM	0.00357143	0.35523314582875504
611961 STEVENSON-CAREY SYNDROME	0.00357143	0.35523314582875504
CENTRAL CONGENITAL HYPOTHYROIDISM	0.00357143	0.35523314582875504
HYPOTHYROIDISM DUE TO DEFICIENT TRANSCRIPTION FACTORS INVOLVED IN PITUITARY DEVELOPMENT OR FUNCTION	0.00357143	0.35523314582875504
WOUND BOTULISM	0.00357143	0.35523314582875504
PERIPHERAL HYPOTHYROIDISM	0.00357143	0.35523314582875504
AUTOSOMAL RECESSIVE DOPA-RESPONSIVE DYSTONIA	0.00357143	0.35523314582875504
CONGENITAL HYPOTHYROIDISM DUE TO MATERNAL INTAKE OF ANTITHYROID DRUGS	0.00357143	0.35523314582875504
MULTIPLE SYSTEM ATROPHY	0.00357143	0.35523314582875504
MULTIPLE SYSTEM ATROPHY, CEREBELLAR TYPE	0.00357143	0.35523314582875504
CONGENITAL HYPOTHYROIDISM	0.00357143	0.35523314582875504
PEROXISOME BIOGENESIS DISORDER 8B; PBD8B	0.00357143	0.35523314582875504
PRUNE BELLY SYNDROME	0.00357143	0.35523314582875504
LIDDLE SYNDROME	0.00357143	0.35523314582875504
X-LINKED CREATINE TRANSPORTER DEFICIENCY	0.00357143	0.35523314582875504
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 32; COXPD32	0.00357143	0.35523314582875504
CONGENITAL HEART DEFECTS AND SKELETAL MALFORMATIONS SYNDROME; CHDSKM	0.00357143	0.35523314582875504
VPS11-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.00357143	0.35523314582875504
INTELLECTUAL DISABILITY-EPILEPSY-EXTRAPYRAMIDAL SYNDROME	0.00357143	0.35523314582875504
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 51; EIEE51	0.00357143	0.35523314582875504
PROPIONIC ACIDEMIA	0.00357143	0.35523314582875504
WOLFRAM SYNDROME	0.00357143	0.35523314582875504
MENTAL RETARDATION, AUTOSOMAL DOMINANT 54; MRD54	0.00357143	0.35523314582875504
9Q33.3Q34.11 MICRODELETION SYNDROME	0.00357143	0.35523314582875504
PARKINSON DISEASE 22, AUTOSOMAL DOMINANT; PARK22	0.00357143	0.35523314582875504
LEUKODYSTROPHY, HYPOMYELINATING, 12	0.00357143	0.35523314582875504
AU-KLINE SYNDROME; AUKS	0.00357143	0.35523314582875504
AICARDI SYNDROME	0.00357143	0.35523314582875504
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18; GPIBD18	0.00357143	0.35523314582875504
NEURODEVELOPMENTAL DISORDER-CRANIOFACIAL DYSMORPHISM-CARDIAC DEFECT-SKELETAL ANOMALIES SYNDROME	0.00357143	0.35523314582875504
FLOATING-HARBOR SYNDROME	0.00357143	0.35523314582875504
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE VII; HSAN7	0.00357143	0.35523314582875504
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 1; IHPRF1	0.00357143	0.35523314582875504
UROFACIAL SYNDROME 2	0.00357143	0.35523314582875504
DIASTASIS RECTI AND WEAKNESS OF THE LINEA ALBA	0.00357143	0.35523314582875504
PAROXYSMAL EXTREME PAIN DISORDER	0.00357143	0.35523314582875504
PURE AUTONOMIC FAILURE	0.00357143	0.35523314582875504
ATTRV30M AMYLOIDOSIS	0.00357143	0.35523314582875504
RETT SYNDROME; RTT	0.00357143	0.35523314582875504
HINMAN SYNDROME	0.00357143	0.35523314582875504
LAMBERT-EATON MYASTHENIC SYNDROME	0.00357143	0.35523314582875504
TOXIN-MEDIATED INFECTIOUS BOTULISM	0.00357143	0.35523314582875504
RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA INVERSA	0.00357143	0.35523314582875504
SEVERE GENERALIZED RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA	0.00357143	0.35523314582875504
EPIDERMOLYSIS BULLOSA SIMPLEX, GENERALIZED SEVERE	0.00357143	0.35523314582875504
INHALATIONAL BOTULISM	0.00357143	0.35523314582875504
MYOPATHY, MYOFIBRILLAR, 1; MFM1	0.00357143	0.35523314582875504
IATROGENIC BOTULISM	0.00357143	0.35523314582875504
FG SYNDROME 2; FGS2	0.00357143	0.35523314582875504
THYROTROPIN-RELEASING HORMONE DEFICIENCY	0.00357143	0.35523314582875504
DIABETES INSIPIDUS, NEPHROGENIC, X-LINKED	0.00357143	0.35523314582875504
TETRA-AMELIA WITH ECTODERMAL DYSPLASIA AND LACRIMAL DUCT ABNORMALITIES	0.00357143	0.35523314582875504
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 1	0.00357143	0.35523314582875504
NON-PROGRESSIVE CEREBELLAR ATAXIA WITH INTELLECTUAL DISABILITY	0.00357143	0.35523314582875504
VISCERAL NEUROPATHY-BRAIN ANOMALIES-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.00357143	0.35523314582875504
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18	0.00357143	0.35523314582875504
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 4; PEOA4	0.00357143	0.35523314582875504
PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.00357143	0.35523314582875504
KAPUR-TORIELLO SYNDROME	0.00357143	0.35523314582875504
AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY	0.00357143	0.35523314582875504
TOWNES-BROCKS SYNDROME	0.00357143	0.35523314582875504
NEPHROPATHIC INFANTILE CYSTINOSIS	0.00357143	0.35523314582875504
MUSCULAR PSEUDOHYPERTROPHY-HYPOTHYROIDISM SYNDROME	0.00357143	0.35523314582875504
INFANTILE DYSTONIA-PARKINSONISM	0.00357143	0.35523314582875504
PROPIONIC ACIDEMIA	0.00357143	0.35523314582875504
PETERS-PLUS SYNDROME; PTRPLS	0.00345826	0.3439766644995843
MACROCEPHALY-INTELLECTUAL DISABILITY-LEFT VENTRICULAR NON COMPACTION SYNDROME	0.00345826	0.3439766644995843
GASTROCUTANEOUS SYNDROME	0.00345826	0.3439766644995843
SPONDYLO-OCULAR SYNDROME	0.00345826	0.3439766644995843
MENTAL RETARDATION, X-LINKED, SYNDROMIC, MARTIN-PROBST TYPE	0.00345826	0.3439766644995843
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, DYSMORPHIC FACIES, AND T-CELL ABNORMALITIES; IDDSFTA	0.00345826	0.3439766644995843
MENTAL RETARDATION, AUTOSOMAL DOMINANT 35; MRD35	0.00345826	0.3439766644995843
ACROMELIC FRONTONASAL DYSPLASIA	0.00345826	0.3439766644995843
TARP SYNDROME	0.00345826	0.3439766644995843
NEURODEVELOPMENTAL DELAY-SEIZURES-OPHTHALMIC ANOMALIES-OSTEOPENIA-CEREBELLAR ATROPHY SYNDROME	0.00345826	0.3439766644995843
CRI-DU-CHAT SYNDROME	0.00345826	0.3439766644995843
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2	0.00345826	0.3439766644995843
INTELLECTUAL DISABILITY-MYOPATHY-SHORT STATURE-ENDOCRINE DEFECT SYNDROME	0.00345826	0.3439766644995843
SPONDYLOEPIMETAPHYSEAL DYSPLASIA CONGENITA, STRUDWICK TYPE	0.00345826	0.3439766644995843
OCULODENTODIGITAL DYSPLASIA	0.00345826	0.3439766644995843
SPONDYLOEPIPHYSEAL DYSPLASIA CONGENITA	0.00345826	0.3439766644995843
ACROMELIC FRONTONASAL DYSOSTOSIS; AFND	0.00345826	0.3439766644995843
TEMTAMY SYNDROME; TEMTYS	0.00345826	0.3439766644995843
X-LINKED INTELLECTUAL DISABILITY, NAJM TYPE	0.00345826	0.3439766644995843
ACROCRANIOFACIAL DYSOSTOSIS	0.00345826	0.3439766644995843
SHPRINTZEN-GOLDBERG SYNDROME	0.00345826	0.3439766644995843
ALOPECIA-CONTRACTURES-DWARFISM-INTELLECTUAL DISABILITY SYNDROME	0.00345826	0.3439766644995843
WHITE FORELOCK WITH MALFORMATIONS	0.00345826	0.3439766644995843
MEGALOCORNEA-INTELLECTUAL DISABILITY SYNDROME	0.00345826	0.3439766644995843
SHORT STATURE, OPTIC NERVE ATROPHY, AND PELGER-HUET ANOMALY; SOPH	0.00345826	0.3439766644995843
MENTAL RETARDATION, BUENOS AIRES TYPE	0.00345826	0.3439766644995843
HYPERTRYPTOPHANEMIA; HYPTRP	0.00345826	0.3439766644995843
DOORS SYNDROME	0.00345826	0.3439766644995843
FETAL AKINESIA DEFORMATION SEQUENCE	0.0027132600000000003	0.2698750599203479
DISTAL MONOSOMY 1Q	0.0027132600000000003	0.2698750599203479
PROGRESSIVE SPONDYLOEPIMETAPHYSEAL DYSPLASIA-SHORT STATURE-SHORT FOURTH METATARSALS-INTELLECTUAL DISABILITY SYNDROME	0.0027132600000000003	0.2698750599203479
NORMOSMIC CONGENITAL HYPOGONADOTROPIC HYPOGONADISM	0.0027132600000000003	0.2698750599203479
48,XYYY SYNDROME	0.0027132600000000003	0.2698750599203479
XQ12-Q13.3 DUPLICATION SYNDROME	0.0027132600000000003	0.2698750599203479
SIX2-RELATED FRONTONASAL DYSPLASIA	0.0027132600000000003	0.2698750599203479
AUTOSOMAL DOMINANT OMODYSPLASIA	0.0027132600000000003	0.2698750599203479
MEGALENCEPHALY-POLYMICROGYRIA-POSTAXIAL POLYDACTYLY-HYDROCEPHALUS SYNDROME	0.0027132600000000003	0.2698750599203479
OTOPALATODIGITAL SYNDROME TYPE 1	0.0027132600000000003	0.2698750599203479
OTOPALATODIGITAL SYNDROME TYPE 2	0.0027132600000000003	0.2698750599203479
AXENFELD-RIEGER SYNDROME	0.0027132600000000003	0.2698750599203479
3C SYNDROME	0.0027132600000000003	0.2698750599203479
PFEIFFER SYNDROME TYPE 1	0.0027132600000000003	0.2698750599203479
PFEIFFER SYNDROME TYPE 2	0.0027132600000000003	0.2698750599203479
PFEIFFER SYNDROME TYPE 3	0.0027132600000000003	0.2698750599203479
APERT SYNDROME	0.0027132600000000003	0.2698750599203479
DOUBLE OUTLET RIGHT VENTRICLE	0.0027132600000000003	0.2698750599203479
ACRODYSOSTOSIS	0.0027132600000000003	0.2698750599203479
DIASTROPHIC DWARFISM	0.0027132600000000003	0.2698750599203479
ALPHA-MANNOSIDOSIS	0.0027132600000000003	0.2698750599203479
DISTAL MONOSOMY 6P	0.0027132600000000003	0.2698750599203479
DISTAL TRISOMY 17Q	0.0027132600000000003	0.2698750599203479
FAMILIAL INTESTINAL MALROTATION	0.0027132600000000003	0.2698750599203479
LARSEN SYNDROME	0.0027132600000000003	0.2698750599203479
RECOMBINANT 8 SYNDROME	0.0027132600000000003	0.2698750599203479
PETERS PLUS SYNDROME	0.0027132600000000003	0.2698750599203479
FRANK-TER HAAR SYNDROME	0.0027132600000000003	0.2698750599203479
CRANIOECTODERMAL DYSPLASIA 2; CED2	0.0027132600000000003	0.2698750599203479
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, SPONASTRIME TYPE; SEMDSP	0.0027132600000000003	0.2698750599203479
SCHINZEL-GIEDION MIDFACE-RETRACTION SYNDROME	0.0027132600000000003	0.2698750599203479
NOONAN SYNDROME 11; NS11	0.0027132600000000003	0.2698750599203479
VITAMIN K ANTAGONIST EMBRYOFETOPATHY	0.0027132600000000003	0.2698750599203479
DEVELOPMENTAL DELAY WITH OR WITHOUT DYSMORPHIC FACIES AND AUTISM; DEDDFA	0.0027132600000000003	0.2698750599203479
MENTAL RETARDATION, AUTOSOMAL DOMINANT 22; MRD22	0.0027132600000000003	0.2698750599203479
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IQ	0.0027132600000000003	0.2698750599203479
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH EARLY-ONSET DIABETES MELLITUS	0.0027132600000000003	0.2698750599203479
CRANIOMETAPHYSEAL DYSPLASIA	0.0027132600000000003	0.2698750599203479
CRANIOFACIAL-DEAFNESS-HAND SYNDROME	0.0027132600000000003	0.2698750599203479
AYME-GRIPP SYNDROME; AYGRP	0.0027132600000000003	0.2698750599203479
GLOBAL DEVELOPMENTAL DELAY, LUNG CYSTS, OVERGROWTH, AND WILMS TUMOR; GLOW	0.0027132600000000003	0.2698750599203479
VERTEBRAL ANOMALIES AND VARIABLE ENDOCRINE AND T-CELL DYSFUNCTION; VETD	0.0027132600000000003	0.2698750599203479
MICROCEPHALY, FACIAL DYSMORPHISM, RENAL AGENESIS, AND AMBIGUOUS GENITALIA SYNDROME; MFRG	0.0027132600000000003	0.2698750599203479
HYDROCEPHALUS, SKELETAL ANOMALIES, AND MENTAL DISTURBANCE	0.0027132600000000003	0.2698750599203479
JOUBERT SYNDROME 32; JBTS32	0.0027132600000000003	0.2698750599203479
CUTIS GYRATA-ACANTHOSIS NIGRICANS-CRANIOSYNOSTOSIS SYNDROME	0.0027132600000000003	0.2698750599203479
ARTHROCHALASIA EHLERS-DANLOS SYNDROME	0.0027132600000000003	0.2698750599203479
RITSCHER-SCHINZEL SYNDROME 1	0.0027132600000000003	0.2698750599203479
8P11.2 DELETION SYNDROME	0.0027132600000000003	0.2698750599203479
SPONDYLOMETAEPIPHYSEAL DYSPLASIA, SHORT LIMB-HAND TYPE	0.0027132600000000003	0.2698750599203479
SHORT-RIB THORACIC DYSPLASIA 20 WITH POLYDACTYLY; SRTD20	0.0027132600000000003	0.2698750599203479
MENTAL RETARDATION, AUTOSOMAL DOMINANT 20	0.0027132600000000003	0.2698750599203479
14Q11.2 MICRODELETION SYNDROME	0.0027132600000000003	0.2698750599203479
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND ROBIN SEQUENCE	0.0027132600000000003	0.2698750599203479
FRONTONASAL DYSPLASIA 2; FND2	0.0027132600000000003	0.2698750599203479
17Q23.1Q23.2 MICRODELETION SYNDROME	0.0027132600000000003	0.2698750599203479
ALKURAYA-KUCINSKAS SYNDROME; ALKKUCS	0.0027132600000000003	0.2698750599203479
CLEIDOCRANIAL DYSPLASIA	0.0027132600000000003	0.2698750599203479
TEMPLE-BARAITSER SYNDROME; TMBTS	0.0027132600000000003	0.2698750599203479
BRACHYCEPHALY, DEAFNESS, CATARACT, MICROSTOMIA, AND MENTAL RETARDATION	0.0027132600000000003	0.2698750599203479
COFFIN-LOWRY SYNDROME	0.0027132600000000003	0.2698750599203479
NOONAN SYNDROME 4; NS4	0.0027132600000000003	0.2698750599203479
FUMARASE DEFICIENCY; FMRD	0.0027132600000000003	0.2698750599203479
%252100 MOHR SYNDROME;;OROFACIODIGITAL SYNDROME II; OFD2;;OFDS II;;ORAL-FACIAL-DIGITAL SYNDROME, TYPE II	0.0027132600000000003	0.2698750599203479
PROGRESSIVE NON-INFECTIOUS ANTERIOR VERTEBRAL FUSION	0.0027132600000000003	0.2698750599203479
FIBROCHONDROGENESIS	0.0027132600000000003	0.2698750599203479
CHAND SYNDROME	0.0027132600000000003	0.2698750599203479
CAMPOMELIC DYSPLASIA	0.0027132600000000003	0.2698750599203479
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.0027132600000000003	0.2698750599203479
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME	0.0027132600000000003	0.2698750599203479
DIAPHANOSPONDYLODYSOSTOSIS	0.0027132600000000003	0.2698750599203479
HARTSFIELD SYNDROME	0.0027132600000000003	0.2698750599203479
HENNEKAM SYNDROME	0.0027132600000000003	0.2698750599203479
SHORT RIB-POLYDACTYLY SYNDROME	0.0027132600000000003	0.2698750599203479
NASODIGITOACOUSTIC SYNDROME	0.0027132600000000003	0.2698750599203479
NABLUS MASK-LIKE FACIAL SYNDROME; NMLFS	0.0027132600000000003	0.2698750599203479
AYMÉ-GRIPP SYNDROME	0.0027132600000000003	0.2698750599203479
AUTOSOMAL RECESSIVE ROBINOW SYNDROME	0.0027132600000000003	0.2698750599203479
HYPERTELORISM AND TETRALOGY OF FALLOT	0.0027132600000000003	0.2698750599203479
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IE	0.0027132600000000003	0.2698750599203479
PAI SYNDROME	0.0027132600000000003	0.2698750599203479
ICF SYNDROME	0.0027132600000000003	0.2698750599203479
234250 HALL-RIGGS MENTAL RETARDATION SYNDROME	0.0027132600000000003	0.2698750599203479
FRONTONASAL DYSPLASIA-ALOPECIA-GENITAL ANOMALIES SYNDROME	0.0027132600000000003	0.2698750599203479
CRANE-HEISE SYNDROME	0.0027132600000000003	0.2698750599203479
OPSISMODYSPLASIA; OPSMD	0.0027132600000000003	0.2698750599203479
RAINE SYNDROME	0.0027132600000000003	0.2698750599203479
CHROMOSOME 18Q DELETION SYNDROME	0.0027132600000000003	0.2698750599203479
%265300 LYMPHANGIECTASIA, PULMONARY, CONGENITAL; CPL;;LYMPHANGIOMATOSIS, PULMONARY;;PULMONARY CYSTIC LYMPHANGIECTASIS	0.0027132600000000003	0.2698750599203479
20P12.3 MICRODELETION SYNDROME	0.0027132600000000003	0.2698750599203479
FRASER SYNDROME	0.0027132600000000003	0.2698750599203479
WEAVER SYNDROME	0.0027132600000000003	0.2698750599203479
FRONTOFACIONASAL DYSPLASIA	0.0027132600000000003	0.2698750599203479
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY	0.0027132600000000003	0.2698750599203479
PEROXISOME BIOGENESIS DISORDER 4A (ZELLWEGER)	0.0027132600000000003	0.2698750599203479
311450 PALLISTER W SYNDROME;;W SYNDROME	0.0027132600000000003	0.2698750599203479
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1; CSCSC1	0.0027132600000000003	0.2698750599203479
MEMBRANOUS CRANIAL OSSIFICATION, DELAYED	0.0027132600000000003	0.2698750599203479
HEART AND BRAIN MALFORMATION SYNDROME	0.0027132600000000003	0.2698750599203479
JACOBSEN SYNDROME	0.0027132600000000003	0.2698750599203479
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 4; ICF4	0.0027132600000000003	0.2698750599203479
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 3; ICF3	0.0027132600000000003	0.2698750599203479
HYPERTELORISM, TEEBI TYPE; TBHS	0.0027132600000000003	0.2698750599203479
OPITZ GBBB SYNDROME, TYPE II; GBBB2	0.0027132600000000003	0.2698750599203479
DEVELOPMENTAL DELAY WITH SHORT STATURE, DYSMORPHIC FEATURES, AND SPARSE HAIR	0.0027132600000000003	0.2698750599203479
ROBINOW SYNDROME, AUTOSOMAL DOMINANT 3; DRS3	0.0027132600000000003	0.2698750599203479
W SYNDROME	0.0027132600000000003	0.2698750599203479
TRISOMY 4P	0.0027132600000000003	0.2698750599203479
CAMPOMELIC DYSPLASIA	0.0027132600000000003	0.2698750599203479
MENTAL RETARDATION AND DISTINCTIVE FACIAL FEATURES WITH OR WITHOUT CARDIAC DEFECTS	0.0027132600000000003	0.2698750599203479
RING CHROMOSOME 14 SYNDROME	0.0027132600000000003	0.2698750599203479
CLEIDOCRANIAL DYSPLASIA; CCD	0.0027132600000000003	0.2698750599203479
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 2; CSCSC2	0.0027132600000000003	0.2698750599203479
SMITH-KINGSMORE SYNDROME; SKS	0.0027132600000000003	0.2698750599203479
SPONDYLOMETAPHYSEAL DYSPLASIA, X-LINKED	0.0027132600000000003	0.2698750599203479
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 1	0.0027132600000000003	0.2698750599203479
ECTODERMAL DYSPLASIA 13, HAIR/TOOTH TYPE; ECTD13	0.0027132600000000003	0.2698750599203479
KEIPERT SYNDROME	0.0027132600000000003	0.2698750599203479
AMASTIA, BILATERAL, WITH URETERAL TRIPLICATION AND DYSMORPHISM	0.0027132600000000003	0.2698750599203479
NON-DISTAL TRISOMY 10Q	0.0027132600000000003	0.2698750599203479
TRISOMY 1Q	0.0027132600000000003	0.2698750599203479
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1; MCAHS1	0.0027132600000000003	0.2698750599203479
INTELLECTUAL DEVELOPMENTAL DISORDER WITH NEUROPSYCHIATRIC FEATURES; IDDNPF	0.0027132600000000003	0.2698750599203479
LETHAL CONGENITAL CONTRACTURE SYNDROME 9; LCCS9	0.0027132600000000003	0.2698750599203479
IMMUNOSKELETAL DYSPLASIA WITH NEURODEVELOPMENTAL ABNORMALITIES; ISDNA	0.0027132600000000003	0.2698750599203479
ANTLEY-BIXLER SYNDROME WITH GENITAL ANOMALIES AND DISORDERED STEROIDOGENESIS; ABS1	0.0027132600000000003	0.2698750599203479
ADAMS-OLIVER SYNDROME 2; AOS2	0.0027132600000000003	0.2698750599203479
EPIPHYSEAL DYSPLASIA-HEARING LOSS-DYSMORPHISM SYNDROME	0.0027132600000000003	0.2698750599203479
ECTODERMAL DYSPLASIA-INTELLECTUAL DISABILITY-CENTRAL NERVOUS SYSTEM MALFORMATION SYNDROME	0.0027132600000000003	0.2698750599203479
NASOPALPEBRAL LIPOMA-COLOBOMA SYNDROME; NPLCS	0.0027132600000000003	0.2698750599203479
122430 CORNEAL HYPESTHESIA WITH RETINAL ABNORMALITIES, SENSORINEURAL DEAFNESS,UNUSUAL FACIES, PERSISTENT DUCTUS ARTERIOSUS, AND MENTAL RETARDATION;;RAMOS-ARROYO SYNDROME	0.0027132600000000003	0.2698750599203479
ENCEPHALOMYOPATHY, MITOCHONDRIAL, DUE TO VOLTAGE-DEPENDENT ANION CHANNEL DEFICIENCY	0.0027132600000000003	0.2698750599203479
ZUNICH NEUROECTODERMAL SYNDROME	0.0027132600000000003	0.2698750599203479
CHROMOSOME 16Q22 DELETION SYNDROME	0.0027132600000000003	0.2698750599203479
RECOMBINANT CHROMOSOME 8 SYNDROME	0.0027132600000000003	0.2698750599203479
300232 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED, WITH MENTAL DETERIORATION;;SEMD, X-LINKED, WITH MENTAL DETERIORATION	0.0027132600000000003	0.2698750599203479
CHITAYAT SYNDROME	0.0027132600000000003	0.2698750599203479
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 25; COXPD25	0.0027132600000000003	0.2698750599203479
PELGER-HUET ANOMALY; PHA	0.0027132600000000003	0.2698750599203479
ENCEPHALOPATHY DUE TO SULFITE OXIDASE DEFICIENCY	0.00246914	0.2455936052762093
CORPUS CALLOSUM AGENESIS-NEURONOPATHY SYNDROME	0.00246914	0.2455936052762093
RENAL COLOBOMA SYNDROME	0.00246914	0.2455936052762093
AURICULAR ABNORMALITIES-CLEFT LIP WITH OR WITHOUT CLEFT PALATE-OCULAR ABNORMALITIES SYNDROME	0.00246914	0.2455936052762093
FRONTOOCULAR SYNDROME	0.00246914	0.2455936052762093
MULTIPLE EPIPHYSEAL DYSPLASIA, BEIGHTON TYPE	0.00246914	0.2455936052762093
CONE-ROD DYSTROPHY, X-LINKED, 1; CORDX1	0.00246914	0.2455936052762093
BIOTINIDASE DEFICIENCY	0.00246914	0.2455936052762093
INTELLECTUAL DISABILITY-HYPERKINETIC MOVEMENT-TRUNCAL ATAXIA SYNDROME	0.00246914	0.2455936052762093
XP22.3 MICRODELETION SYNDROME	0.00246914	0.2455936052762093
SJÖGREN-LARSSON SYNDROME	0.00246914	0.2455936052762093
%310460 MYOPIA 1, X-LINKED; MYP1	0.00246914	0.2455936052762093
MACROPHTHALMIA, COLOBOMATOUS, WITH MICROCORNEA; MACOM	0.00246914	0.2455936052762093
CRANIOECTODERMAL DYSPLASIA	0.00246914	0.2455936052762093
RETINAL CILIOPATHY DUE TO MUTATION IN USHER GENE	0.00246914	0.2455936052762093
CLASSIC HOMOCYSTINURIA	0.00246914	0.2455936052762093
OPHTHALMOPLEGIA, EXTERNAL, AND MYOPIA	0.00246914	0.2455936052762093
ATAXIA-INTELLECTUAL DISABILITY-OCULOMOTOR APRAXIA-CEREBELLAR CYSTS SYNDROME	0.00246914	0.2455936052762093
CONGENITAL MUSCULAR DYSTROPHY WITH CEREBELLAR INVOLVEMENT	0.00246914	0.2455936052762093
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY	0.00246914	0.2455936052762093
RETINAL DEGENERATION-NANOPHTHALMOS-GLAUCOMA SYNDROME	0.00246914	0.2455936052762093
CHORIORETINAL ATROPHY, PROGRESSIVE BIFOCAL	0.00246914	0.2455936052762093
GLAUCOMA-RELATED PIGMENT DISPERSION SYNDROME; GPDS1	0.00246914	0.2455936052762093
PROTEUS-LIKE SYNDROME	0.00246914	0.2455936052762093
CATARACT, AUTOSOMAL DOMINANT, MULTIPLE TYPES 1	0.00246914	0.2455936052762093
SYNDACTYLY-TELECANTHUS-ANOGENITAL AND RENAL MALFORMATIONS SYNDROME	0.00246914	0.2455936052762093
WEILL-MARCHESANI SYNDROME 3	0.00246914	0.2455936052762093
SHORT STATURE, HEARING LOSS, RETINITIS PIGMENTOSA, AND DISTINCTIVE FACIES; SHRF	0.00246914	0.2455936052762093
MUSCLE-EYE-BRAIN DISEASE	0.00246914	0.2455936052762093
MUCOPOLYSACCHARIDOSIS TYPE 3	0.00246914	0.2455936052762093
LOPES-MACIEL-RODAN SYNDROME; LOMARS	0.00246914	0.2455936052762093
SHORT-RIB THORACIC DYSPLASIA 5 WITH OR WITHOUT POLYDACTYLY; SRTD5	0.00246914	0.2455936052762093
LEUKODYSTROPHY, HYPOMYELINATING, 8, WITH OR WITHOUT OLIGODONTIA AND/OR HYPOGONADOTROPIC HYPOGONADISM	0.00246914	0.2455936052762093
OPTIC ATROPHY 11; OPA11	0.00246914	0.2455936052762093
OCULOCUTANEOUS ALBINISM	0.00246914	0.2455936052762093
SHORT STATURE, RHIZOMELIC, WITH MICROCEPHALY, MICROGNATHIA, AND DEVELOPMENTAL DELAY; SRMMD	0.00246914	0.2455936052762093
EHLERS-DANLOS SYNDROME, KYPHOSCOLIOTIC TYPE, 2; EDSKSCL2	0.00246914	0.2455936052762093
NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1E	0.00246914	0.2455936052762093
X-LINKED RECESSIVE OCULAR ALBINISM	0.00246914	0.2455936052762093
MEIER-GORLIN SYNDROME 7	0.00246914	0.2455936052762093
WEILL-MARCHESANI SYNDROME 4; WMS4	0.00246914	0.2455936052762093
RETINITIS PIGMENTOSA 75; RP75	0.00246914	0.2455936052762093
RETINITIS PIGMENTOSA AND ERYTHROCYTIC MICROCYTOSIS; RPEM	0.00246914	0.2455936052762093
COWDEN SYNDROME 5; CWS5	0.00246914	0.2455936052762093
COWDEN SYNDROME 6; CWS6	0.00246914	0.2455936052762093
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 11; MDDGA11	0.00246914	0.2455936052762093
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 18; LGMDR18	0.00246914	0.2455936052762093
SPASTIC PARAPLEGIA 79, AUTOSOMAL RECESSIVE; SPG79	0.00246914	0.2455936052762093
LONG CHAIN 3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.00246914	0.2455936052762093
MYOPIA 24, AUTOSOMAL DOMINANT; MYP24	0.00246914	0.2455936052762093
PORETTI-BOLTSHAUSER SYNDROME; PTBHS	0.00246914	0.2455936052762093
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 9; MDDGA9	0.00246914	0.2455936052762093
LEUKODYSTROPHY, HYPOMYELINATING, 11; HLD11	0.00246914	0.2455936052762093
LEBER CONGENITAL AMAUROSIS 15; LCA15	0.00246914	0.2455936052762093
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 2	0.00246914	0.2455936052762093
MICROPHTHALMIA WITH BRAIN AND DIGIT ANOMALIES	0.00246914	0.2455936052762093
%609259 MYOPIA 10; MYP10	0.00246914	0.2455936052762093
PSEUDOXANTHOMA ELASTICUM	0.00246914	0.2455936052762093
MICROPHTHALMIA, SYNDROMIC 6; MCOPS6	0.00246914	0.2455936052762093
GYRATE ATROPHY OF CHOROID AND RETINA	0.00246914	0.2455936052762093
CATARACT-MICROCORNEA SYNDROME	0.00246914	0.2455936052762093
CONGENITAL CATARACT-HYPERTROPHIC CARDIOMYOPATHY-MITOCHONDRIAL MYOPATHY SYNDROME	0.00246914	0.2455936052762093
DISTAL LIMB DEFICIENCIES-MICROGNATHIA SYNDROME	0.00246914	0.2455936052762093
BLEPHAROPTOSIS-MYOPIA-ECTOPIA LENTIS SYNDROME	0.00246914	0.2455936052762093
MARFANOID HABITUS WITH SITUS INVERSUS	0.00246914	0.2455936052762093
FANCONI ANEMIA, COMPLEMENTATION GROUP I; FANCI	0.00246914	0.2455936052762093
%609256 MYOPIA 7; MYP7	0.00246914	0.2455936052762093
%609257 MYOPIA 8; MYP8	0.00246914	0.2455936052762093
%609258 MYOPIA 9; MYP9	0.00246914	0.2455936052762093
APLASIA CUTIS CONGENITA-INTESTINAL LYMPHANGIECTASIA SYNDROME	0.00246914	0.2455936052762093
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 1; MDDGB1	0.00246914	0.2455936052762093
RETINAL CONE DYSTROPHY 3B	0.00246914	0.2455936052762093
ANOPHTHALMIA-MEGALOCORNEA-CARDIOPATHY-SKELETAL ANOMALIES SYNDROME	0.00246914	0.2455936052762093
ANIRIDIA-PTOSIS-INTELLECTUAL DISABILITY-FAMILIAL OBESITY SYNDROME	0.00246914	0.2455936052762093
ALPORT SYNDROME, X-LINKED; ATS	0.00246914	0.2455936052762093
INTELLECTUAL DEVELOPMENTAL DISORDER 59; MRD59	0.00246914	0.2455936052762093
CONGENITAL ARTHROGRYPOSIS WITH ANTERIOR HORN CELL DISEASE; CAAHD	0.00246914	0.2455936052762093
HUNTER-MACDONALD SYNDROME	0.00246914	0.2455936052762093
TREMOR-ATAXIA-CENTRAL HYPOMYELINATION SYNDROME	0.00246914	0.2455936052762093
BONE FRAGILITY WITH CONTRACTURES, ARTERIAL RUPTURE, AND DEAFNESS	0.00246914	0.2455936052762093
MYOPIA 15; MYP15	0.00246914	0.2455936052762093
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 5; MDDGA5	0.00246914	0.2455936052762093
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 65; MRT65	0.00246914	0.2455936052762093
BLUE CONE MONOCHROMACY; BCM	0.00246914	0.2455936052762093
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 3; LSDMCA3	0.00246914	0.2455936052762093
EXUDATIVE VITREORETINOPATHY 6; EVR6	0.00246914	0.2455936052762093
SPONDYLOMETAPHYSEAL DYSPLASIA, ALGERIAN TYPE	0.00246914	0.2455936052762093
HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY	0.00246914	0.2455936052762093
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE	0.00246914	0.2455936052762093
SPONDYLOEPIPHYSEAL DYSPLASIA CONGENITA	0.00246914	0.2455936052762093
FAMILIAL PRIMARY HYPOMAGNESEMIA WITH HYPERCALCIURIA AND NEPHROCALCINOSIS WITH SEVERE OCULAR INVOLVEMENT	0.00246914	0.2455936052762093
SINGLETON-MERTEN SYNDROME 1; SGMRT1	0.00246914	0.2455936052762093
ICHTHYOSIFORM ERYTHRODERMA, CORNEAL INVOLVEMENT, AND DEAFNESS	0.00246914	0.2455936052762093
HALLERMANN-STREIFF SYNDROME	0.00246914	0.2455936052762093
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 9	0.00246914	0.2455936052762093
HYPOMAGNESEMIA 5, RENAL, WITH OR WITHOUT OCULAR INVOLVEMENT; HOMG5	0.00246914	0.2455936052762093
RETINITIS PIGMENTOSA 1	0.00246914	0.2455936052762093
PSEUDOXANTHOMA ELASTICUM, FORME FRUSTE	0.00246914	0.2455936052762093
STICKLER SYNDROME TYPE 2	0.00246914	0.2455936052762093
STICKLER SYNDROME TYPE 1	0.00246914	0.2455936052762093
POLYDACTYLY, POSTAXIAL, WITH PROGRESSIVE MYOPIA	0.00246914	0.2455936052762093
MICROSPHEROPHAKIA AND/OR MEGALOCORNEA, WITH ECTOPIA LENTIS AND WITH OR WITHOUT SECONDARY GLAUCOMA; MSPKA	0.00246914	0.2455936052762093
MUCOLIPIDOSIS III GAMMA	0.00246914	0.2455936052762093
SPONDYLOEPIPHYSEAL DYSPLASIA AND SPONDYLOEPIMETAPHYSEAL DYSPLASIA	0.00246914	0.2455936052762093
FLYNN-AIRD SYNDROME	0.00246914	0.2455936052762093
COWDEN SYNDROME	0.00246914	0.2455936052762093
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 3; MDDGA3	0.00246914	0.2455936052762093
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 4; MDDGA4	0.00246914	0.2455936052762093
184000 SPONDYLOEPIPHYSEAL DYSPLASIA, MYOPIA, AND SENSORINEURAL DEAFNESS	0.00246914	0.2455936052762093
CARDIAC-VALVULAR EHLERS-DANLOS SYNDROME	0.00246914	0.2455936052762093
MICROSPHEROPHAKIA-METAPHYSEAL DYSPLASIA	0.00246914	0.2455936052762093
MESOMELIC DWARFISM, REINHARDT-PFEIFFER TYPE	0.00246914	0.2455936052762093
MULTIPLE EPIPHYSEAL DYSPLASIA	0.00246914	0.2455936052762093
SPASTIC ATAXIA-CORNEAL DYSTROPHY SYNDROME	0.00246914	0.2455936052762093
AUTOSOMAL RECESSIVE STICKLER SYNDROME	0.00246914	0.2455936052762093
CRANIOECTODERMAL DYSPLASIA 1	0.00246914	0.2455936052762093
16Q24.3 MICRODELETION SYNDROME	0.00246914	0.2455936052762093
MESOMELIA-SYNOSTOSES SYNDROME	0.00246914	0.2455936052762093
SENGERS SYNDROME	0.00246914	0.2455936052762093
BRACHYMETAPODY-ANODONTIA-HYPOTRICHOSIS-ALBINOIDISM	0.00246914	0.2455936052762093
223330 DIVERTICULOSIS OF BOWEL, HERNIA, AND RETINAL DETACHMENT	0.00246914	0.2455936052762093
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 45	0.00246914	0.2455936052762093
EPIDERMOLYSIS BULLOSA SIMPLEX WITH ANODONTIA/HYPODONTIA	0.00246914	0.2455936052762093
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY	0.00246914	0.2455936052762093
DEAFNESS-EPIPHYSEAL DYSPLASIA-SHORT STATURE SYNDROME	0.00246914	0.2455936052762093
ALPORT SYNDROME, AUTOSOMAL RECESSIVE	0.00246914	0.2455936052762093
ALOPECIA-CONTRACTURES-DWARFISM MENTAL RETARDATION SYNDROME	0.00246914	0.2455936052762093
CONDUCTIVE DEAFNESS-PTOSIS-SKELETAL ANOMALIES SYNDROME	0.00246914	0.2455936052762093
USHER SYNDROME TYPE 2	0.00246914	0.2455936052762093
BRITTLE CORNEA SYNDROME	0.00246914	0.2455936052762093
ALBINISM, OCULOCUTANEOUS, TYPE II; OCA2	0.00246914	0.2455936052762093
SPONDYLOMETAPHYSEAL DYSPLASIA, SCHMIDT TYPE	0.00246914	0.2455936052762093
ALBINISM, OCULOCUTANEOUS, TYPE IA; OCA1A	0.00246914	0.2455936052762093
CONGENITAL MUSCULAR DYSTROPHY, FUKUYAMA TYPE	0.00246914	0.2455936052762093
DANDY-WALKER MALFORMATION WITH MENTAL RETARDATION, MACROCEPHALY, MYOPIA, AND BRACHYTELEPHALANGY	0.00246914	0.2455936052762093
MYOPIA, INFANTILE SEVERE	0.00246914	0.2455936052762093
CONE-ROD DYSTROPHY, X-LINKED, 3	0.00246914	0.2455936052762093
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME DUE TO LYSYL HYDROXYLASE 1 DEFICIENCY	0.00246914	0.2455936052762093
GLAUCOMA, PRIMARY OPEN ANGLE	0.00246914	0.2455936052762093
GLAUCOMA 1, OPEN ANGLE, A	0.00246914	0.2455936052762093
FLYNN-AIRD SYNDROME	0.00246914	0.2455936052762093
DEAFNESS-INTELLECTUAL DISABILITY SYNDROME, MARTIN-PROBST TYPE	0.00246914	0.2455936052762093
SCHWARTZ-JAMPEL SYNDROME, TYPE 1; SJS1	0.00246914	0.2455936052762093
CHOROIDEREMIA	0.00246914	0.2455936052762093
CATARACT, POSTERIOR POLAR, 1 CTPA CATARACT, CONGENITAL TOTAL, INCLUDED	0.00246914	0.2455936052762093
ALAND ISLAND EYE DISEASE	0.00246914	0.2455936052762093
SPINOCEREBELLAR DEGENERATION WITH MACULAR CORNEAL DYSTROPHY, CONGENITALCATARACTS, AND MYOPIA	0.00246914	0.2455936052762093
ÅLAND ISLANDS EYE DISEASE	0.00246914	0.2455936052762093
POLAND SYNDROME	0.00246914	0.2455936052762093
POLYDACTYLY-MYOPIA SYNDROME	0.00246914	0.2455936052762093
BLEPHAROPTOSIS, MYOPIA, AND ECTOPIA LENTIS	0.00246914	0.2455936052762093
FAMILIAL DYSAUTONOMIA	0.00246914	0.2455936052762093
SPONDYLOMETAPHYSEAL DYSPLASIA-CONE-ROD DYSTROPHY SYNDROME	0.00246914	0.2455936052762093
SVEINSSON CHORIORETINAL ATROPHY	0.00246914	0.2455936052762093
MENTAL RETARDATION, X-LINKED, SYNDROMIC 34; MRXS34	0.00246914	0.2455936052762093
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 1, WITH OR WITHOUT FRACTURES; SEMDJL1	0.00246914	0.2455936052762093
EHLERS-DANLOS SYNDROME, TYPE I	0.00246914	0.2455936052762093
FUNDUS DYSTROPHY, PSEUDOINFLAMMATORY, RECESSIVE FORM	0.00246914	0.2455936052762093
ORNITHINE AMINOTRANSFERASE DEFICIENCY	0.00246914	0.2455936052762093
MICROSPHEROPHAKIA WITH HERNIA	0.00246914	0.2455936052762093
MICROCORIA, CONGENITAL	0.00246914	0.2455936052762093
SHORT SYNDROME	0.00246914	0.2455936052762093
OSTEOPOROSIS-OCULOCUTANEOUS HYPOPIGMENTATION SYNDROME	0.00246914	0.2455936052762093
USHER SYNDROME	0.00246914	0.2455936052762093
OCULODENTODIGITAL DYSPLASIA, AUTOSOMAL RECESSIVE	0.00246914	0.2455936052762093
MICROPHTHALMIA, ISOLATED, WITH CORECTOPIA	0.00246914	0.2455936052762093
CHROMOSOME 17Q12 DELETION SYNDROME	0.00172414	0.17149200069697285
COFFIN-SIRIS SYNDROME 2; CSS2	0.00172414	0.17149200069697285
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.00172414	0.17149200069697285
ASPARTYLGLUCOSAMINURIA; AGU	0.00172414	0.17149200069697285
KYPHOMELIC DYSPLASIA	0.00172414	0.17149200069697285
113480 BRACHYTELEPHALANGY WITH CHARACTERISTIC FACIES AND KALLMANN SYNDROME	0.00172414	0.17149200069697285
CHROMOSOME 14Q11-Q22 DELETION SYNDROME	0.00172414	0.17149200069697285
113470 BRACHYMESOMELIA-RENAL SYNDROME	0.00172414	0.17149200069697285
PEROXISOME BIOGENESIS DISORDER 11A (ZELLWEGER)	0.00172414	0.17149200069697285
OSTEOGENESIS IMPERFECTA, TYPE XII; OI12	0.00172414	0.17149200069697285
MARTSOLF SYNDROME	0.00172414	0.17149200069697285
BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS	0.00172414	0.17149200069697285
SPONDYLOMETAPHYSEAL DYSPLASIA, MEGARBANE-DAGHER-MELKI TYPE; SMDMDM	0.00172414	0.17149200069697285
OMODYSPLASIA	0.00172414	0.17149200069697285
MENTAL RETARDATION, AUTOSOMAL DOMINANT 38; MRD38	0.00172414	0.17149200069697285
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 44	0.00172414	0.17149200069697285
MULTIPLE SULFATASE DEFICIENCY	0.00172414	0.17149200069697285
SHORT STATURE WITH MICROCEPHALY AND DISTINCTIVE FACIES; SSMCF	0.00172414	0.17149200069697285
129540 ECTODERMAL DYSPLASIA SYNDROME WITH DISTINCTIVE FACIAL APPEARANCE ANDPREAXIAL POLYDACTYLY OF FEET	0.00172414	0.17149200069697285
ALAZAMI SYNDROME; ALAZS	0.00172414	0.17149200069697285
HOLOPROSENCEPHALY 3; HPE3	0.00172414	0.17149200069697285
HOLOPROSENCEPHALY 4	0.00172414	0.17149200069697285
PALLISTER-HALL SYNDROME	0.00172414	0.17149200069697285
138770 GMS SYNDROME;;GONIODYSGENESIS--MENTAL RETARDATION--SHORT STATURE SYNDROME	0.00172414	0.17149200069697285
PROTEUS SYNDROME	0.00172414	0.17149200069697285
%155050 MAXILLONASAL DYSPLASIA, BINDER TYPE;;BINDER SYNDROME	0.00172414	0.17149200069697285
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 2; MVA2	0.00172414	0.17149200069697285
ECTODERMAL DYSPLASIA 11B, HYPOHIDROTIC/HAIR/TOOTH TYPE, AUTOSOMAL RECESSIVE; ECTD11B	0.00172414	0.17149200069697285
PONTOCEREBELLAR HYPOPLASIA, TYPE 7; PCH7	0.00172414	0.17149200069697285
DERMOTRICHIC SYNDROME	0.00172414	0.17149200069697285
MUCOLIPIDOSIS TYPE II	0.00172414	0.17149200069697285
SHORT STATURE AND ADVANCED BONE AGE, WITH OR WITHOUT EARLY-ONSET OSTEOARTHRITIS AND/OR OSTEOCHONDRITIS DISSECANS; SSOAOD	0.00172414	0.17149200069697285
MUCOPOLYSACCHARIDOSIS TYPE 1	0.00172414	0.17149200069697285
SCALP-EAR-NIPPLE SYNDROME; SENS	0.00172414	0.17149200069697285
ANTLEY-BIXLER SYNDROME WITHOUT GENITAL ANOMALIES OR DISORDERED STEROIDOGENESIS; ABS2	0.00172414	0.17149200069697285
OROFACIODIGITAL SYNDROME X	0.00172414	0.17149200069697285
LEUKOENCEPHALOPATHY-SPONDYLOMETAPHYSEAL DYSPLASIA SYNDROME	0.00172414	0.17149200069697285
DANDY-WALKER MALFORMATION WITH POSTAXIAL POLYDACTYLY	0.00172414	0.17149200069697285
MUCOPOLYSACCHARIDOSIS TYPE IX	0.00172414	0.17149200069697285
TIMOTHY SYNDROME; TS	0.00172414	0.17149200069697285
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE ID; CDG1D	0.00172414	0.17149200069697285
SONODA SYNDROME	0.00172414	0.17149200069697285
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 2	0.00172414	0.17149200069697285
268650 RUDIGER SYNDROME	0.00172414	0.17149200069697285
266910 RENAL DYSPLASIA-LIMB DEFECTS SYNDROME;;RL SYNDROME	0.00172414	0.17149200069697285
PREMATURE AGING SYNDROME, OKAMOTO TYPE	0.00172414	0.17149200069697285
CRISPONI/COLD-INDUCED SWEATING SYNDROME 1; CISS1	0.00172414	0.17149200069697285
%601927 LYMPHEDEMA, CARDIAC SEPTAL DEFECTS, AND CHARACTERISTIC FACIES;;IRONS-BIANCHI SYNDROME;;LYMPHEDEMA, ATRIAL SEPTAL DEFECT, AND CHARACTERISTIC FACIES	0.00172414	0.17149200069697285
601976 OTOFACIOOSSEOUS-GONADAL SYNDROME	0.00172414	0.17149200069697285
OMODYSPLASIA 1; OMOD1	0.00172414	0.17149200069697285
ATELOSTEOGENESIS, TYPE II	0.00172414	0.17149200069697285
CAREY-FINEMAN-ZITER SYNDROME; CFZS	0.00172414	0.17149200069697285
SKELETAL DYSPLASIA AND PROGRESSIVE CENTRAL NERVOUS SYSTEM DEGENERATION, LETHAL	0.00172414	0.17149200069697285
VAN DEN ENDE-GUPTA SYNDROME; VDEGS	0.00172414	0.17149200069697285
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 4	0.00172414	0.17149200069697285
CARPENTER-WAZIRI SYNDROME	0.00172414	0.17149200069697285
KEUTEL SYNDROME	0.00172414	0.17149200069697285
CHONDRODYSPLASIA PUNCTATA 1, X-LINKED RECESSIVE	0.00172414	0.17149200069697285
OGDEN SYNDROME; OGDNS	0.00172414	0.17149200069697285
PLATYSPONDYLIC DYSPLASIA, TORRANCE TYPE	0.00172414	0.17149200069697285
ECTODERMAL DYSPLASIA 1, HYPOHIDROTIC, X-LINKED; XHED	0.00172414	0.17149200069697285
IMAGE SYNDROME	0.00172414	0.17149200069697285
MENTAL RETARDATION, X-LINKED 9	0.00172414	0.17149200069697285
FETAL GAUCHER DISEASE	0.00172414	0.17149200069697285
WEILL-MARCHESANI SYNDROME 1; WMS1	0.00172414	0.17149200069697285
%300660 LEUKOENCEPHALOPATHY WITH METAPHYSEAL CHONDRODYSPLASIA; LKMCD	0.00172414	0.17149200069697285
X-LINKED INTELLECTUAL DISABILITY, ARMFIELD TYPE	0.00172414	0.17149200069697285
OCULOECTODERMAL SYNDROME; OES	0.00172414	0.17149200069697285
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CABEZAS TYPE; MRXSC	0.00172414	0.17149200069697285
CODAS SYNDROME	0.00172414	0.17149200069697285
PECTUS EXCAVATUM, MACROCEPHALY, SHORT STATURE, AND DYSPLASTIC NAILS	0.00172414	0.17149200069697285
OHDO SYNDROME, SBBYS VARIANT; SBBYSS	0.00172414	0.17149200069697285
MACROCEPHALY AND EPILEPTIC ENCEPHALOPATHY	0.00172414	0.17149200069697285
HYPOTONIA-CYSTINURIA SYNDROME	0.00172414	0.17149200069697285
FOCAL FACIAL DERMAL DYSPLASIA 3, SETLEIS TYPE	0.00172414	0.17149200069697285
FIBROCHONDROGENESIS 1; FBCG1	0.00172414	0.17149200069697285
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, SHOHAT TYPE	0.00172414	0.17149200069697285
CALVARIAL HYPEROSTOSIS	0.00172414	0.17149200069697285
SPONASTRIME DYSPLASIA	0.00172414	0.17149200069697285
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH MULTIPLE DISLOCATIONS	0.00172414	0.17149200069697285
HURLER SYNDROME	0.00172414	0.17149200069697285
ECTODERMAL DYSPLASIA 10B, HYPOHIDROTIC/HAIR/TOOTH TYPE, AUTOSOMAL RECESSIVE; ECTD10B	0.00172414	0.17149200069697285
SCHEIE SYNDROME	0.00172414	0.17149200069697285
CHROMOSOME 1Q41-Q42 DELETION SYNDROME	0.00172414	0.17149200069697285
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 2	0.00172414	0.17149200069697285
JUBERG-MARSIDI SYNDROME	0.00172414	0.17149200069697285
FACIOCARDIOMELIC SYNDROME	0.00172414	0.17149200069697285
THREE M SYNDROME 2; 3M2	0.00172414	0.17149200069697285
PITUITARY HORMONE DEFICIENCY, COMBINED, 1	0.00172414	0.17149200069697285
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIH	0.00172414	0.17149200069697285
AUTOSOMAL RECESSIVE OMODYSPLASIA	0.00172414	0.17149200069697285
DIABETES MELLITUS, NEONATAL, WITH CONGENITAL HYPOTHYROIDISM; NDH	0.00172414	0.17149200069697285
GLUTAMINE DEFICIENCY, CONGENITAL	0.00172414	0.17149200069697285
SPONDYLOMETAPHYSEAL DYSPLASIA, KOZLOWSKI TYPE	0.00172414	0.17149200069697285
THANATOPHORIC DYSPLASIA TYPE 2	0.00172414	0.17149200069697285
ARTHROGRYPOSIS, DISTAL, TYPE 4; DA4	0.00172414	0.17149200069697285
SHORT RIB-POLYDACTYLY SYNDROME, VERMA-NAUMOFF TYPE	0.00172414	0.17149200069697285
HYPERTRICHOTIC OSTEOCHONDRODYSPLASIA	0.00172414	0.17149200069697285
WEILL-MARCHESANI SYNDROME 2; WMS2	0.00172414	0.17149200069697285
HYPOPARATHYROIDISM-RETARDATION-DYSMORPHISM SYNDROME	0.00172414	0.17149200069697285
241800 HYPOTHALAMIC HAMARTOMASCONGENITAL HYPOTHALAMIC HAMARTOMA SYNDROME, INCLUDED; CHHS, INCLUDED	0.00172414	0.17149200069697285
KEUTEL SYNDROME; KTLS	0.00172414	0.17149200069697285
OHDO SYNDROME	0.00172414	0.17149200069697285
BRAIN MALFORMATION-CONGENITAL HEART DISEASE-POSTAXIAL POLYDACTYLY SYNDROME	0.00172414	0.17149200069697285
%249650 MERCAPTOLACTATE-CYSTEINE DISULFIDURIA; MCDU;;DISULFIDURIA, MIXED	0.00172414	0.17149200069697285
SPONDYLOMETAPHYSEAL DYSPLASIA, SEDAGHATIAN TYPE; SMDS	0.00172414	0.17149200069697285
SPONDYLOEPIPHYSEAL DYSPLASIA-BRACHYDACTYLY AND DISTINCTIVE SPEECH	0.00172414	0.17149200069697285
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 27	0.00172414	0.17149200069697285
DERMATOSPARAXIS EHLERS-DANLOS SYNDROME	0.00172414	0.17149200069697285
SANJAD-SAKATI SYNDROME	0.00172414	0.17149200069697285
MICROCEPHALY, GROWTH DEFICIENCY, SEIZURES, AND BRAIN MALFORMATIONS; MIGSB	0.00172414	0.17149200069697285
METATROPIC DYSPLASIA	0.00172414	0.17149200069697285
THANATOPHORIC DYSPLASIA	0.00172414	0.17149200069697285
MULTIPLE ACYL-COA DEHYDROGENASE DEFICIENCY	0.00172414	0.17149200069697285
SHORT-RIB THORACIC DYSPLASIA 19 WITH OR WITHOUT POLYDACTYLY; SRTD19	0.00172414	0.17149200069697285
RHIZOMELIC SYNDROME, URBACH TYPE	0.00172414	0.17149200069697285
SPONDYLOEPIPHYSEAL DYSPLASIA, CANTU TYPE	0.00172414	0.17149200069697285
2P21 MICRODELETION SYNDROME	0.00172414	0.17149200069697285
GELEOPHYSIC DYSPLASIA 3; GPHYSD3	0.00172414	0.17149200069697285
COSTELLO SYNDROME	0.00172414	0.17149200069697285
POPOV-CHANG SYNDROME; POPCHAS	0.00172414	0.17149200069697285
OPSISMODYSPLASIA	0.00172414	0.17149200069697285
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 2; VCRL2	0.00172414	0.17149200069697285
OROFACIODIGITAL SYNDROME XVI; OFD16	0.00172414	0.17149200069697285
ODONTOCHONDRODYSPLASIA	0.00172414	0.17149200069697285
BRACHYCEPHALY, TRICHOMEGALY, AND DEVELOPMENTAL DELAY; BTDD	0.00172414	0.17149200069697285
OROFACIODIGITAL SYNDROME TYPE 10	0.00172414	0.17149200069697285
MOSAIC TRISOMY 1	0.00172414	0.17149200069697285
OTOFACIOCERVICAL SYNDROME	0.00172414	0.17149200069697285
CONGENITAL HEART DEFECTS AND ECTODERMAL DYSPLASIA	0.00172414	0.17149200069697285
GRANT SYNDROME	0.00172414	0.17149200069697285
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME X	0.00172414	0.17149200069697285
GLYCINE ENCEPHALOPATHY WITH NORMAL SERUM GLYCINE	0.00172414	0.17149200069697285
1Q41Q42 MICRODELETION SYNDROME	0.00172414	0.17149200069697285
JUNG SYNDROME	0.00172414	0.17149200069697285
CODAS SYNDROME	0.00172414	0.17149200069697285
CATARACT-INTELLECTUAL DISABILITY-HYPOGONADISM SYNDROME	0.00172414	0.17149200069697285
BETA-THALASSEMIA MAJOR	0.00172414	0.17149200069697285
CATARACT-HYPERTRICHOSIS-INTELLECTUAL DISABILITY SYNDROME	0.00172414	0.17149200069697285
FEINGOLD SYNDROME	0.00172414	0.17149200069697285
LÉRI-WEILL DYSCHONDROSTEOSIS	0.00172414	0.17149200069697285
COFFIN-SIRIS SYNDROME	0.00172414	0.17149200069697285
X-LINKED INTELLECTUAL DISABILITY-CARDIOMEGALY-CONGESTIVE HEART FAILURE SYNDROME	0.00172414	0.17149200069697285
MAXILLONASAL DYSPLASIA	0.00172414	0.17149200069697285
HOLOPROSENCEPHALY 12 WITH OR WITHOUT PANCREATIC AGENESIS; HPE12	0.00172414	0.17149200069697285
ACROMESOMELIC DYSPLASIA, MAROTEAUX TYPE	0.00172414	0.17149200069697285
AUTOSOMAL RECESSIVE SPONDYLOCOSTAL DYSOSTOSIS	0.00172414	0.17149200069697285
CRANIODIAPHYSEAL DYSPLASIA	0.00172414	0.17149200069697285
ISOTRETINOIN SYNDROME	0.00172414	0.17149200069697285
14Q12 MICRODELETION SYNDROME	0.00172414	0.17149200069697285
INTELLECTUAL DISABILITY-COARSE FACE-MACROCEPHALY-CEREBELLAR HYPOTROPHY SYNDROME	0.00172414	0.17149200069697285
MICROPHTHALMIA WITH LIMB ANOMALIES	0.00172414	0.17149200069697285
INTELLECTUAL DISABILITY-HYPOTONIA-BRACHYCEPHALY-PYLORIC STENOSIS-CRYPTORCHIDISM SYNDROME	0.00172414	0.17149200069697285
ANIRIDIA-RENAL AGENESIS-PSYCHOMOTOR RETARDATION SYNDROME	0.00172414	0.17149200069697285
ULBRIGHT-HODES SYNDROME	0.00172414	0.17149200069697285
DESBUQUOIS SYNDROME	0.00172414	0.17149200069697285
MEIER-GORLIN SYNDROME 6; MGORS6	0.00172414	0.17149200069697285
PENILE AGENESIS	0.00172414	0.17149200069697285
PECTUS EXCAVATUM-MACROCEPHALY-DYSPLASTIC NAILS SYNDROME	0.00172414	0.17149200069697285
SHORT-RIB THORACIC DYSPLASIA 15 WITH POLYDACTYLY; SRTD15	0.00172414	0.17149200069697285
PONTOCEREBELLAR HYPOPLASIA TYPE 7	0.00172414	0.17149200069697285
PHAVER SYNDROME	0.00172414	0.17149200069697285
COFFIN-SIRIS SYNDROME 5	0.00172414	0.17149200069697285
EMERY-NELSON SYNDROME	0.00172414	0.17149200069697285
SCHIMKE IMMUNO-OSSEOUS DYSPLASIA	0.00172414	0.17149200069697285
EARLY INFANTILE EPILEPTIC ENCEPHALOPATHY	0.00172414	0.17149200069697285
ACHONDROPLASIA, SEVERE, WITH DEVELOPMENTAL DELAY AND ACANTHOSIS NIGRICANS; SADDAN	0.00172414	0.17149200069697285
FETAL MINOXIDIL SYNDROME	0.00172414	0.17149200069697285
CRISPONI/COLD-INDUCED SWEATING SYNDROME 3; CISS3	0.00172414	0.17149200069697285
SHORT-RIB THORACIC DYSPLASIA 16 WITH OR WITHOUT POLYDACTYLY; SRTD16	0.00172414	0.17149200069697285
PELVIC DYSPLASIA-ARTHROGRYPOSIS OF LOWER LIMBS SYNDROME	0.00172414	0.17149200069697285
SHORT-RIB THORACIC DYSPLASIA 14 WITH POLYDACTYLY	0.00172414	0.17149200069697285
GM1 GANGLIOSIDOSIS	0.00172414	0.17149200069697285
DESMOSTEROLOSIS	0.00172414	0.17149200069697285
CROSSED POLYSYNDACTYLY	0.00172414	0.17149200069697285
20Q11.2 MICRODUPLICATION SYNDROME	0.00172414	0.17149200069697285
RADIO-RENAL SYNDROME	0.00172414	0.17149200069697285
THANATOPHORIC DYSPLASIA TYPE 1	0.00172414	0.17149200069697285
HYPERTELORISM-HYPOSPADIAS-POLYSYNDACTYLY SYNDROME	0.00098912	0.09838305922337501
CENANI-LENZ SYNDROME	0.00098912	0.09838305922337501
RENAL AND MULLERIAN DUCT HYPOPLASIA	0.00098912	0.09838305922337501
239710 ACROFRONTOFACIONASAL DYSOSTOSIS 2;;AFFN DYSOSTOSIS 2; AFFND2;;ACROFRONTOFACIONASAL DYSOSTOSIS WITH GENITOURINARY ANOMALIES;;NAGUIB-RICHIERI-COSTA SYNDROME;;HYPERTELORISM, HYPOSPADIAS, AND POLYSYNDACTYLY SYNDROME	0.00098912	0.09838305922337501
ROBERTS SYNDROME; RBS	0.00098912	0.09838305922337501
HIRSCHSPRUNG DISEASE WITH POLYDACTYLY, RENAL AGENESIS, AND DEAFNESS	0.00098912	0.09838305922337501
HYPERTELORISM, MICROTIA, FACIAL CLEFTING SYNDROME	0.00098912	0.09838305922337501
ASPARTYLGLUCOSAMINURIA	0.00098912	0.09838305922337501
POSTERIOR URETHRAL VALVE	0.00098912	0.09838305922337501
FAMILIAL THORACIC AORTIC ANEURYSM AND AORTIC DISSECTION	0.00098912	0.09838305922337501
ACROCEPHALOPOLYDACTYLY	0.00098912	0.09838305922337501
MULLERIAN DERIVATIVES, PERSISTENCE OF, WITH LYMPHANGIECTASIA AND POSTAXIAL POLYDACTYLY	0.00098912	0.09838305922337501
PSEUDOAMINOPTERIN SYNDROME	0.00098912	0.09838305922337501
FRYNS SYNDROME; FRNS	0.00098912	0.09838305922337501
234800 HEMANGIOMATOSIS, CUTANEOUS, WITH ASSOCIATED FEATURES	0.00098912	0.09838305922337501
DYSMORPHISM-SHORT STATURE-DEAFNESS-DISORDER OF SEX DEVELOPMENT SYNDROME	0.00098912	0.09838305922337501
YUNIS-VARON SYNDROME	0.00098912	0.09838305922337501
DEAFNESS-GENITAL ANOMALIES-METACARPAL AND METATARSAL SYNOSTOSIS SYNDROME	0.00098912	0.09838305922337501
JUBERG-HAYWARD SYNDROME	0.00098912	0.09838305922337501
PELVISCAPULAR DYSPLASIA	0.00098912	0.09838305922337501
AMINOPTERIN/METHOTREXATE EMBRYOFETOPATHY	0.00098912	0.09838305922337501
DIARRHEA 3, SECRETORY SODIUM, CONGENITAL, WITH OR WITHOUT OTHER CONGENITAL ANOMALIES	0.00098912	0.09838305922337501
FETAL HYDANTOIN SYNDROME	0.00098912	0.09838305922337501
SHORT-RIB THORACIC DYSPLASIA 12; SRTD12	0.00098912	0.09838305922337501
AUTOSOMAL DOMINANT KENNY-CAFFEY SYNDROME	0.00098912	0.09838305922337501
AUTOSOMAL RECESSIVE KENNY-CAFFEY SYNDROME	0.00098912	0.09838305922337501
%229400 FRONTOFACIONASAL DYSPLASIA;;FFND;;FRONTOFACIONASAL DYSOSTOSIS	0.00098912	0.09838305922337501
ALG13-CDG	0.00098912	0.09838305922337501
PHENOBARBITAL EMBRYOPATHY	0.00098912	0.09838305922337501
ROTHMUND-THOMSON SYNDROME	0.00098912	0.09838305922337501
BENIGN SAMARITAN CONGENITAL MYOPATHY	0.00098912	0.09838305922337501
TETRASOMY 12P	0.00098912	0.09838305922337501
WEAVER SYNDROME	0.00098912	0.09838305922337501
CLOVERLEAF SKULL-MULTIPLE CONGENITAL ANOMALIES SYNDROME	0.00098912	0.09838305922337501
17P13.3 MICRODUPLICATION SYNDROME	0.00098912	0.09838305922337501
FRONTAL ENCEPHALOCELE	0.00098912	0.09838305922337501
3MC SYNDROME 1	0.00098912	0.09838305922337501
HIRSCHSPRUNG DISEASE-DEAFNESS-POLYDACTYLY SYNDROME	0.00098912	0.09838305922337501
ACROCARDIOFACIAL SYNDROME	0.00098912	0.09838305922337501
GENITOPALATOCARDIAC SYNDROME	0.00098912	0.09838305922337501
FRYNS SYNDROME	0.00098912	0.09838305922337501
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP A; MOCODA	0.00098912	0.09838305922337501
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP B; MOCODB	0.00098912	0.09838305922337501
AUTOSOMAL DOMINANT CUTIS LAXA	0.00098912	0.09838305922337501
EXTRASYSTOLES-SHORT STATURE-HYPERPIGMENTATION-MICROCEPHALY SYNDROME	0.00098912	0.09838305922337501
FREEMAN-SHELDON SYNDROME	0.00098912	0.09838305922337501
OROFACIODIGITAL SYNDROME IX; OFD9	0.00098912	0.09838305922337501
OROFACIODIGITAL SYNDROME IV; OFD4	0.00098912	0.09838305922337501
TRIOPIA	0.00098912	0.09838305922337501
DEAFNESS-HYPOGONADISM SYNDROME	0.00098912	0.09838305922337501
OROFACIODIGITAL SYNDROME III	0.00098912	0.09838305922337501
ALAR CARTILAGES HYPOPLASIA-COLOBOMA-TELECANTHUS SYNDROME	0.00098912	0.09838305922337501
TRIPLOIDY	0.00098912	0.09838305922337501
CLEFT LIP/PALATE-INTESTINAL MALROTATION-CARDIOPATHY SYNDROME	0.00098912	0.09838305922337501
TRISOMY 18	0.00098912	0.09838305922337501
NEMALINE MYOPATHY 2; NEM2	0.00098912	0.09838305922337501
BLEPHARO-CHEILO-ODONTIC SYNDROME	0.00098912	0.09838305922337501
FACIOCARDIORENAL SYNDROME	0.00098912	0.09838305922337501
AUTOSOMAL RECESSIVE FACIODIGITOGENITAL SYNDROME	0.00098912	0.09838305922337501
CAT-EYE SYNDROME	0.00098912	0.09838305922337501
GALLOWAY-MOWAT SYNDROME 1; GAMOS1	0.00098912	0.09838305922337501
CRANIOSYNOSTOSIS, HERRMANN-OPITZ TYPE	0.00098912	0.09838305922337501
3MC SYNDROME 3	0.00098912	0.09838305922337501
VICI SYNDROME; VICIS	0.00098912	0.09838305922337501
HALL-RIGGS SYNDROME	0.00098912	0.09838305922337501
GASTROINTESTINAL DEFECTS AND IMMUNODEFICIENCY SYNDROME; GIDID	0.00098912	0.09838305922337501
BARAITSER-WINTER SYNDROME 1; BRWS1	0.00098912	0.09838305922337501
STROMME SYNDROME; STROMS	0.00098912	0.09838305922337501
KERATOCONUS POSTICUS CIRCUMSCRIPTUS	0.00098912	0.09838305922337501
PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY	0.00098912	0.09838305922337501
LAMBOTTE SYNDROME	0.00098912	0.09838305922337501
FALLOT COMPLEX-INTELLECTUAL DISABILITY-GROWTH DELAY SYNDROME	0.00098912	0.09838305922337501
MANITOBA OCULOTRICHOANAL SYNDROME	0.00098912	0.09838305922337501
THOMAS SYNDROME	0.00098912	0.09838305922337501
MARDEN-WALKER SYNDROME	0.00098912	0.09838305922337501
MECKEL SYNDROME, TYPE 1; MKS1	0.00098912	0.09838305922337501
FRANK-TER HAAR SYNDROME; FTHS	0.00098912	0.09838305922337501
GORLIN-CHAUDHRY-MOSS SYNDROME	0.00098912	0.09838305922337501
WIEDEMANN-RAUTENSTRAUCH SYNDROME; WDRTS	0.00098912	0.09838305922337501
BARTSOCAS-PAPAS SYNDROME; BPS	0.00098912	0.09838305922337501
TETRASOMY 5P	0.00098912	0.09838305922337501
%263210 POLYCYSTIC KIDNEY DISEASE, POTTER TYPE I, WITH MICROBRACHYCEPHALY,HYPERTELORISM, AND BRACHYMELIA	0.00098912	0.09838305922337501
AUTOSOMAL AGAMMAGLOBULINEMIA	0.00098912	0.09838305922337501
CUTIS LAXA	0.00098912	0.09838305922337501
BASEL-VANAGAITE-SMIRIN-YOSEF SYNDROME; BVSYS	0.00098912	0.09838305922337501
OSTEOPENIA-INTELLECTUAL DISABILITY-SPARSE HAIR SYNDROME	0.00098912	0.09838305922337501
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.00098912	0.09838305922337501
WOLF-HIRSCHHORN SYNDROME	0.00098912	0.09838305922337501
DELAYED MEMBRANOUS CRANIAL OSSIFICATION	0.00098912	0.09838305922337501
SPONDYLOEPIPHYSEAL DYSPLASIA WITH CONGENITAL JOINT DISLOCATIONS	0.00098912	0.09838305922337501
HYPERTELORISM	0.00098912	0.09838305922337501
DELAYED SPEECH-FACIAL ASYMMETRY-STRABISMUS-EAR LOBE CREASES SYNDROME	0.00098912	0.09838305922337501
CHROMOSOME 18P DELETION SYNDROME	0.00098912	0.09838305922337501
ALPHA-THALASSEMIA-INTELLECTUAL DISABILITY SYNDROME LINKED TO CHROMOSOME 16	0.00098912	0.09838305922337501
LATERAL MENINGOCELE SYNDROME	0.00098912	0.09838305922337501
CONGENITAL OSTEOGENESIS IMPERFECTA-MICROCEPHALY-CATARACTS SYNDROME	0.00098912	0.09838305922337501
KBG SYNDROME	0.00098912	0.09838305922337501
LACRIMOAURICULODENTODIGITAL SYNDROME; LADD	0.00098912	0.09838305922337501
CLEFT, MEDIAN, OF UPPER LIP WITH POLYPS OF FACIAL SKIN AND NASAL MUCOSA	0.00098912	0.09838305922337501
MONOSOMY 5P	0.00098912	0.09838305922337501
OROFACIODIGITAL SYNDROME TYPE 3	0.00098912	0.09838305922337501
METAPHYSEAL CHONDRODYSPLASIA, JANSEN TYPE	0.00098912	0.09838305922337501
OROFACIODIGITAL SYNDROME TYPE 1	0.00098912	0.09838305922337501
OPITZ G/BBB SYNDROME	0.00098912	0.09838305922337501
FRONTONASAL DYSPLASIA-SEVERE MICROPHTHALMIA-SEVERE FACIAL CLEFTING SYNDROME	0.00098912	0.09838305922337501
EYE DEFECTS-ARACHNODACTYLY-CARDIOPATHY SYNDROME	0.00098912	0.09838305922337501
CARDIOSPONDYLOCARPOFACIAL SYNDROME; CSCF	0.00098912	0.09838305922337501
OCULOTRICHOANAL SYNDROME	0.00098912	0.09838305922337501
INTELLECTUAL DISABILITY-SHORT STATURE-HYPERTELORISM SYNDROME	0.00098912	0.09838305922337501
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR	0.00098912	0.09838305922337501
CHAR SYNDROME	0.00098912	0.09838305922337501
EXTERNAL AUDITORY CANAL ATRESIA-VERTICAL TALUS-HYPERTELORISM SYNDROME	0.00098912	0.09838305922337501
MELANOCYTIC NEVUS SYNDROME, CONGENITAL; CMNS	0.00098912	0.09838305922337501
TRISOMY 9P	0.00098912	0.09838305922337501
BLEPHAROCHEILODONTIC SYNDROME 1; BCDS1	0.00098912	0.09838305922337501
8P23.1 DUPLICATION SYNDROME	0.00098912	0.09838305922337501
100050 AARSKOG SYNDROME, AUTOSOMAL DOMINANT	0.00098912	0.09838305922337501
ACROCEPHALOPOLYSYNDACTYLY TYPE III	0.00098912	0.09838305922337501
3MC SYNDROME	0.00098912	0.09838305922337501
AXENFELD-RIEGER ANOMALY WITH PARTIALLY ABSENT EYE MUSCLES, DISTINCTIVE FACE, HYDROCEPHALY, AND SKELETAL ABNORMALITIES	0.00098912	0.09838305922337501
BASAL CELL NEVUS SYNDROME	0.00098912	0.09838305922337501
OROFACIODIGITAL SYNDROME TYPE 5	0.00098912	0.09838305922337501
PTERYGIUM COLLI-INTELLECTUAL DISABILITY-DIGITAL ANOMALIES SYNDROME	0.00098912	0.09838305922337501
AUTOSOMAL RECESSIVE MULTIPLE PTERYGIUM SYNDROME	0.00098912	0.09838305922337501
SHORT STATURE-CRANIOFACIAL ANOMALIES-GENITAL HYPOPLASIA SYNDROME	0.00098912	0.09838305922337501
HEREDITARY OROTIC ACIDURIA	0.00098912	0.09838305922337501
CARDIOCRANIAL SYNDROME, PFEIFFER TYPE	0.00098912	0.09838305922337501
FRONTONASAL DYSPLASIA 1; FND1	0.00098912	0.09838305922337501
MOSAIC TRISOMY 9	0.00098912	0.09838305922337501
CRANIOFACIAL-DEAFNESS-HAND SYNDROME; CDHS	0.00098912	0.09838305922337501
CRANIOMETAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT	0.00098912	0.09838305922337501
8Q21.11 MICRODELETION SYNDROME	0.00098912	0.09838305922337501
CROUZON SYNDROME	0.00098912	0.09838305922337501
BEARE-STEVENSON CUTIS GYRATA SYNDROME; BSTVS	0.00098912	0.09838305922337501
49,XYYYY SYNDROME	0.00098912	0.09838305922337501
DIABETES INSIPIDUS, NEUROHYPOPHYSEAL TYPE	0.00098912	0.09838305922337501
%129900 ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME1; EEC1;;EEC;;EEC SYNDROME 1	0.00098912	0.09838305922337501
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 1; EDSSPD1	0.00098912	0.09838305922337501
WRINKLY SKIN SYNDROME	0.00098912	0.09838305922337501
INTELLECTUAL DISABILITY, BUENOS-AIRES TYPE	0.00098912	0.09838305922337501
OROFACIODIGITAL SYNDROME V; OFD5	0.00098912	0.09838305922337501
INTELLECTUAL DISABILITY, WOLFF TYPE	0.00098912	0.09838305922337501
SPONDYLOCOSTAL DYSOSTOSIS WITH ANAL ATRESIA AND UROGENITAL ANOMALIES	0.00098912	0.09838305922337501
TRISOMY 17P	0.00098912	0.09838305922337501
DUPLICATION OF THE PITUITARY GLAND	0.00098912	0.09838305922337501
PEROXISOME BIOGENESIS DISORDER 1A (ZELLWEGER)	0.00098912	0.09838305922337501
PEROXISOME BIOGENESIS DISORDER 2A (ZELLWEGER); PBD2A	0.00098912	0.09838305922337501
CHARGE SYNDROME	0.00098912	0.09838305922337501
CLEFT LIP/PALATE WITH ABNORMAL THUMBS AND MICROCEPHALY	0.00098912	0.09838305922337501
COACH SYNDROME	0.00098912	0.09838305922337501
CONGENITAL HEART DEFECTS, HAMARTOMAS OF TONGUE, AND POLYSYNDACTYLY	0.00098912	0.09838305922337501
ACALVARIA	0.00098912	0.09838305922337501
CYSTIC FIBROSIS-GASTRITIS-MEGALOBLASTIC ANEMIA SYNDROME	0.00098912	0.09838305922337501
CRANIOSYNOSTOSIS-MENTAL RETARDATION SYNDROME OF LIN AND GETTIG	0.00098912	0.09838305922337501
6Q25 MICRODELETION SYNDROME	0.00098912	0.09838305922337501
BIFID NOSE	0.00098912	0.09838305922337501
SEVERE INTELLECTUAL DISABILITY-EPILEPSY-ANAL ANOMALIES-DISTAL PHALANGEAL HYPOPLASIA	0.00098912	0.09838305922337501
INFANTILE SPASMS-BROAD THUMBS SYNDROME	0.00098912	0.09838305922337501
SMITH-FINEMAN-MYERS SYNDROME	0.00098912	0.09838305922337501
FRONTONASAL DYSPLASIA	0.00098912	0.09838305922337501
TRICHOHEPATOENTERIC SYNDROME 1	0.00098912	0.09838305922337501
MELNICK-NEEDLES SYNDROME	0.00098912	0.09838305922337501
DISLOCATION OF THE HIP-DYSMORPHISM SYNDROME	0.00098912	0.09838305922337501
NASOPALPEBRAL LIPOMA-COLOBOMA SYNDROME	0.00098912	0.09838305922337501
227250 FACIAL ABNORMALITIES, KYPHOSCOLIOSIS, AND MENTAL RETARDATION	0.00098912	0.09838305922337501
LAURIN-SANDROW SYNDROME	0.00098912	0.09838305922337501
FACIODIGITOGENITAL SYNDROME, AUTOSOMAL RECESSIVE	0.00098912	0.09838305922337501
%211960 CAMPTODACTYLY WITH MUSCULAR HYPOPLASIA, SKELETAL DYSPLASIA, AND ABNORMALPALMAR CREASES;;TEL HASHOMER CAMPTODACTYLY SYNDROME	0.00098912	0.09838305922337501
PATERNAL 20Q13.2Q13.3 MICRODELETION SYNDROME	0.00098912	0.09838305922337501
BARBER-SAY SYNDROME; BBRSAY	0.00098912	0.09838305922337501
20Q13.33 MICRODELETION SYNDROME	0.00098912	0.09838305922337501
MYCOPHENOLATE MOFETIL EMBRYOPATHY	0.00098912	0.09838305922337501
X SMALL RINGS	0.00098912	0.09838305922337501
NEUROFACIODIGITORENAL SYNDROME	0.00098912	0.09838305922337501
ROBINOW-SORAUF SYNDROME	0.00098912	0.09838305922337501
NEU-LAXOVA SYNDROME	0.00098912	0.09838305922337501
SCHIZOPHRENIA 1; SCZD1	0.00098912	0.09838305922337501
OSTEOGLOSPHONIC DYSPLASIA	0.00098912	0.09838305922337501
14Q22Q23 MICRODELETION SYNDROME	0.00098912	0.09838305922337501
WIDOW'S PEAK	0.00098912	0.09838305922337501
ABLEPHARON-MACROSTOMIA SYNDROME	0.00098912	0.09838305922337501
ACROCALLOSAL SYNDROME; ACLS	0.00098912	0.09838305922337501
ACROCEPHALOPOLYDACTYLOUS DYSPLASIA	0.00098912	0.09838305922337501
ACROFACIAL DYSOSTOSIS SYNDROME OF RODRIGUEZ	0.00098912	0.09838305922337501
DISTAL TRISOMY 5Q	0.00098912	0.09838305922337501
ACROFRONTOFACIONASAL DYSOSTOSIS 1	0.00098912	0.09838305922337501
MOSAIC TRISOMY 8	0.00098912	0.09838305922337501
ACRO-RENAL-OCULAR SYNDROME	0.00098912	0.09838305922337501
CHST3-RELATED SKELETAL DYSPLASIA	0.00098912	0.09838305922337501
PARTIAL TRISOMY/TETRASOMY OF THE SHORT ARM OF CHROMOSOME 9	0.00098912	0.09838305922337501
FAMILIAL ADENOMATOUS POLYPOSIS DUE TO 5Q22.2 MICRODELETION	0.00098912	0.09838305922337501
21Q22.11Q22.12 MICRODELETION SYNDROME	0.00098912	0.09838305922337501
TRISOMY 20P	0.00098912	0.09838305922337501
ARTERIAL TORTUOSITY SYNDROME	0.00098912	0.09838305922337501
SHORT SYNDROME	0.00098912	0.09838305922337501
ACROFRONTOFACIONASAL DYSOSTOSIS	0.00098912	0.09838305922337501
TREACHER-COLLINS SYNDROME	0.00098912	0.09838305922337501
LOEYS-DIETZ SYNDROME, TYPE 1A LOEYS-DIETZ AORTIC ANEURYSM SYNDROME	0.00098912	0.09838305922337501
MYOPATHY, CONGENITAL, COMPTON-NORTH	0.00098912	0.09838305922337501
DIAMOND-BLACKFAN ANEMIA 6; DBA6	0.00098912	0.09838305922337501
DIAMOND-BLACKFAN ANEMIA 8	0.00098912	0.09838305922337501
SNIJDERS BLOK-CAMPEAU SYNDROME; SNIBCPS	0.00098912	0.09838305922337501
NOONAN SYNDROME	0.00098912	0.09838305922337501
HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME 3; HKLLS3	0.00098912	0.09838305922337501
INTELLECTUAL DEVELOPMENTAL DISORDER WITH HYPERTELORISM AND DISTINCTIVE FACIES; IDDHDF	0.00098912	0.09838305922337501
X-LINKED INTELLECTUAL DISABILITY-SHORT STATURE-OVERWEIGHT SYNDROME	0.00098912	0.09838305922337501
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND BEHAVIORAL ABNORMALITIES; IDDFBA	0.00098912	0.09838305922337501
CHROMOSOME 1P35 DELETION SYNDROME	0.00098912	0.09838305922337501
CHROMOSOME 5P13 DUPLICATION SYNDROME	0.00098912	0.09838305922337501
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IC; ARCL1C	0.00098912	0.09838305922337501
MEGALENCEPHALY-SEVERE KYPHOSCOLIOSIS-OVERGROWTH SYNDROME	0.00098912	0.09838305922337501
SPONDYLO-MEGAEPIPHYSEAL-METAPHYSEAL DYSPLASIA; SMMD	0.00098912	0.09838305922337501
FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS	0.00098912	0.09838305922337501
SHORT-RIB THORACIC DYSPLASIA 18 WITH POLYDACTYLY; SRTD18	0.00098912	0.09838305922337501
CHROMOSOME 4Q21 DELETION SYNDROME	0.00098912	0.09838305922337501
CHROMOSOME 6Q11-Q14 DELETION SYNDROME	0.00098912	0.09838305922337501
CORPUS CALLOSUM AGENESIS-MACROCEPHALY-HYPERTELORISM SYNDROME	0.00098912	0.09838305922337501
LOEYS-DIETZ SYNDROME 3; LDS3	0.00098912	0.09838305922337501
MENTAL RETARDATION, AUTOSOMAL DOMINANT 53; MRD53	0.00098912	0.09838305922337501
NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND DISTAL LIMB ANOMALIES; NEDDFL	0.00098912	0.09838305922337501
SWEENEY-COX SYNDROME; SWCOS	0.00098912	0.09838305922337501
LOEYS-DIETZ SYNDROME	0.00098912	0.09838305922337501
RHOMBENCEPHALOSYNAPSIS	0.00098912	0.09838305922337501
NEURODEVELOPMENTAL DISORDER AND LANGUAGE DELAY WITH OR WITHOUT STRUCTURAL BRAIN ABNORMALITIES; NEDLBA	0.00098912	0.09838305922337501
DIAMOND-BLACKFAN ANEMIA 5	0.00098912	0.09838305922337501
NEURODEVELOPMENTAL DISORDER WITH CENTRAL AND PERIPHERAL MOTOR DYSFUNCTION; NEDCPMD	0.00098912	0.09838305922337501
POTOCKI-LUPSKI SYNDROME	0.00098912	0.09838305922337501
BALLER-GEROLD SYNDROME	0.00098912	0.09838305922337501
CHOANAL ATRESIA-HEARING LOSS-CARDIAC DEFECTS-CRANIOFACIAL DYSMORPHISM SYNDROME	0.00098912	0.09838305922337501
ATELOSTEOGENESIS TYPE I	0.00098912	0.09838305922337501
PFEIFFER SYNDROME	0.00098912	0.09838305922337501
FRIAS SYNDROME	0.00098912	0.09838305922337501
AMINOACYLASE 1 DEFICIENCY; ACY1D	0.00098912	0.09838305922337501
NOONAN SYNDROME 3; NS3	0.00098912	0.09838305922337501
609945 BRACHYPHALANGY, POLYDACTYLY, AND TIBIAL APLASIA/HYPOPLASIA	0.00098912	0.09838305922337501
ARRHINIA-CHOANAL ATRESIA-MICROPHTHALMIA SYNDROME	0.00098912	0.09838305922337501
ISOLATED ARRHINIA	0.00098912	0.09838305922337501
ANOPHTHALMIA PLUS SYNDROME	0.00098912	0.09838305922337501
HAMAMY SYNDROME; HMMS	0.00098912	0.09838305922337501
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 75; EIEE75	0.00098912	0.09838305922337501
PENTASOMY X	0.00098912	0.09838305922337501
ROBINOW SYNDROME, AUTOSOMAL RECESSIVE 2; RRS2	0.00098912	0.09838305922337501
PALLISTER-HALL SYNDROME	0.00098912	0.09838305922337501
20Q11.2 MICRODELETION SYNDROME	0.00098912	0.09838305922337501
CHROMOSOME 16P11.2 DELETION SYNDROME, 593-KB	0.00098912	0.09838305922337501
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE III	0.00098912	0.09838305922337501
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SEVERE SPEECH AND AMBULATION DEFECTS; IDDSSAD	0.00098912	0.09838305922337501
CEDNIK SYNDROME	0.00098912	0.09838305922337501
CHROMOSOME 10Q22.3-Q23.2 DELETION SYNDROME	0.00098912	0.09838305922337501
CROUZON SYNDROME WITH ACANTHOSIS NIGRICANS	0.00098912	0.09838305922337501
CEREBROOCULONASAL SYNDROME	0.00098912	0.09838305922337501
SPASTIC PARAPLEGIA 52, AUTOSOMAL RECESSIVE	0.00098912	0.09838305922337501
GALLOWAY-MOWAT SYNDROME 4; GAMOS4	0.00098912	0.09838305922337501
GALLOWAY-MOWAT SYNDROME 3; GAMOS3	0.00098912	0.09838305922337501
MENTAL RETARDATION, AUTOSOMAL DOMINANT 21	0.00098912	0.09838305922337501
MACROCEPHALY, DYSMORPHIC FACIES, AND PSYCHOMOTOR RETARDATION; MDFPMR	0.00098912	0.09838305922337501
OSTEOCHONDRODYSPLASIA, COMPLEX LETHAL, SYMOENS-BARNES-GISTELINCK TYPE	0.00098912	0.09838305922337501
MENTAL RETARDATION, AUTOSOMAL DOMINANT 18; MRD18	0.00098912	0.09838305922337501
STEEL SYNDROME; STLS	0.00098912	0.09838305922337501
OROFACIAL CLEFT 15	0.00098912	0.09838305922337501
NOONAN SYNDROME 8; NS8	0.00098912	0.09838305922337501
JOUBERT SYNDROME 26	0.00098912	0.09838305922337501
HARTSFIELD SYNDROME; HRTFDS	0.00098912	0.09838305922337501
BAINBRIDGE-ROPERS SYNDROME; BRPS	0.00098912	0.09838305922337501
FRONTONASAL DYSPLASIA-BIFID NOSE-UPPER LIMB ANOMALIES SYNDROME	0.00098912	0.09838305922337501
CRANIOSYNOSTOSIS 6; CRS6	0.00098912	0.09838305922337501
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 2; EDSMC2	0.00098912	0.09838305922337501
PEROXISOME BIOGENESIS DISORDER 5A (ZELLWEGER)	0.00098912	0.09838305922337501
VAN MALDERGEM SYNDROME 2; VMLDS2	0.00098912	0.09838305922337501
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 4	0.00098912	0.09838305922337501
NOONAN SYNDROME 10; NS10	0.00098912	0.09838305922337501
NOONAN SYNDROME 9; NS9	0.00098912	0.09838305922337501
NOONAN SYNDROME WITH MULTIPLE LENTIGINES	0.00098912	0.09838305922337501
NEU-LAXOVA SYNDROME 2; NLS2	0.00098912	0.09838305922337501
NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET; IMNEPD	0.00098912	0.09838305922337501
CRANIOLENTICULOSUTURAL DYSPLASIA	0.00098912	0.09838305922337501
COLE-CARPENTER SYNDROME 2; CLCRP2	0.00098912	0.09838305922337501
SHORT-RIB THORACIC DYSPLASIA 13 WITH OR WITHOUT POLYDACTYLY; SRTD13	0.00098912	0.09838305922337501
ROBINOW SYNDROME, AUTOSOMAL DOMINANT 2; DRS2	0.00098912	0.09838305922337501
PEROXISOME BIOGENESIS DISORDER 10A (ZELLWEGER); PBD10A	0.00098912	0.09838305922337501
PEROXISOME BIOGENESIS DISORDER 4B; PBD4B	0.00098912	0.09838305922337501
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 1; IECEE1	0.00098912	0.09838305922337501
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIC; ARCL2C	0.00098912	0.09838305922337501
BLEPHAROCHEILODONTIC SYNDROME 2; BCDS2	0.00098912	0.09838305922337501
STANKIEWICZ-ISIDOR SYNDROME; STISS	0.00098912	0.09838305922337501
%614187 HYPERTELORISM, PREAURICULAR SINUS, PUNCTAL PITS, AND DEAFNESS; HPPD	0.00098912	0.09838305922337501
CRANIOSYNOSTOSIS AND DENTAL ANOMALIES; CRSDA	0.00098912	0.09838305922337501
MECKEL SYNDROME	0.00098912	0.09838305922337501
MICROCEPHALY-CAPILLARY MALFORMATION SYNDROME	0.00098912	0.09838305922337501
HYPERMETHIONINEMIA DUE TO ADENOSINE KINASE DEFICIENCY	0.00098912	0.09838305922337501
MARSHALL-SMITH SYNDROME	0.00098912	0.09838305922337501
SCLEROSTEOSIS 2; SOST2	0.00098912	0.09838305922337501
DE BARSY SYNDROME	0.00098912	0.09838305922337501
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IID; ARCL2D	0.00098912	0.09838305922337501
JOUBERT SYNDROME 14	0.00098912	0.09838305922337501
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLJ TYPE	0.00098912	0.09838305922337501
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND PTOSIS; IDDDFP	0.00098912	0.09838305922337501
SHASHI-PENA SYNDROME; SHAPNS	0.00098912	0.09838305922337501
SIFRIM-HITZ-WEISS SYNDROME	0.00098912	0.09838305922337501
OROFACIODIGITAL SYNDROME XV; OFD15	0.00098912	0.09838305922337501
BARAITSER-WINTER SYNDROME 2; BRWS2	0.00098912	0.09838305922337501
TRICHOHEPATOENTERIC SYNDROME 2	0.00098912	0.09838305922337501
THAUVIN-ROBINET-FAIVRE SYNDROME	0.00098912	0.09838305922337501
INTERSTITIAL LUNG DISEASE, NEPHROTIC SYNDROME, AND EPIDERMOLYSIS BULLOSA, CONGENITAL; ILNEB	0.00098912	0.09838305922337501
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 2; HPMRS2	0.00098912	0.09838305922337501
SHORT STATURE, ONYCHODYSPLASIA, FACIAL DYSMORPHISM, AND HYPOTRICHOSIS	0.00098912	0.09838305922337501
MICROCEPHALY 17, PRIMARY, AUTOSOMAL RECESSIVE; MCPH17	0.00098912	0.09838305922337501
BARBER-SAY SYNDROME	0.00098912	0.09838305922337501
SEVERE MICROBRACHYCEPHALY-INTELLECTUAL DISABILITY-ATHETOID CEREBRAL PALSY SYNDROME	0.00098912	0.09838305922337501
CHIME SYNDROME	0.00098912	0.09838305922337501
METAPHYSEAL ACROSCYPHODYSPLASIA	0.00098912	0.09838305922337501
FAMILIAL SCAPHOCEPHALY SYNDROME, MCGILLIVRAY TYPE	0.00098912	0.09838305922337501
MACROSTOMIA-PREAURICULAR TAGS-EXTERNAL OPHTHALMOPLEGIA SYNDROME	0.00098912	0.09838305922337501
MENTAL RETARDATION, X-LINKED 106; MRX106	0.00098912	0.09838305922337501
KEIPERT SYNDROME; KPTS	0.00098912	0.09838305922337501
AXIAL SPONDYLOMETAPHYSEAL DYSPLASIA	0.00098912	0.09838305922337501
WORMIAN BONE-MULTIPLE FRACTURES-DENTINOGENESIS IMPERFECTA-SKELETAL DYSPLASIA	0.00098912	0.09838305922337501
COFFIN-LOWRY SYNDROME; CLS	0.00098912	0.09838305922337501
RESTRICTIVE DERMOPATHY	0.00098912	0.09838305922337501
MULTIPLE EPIPHYSEAL DYSPLASIA, LOWRY TYPE	0.00098912	0.09838305922337501
MÜLLERIAN DERIVATIVES-LYMPHANGIECTASIA-POLYDACTYLY SYNDROME	0.00098912	0.09838305922337501
ANTLEY-BIXLER SYNDROME	0.00098912	0.09838305922337501
CRANIOFRONTONASAL SYNDROME; CFNS	0.00098912	0.09838305922337501
OCULOCEREBROCUTANEOUS SYNDROME	0.00098912	0.09838305922337501
HETEROTAXY, VISCERAL, 1, X-LINKED; HTX1	0.00098912	0.09838305922337501
MELNICK-NEEDLES SYNDROME	0.00098912	0.09838305922337501
DISTAL MONOSOMY 9P	0.00098912	0.09838305922337501
MENTAL RETARDATION, X-LINKED, SYNDROMIC, SNYDER-ROBINSON TYPE	0.00098912	0.09838305922337501
X-LINKED CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME	0.00098912	0.09838305922337501
OROFACIODIGITAL SYNDROME I; OFD1	0.00098912	0.09838305922337501
3Q13 MICRODELETION SYNDROME	0.00098912	0.09838305922337501
TARP SYNDROME; TARPS	0.00098912	0.09838305922337501
DISTAL MONOSOMY 3P	0.00098912	0.09838305922337501
SCHINZEL-GIEDION SYNDROME	0.00098912	0.09838305922337501
2Q24 MICRODELETION SYNDROME	0.00098912	0.09838305922337501
CARDIAC VALVULAR DYSPLASIA, X-LINKED; CVD1	0.00098912	0.09838305922337501
TONNE-KALSCHEUER SYNDROME; TOKAS	0.00098912	0.09838305922337501
FANCONI ANEMIA	0.00098912	0.09838305922337501
RITSCHER-SCHINZEL SYNDROME 2; RTSC2	0.00098912	0.09838305922337501
TERMINAL OSSEOUS DYSPLASIA; TOD	0.00098912	0.09838305922337501
ISOLATED BRACHYCEPHALY	0.00098912	0.09838305922337501
SPONDYLOCARPOTARSAL SYNOSTOSIS SYNDROME; SCT	0.00098912	0.09838305922337501
TEEBI-SHALTOUT SYNDROME; TBSH	0.00098912	0.09838305922337501
RENAL AGENESIS, BILATERAL	0.00098912	0.09838305922337501
X-LINKED INTELLECTUAL DISABILITY, STOLL TYPE	0.00098912	0.09838305922337501
X-LINKED INTELLECTUAL DISABILITY, SEEMANOVA TYPE	0.00098912	0.09838305922337501
FRONTOMETAPHYSEAL DYSPLASIA	0.00098912	0.09838305922337501
WHISTLING FACE SYNDROME, RECESSIVE FORM	0.00098912	0.09838305922337501
WHITE FORELOCK WITH MALFORMATIONS	0.00098912	0.09838305922337501
ROIFMAN SYNDROME	0.00098912	0.09838305922337501
OPITZ GBBB SYNDROME, TYPE I; GBBB1	0.00098912	0.09838305922337501
DYSOSTOSIS, STANESCU TYPE	0.00098912	0.09838305922337501
TRISOMY 12P	0.00098912	0.09838305922337501
OROFACIODIGITAL SYNDROME VIII; OFD8	0.00098912	0.09838305922337501
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2, CLASSIC TYPE	0.00098912	0.09838305922337501
DYSOSTEOSCLEROSIS	0.00098912	0.09838305922337501
THAKKER-DONNAI SYNDROME	0.00098912	0.09838305922337501
ACROCALLOSAL SYNDROME	0.00098912	0.09838305922337501
FACIAL DYSMORPHISM-SHAWL SCROTUM-JOINT LAXITY SYNDROME	0.00098912	0.09838305922337501
GENITOPATELLAR SYNDROME	0.00098912	0.09838305922337501
MENTAL RETARDATION AND MICROCEPHALY WITH PONTINE AND CEREBELLAR HYPOPLASIA; MICPCH	0.00098912	0.09838305922337501
TEMTAMY SYNDROME	0.00098912	0.09838305922337501
CHILDHOOD-ONSET NEMALINE MYOPATHY	0.00098912	0.09838305922337501
MOSAIC TRISOMY 14	0.00098912	0.09838305922337501
PTERYGIUM COLLI AND MENTAL RETARDATION WITH FACIAL AND DIGITAL ANOMALIES	0.00098912	0.09838305922337501
DISTAL MONOSOMY 13Q	0.00098912	0.09838305922337501
MONOSOMY 13Q14	0.00098912	0.09838305922337501
DUANE-RADIAL RAY SYNDROME; DRRS	0.00098912	0.09838305922337501
603463 HYPOSPADIAS, HYPERTELORISM, UPPER LID COLOBOMA, AND MIXED-TYPE HEARINGLOSS	0.00098912	0.09838305922337501
LETHAL CONGENITAL CONTRACTURE SYNDROME TYPE 1	0.00098912	0.09838305922337501
CORTICAL DEFECTS, WORMIAN BONES, AND DENTINOGENESIS IMPERFECTA	0.00098912	0.09838305922337501
NOONAN SYNDROME 2; NS2	0.00098912	0.09838305922337501
CEREBROOCULONASAL SYNDROME	0.00098912	0.09838305922337501
606156 SENER SYNDROME;;FRONTONASAL DYSPLASIA AND DILATED VIRCHOW-ROBIN SPACES	0.00098912	0.09838305922337501
RING CHROMOSOME 6 SYNDROME	0.00098912	0.09838305922337501
RING CHROMOSOME 10 SYNDROME	0.00098912	0.09838305922337501
PYRUVATE DEHYDROGENASE DEFICIENCY	0.00098912	0.09838305922337501
CREE MENTAL RETARDATION SYNDROME	0.00098912	0.09838305922337501
CHARLIE M SYNDROME	0.00098912	0.09838305922337501
CATEL-MANZKE SYNDROME	0.00098912	0.09838305922337501
MEND SYNDROME	0.00098912	0.09838305922337501
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 1; NSLH1	0.00098912	0.09838305922337501
NEUROLOGICAL CONDITIONS ASSOCIATED WITH AMINOACYLASE 1 DEFICIENCY	0.00098912	0.09838305922337501
X-LINKED INTELLECTUAL DISABILITY-LIMB SPASTICITY-RETINAL DYSTROPHY-DIABETES INSIPIDUS SYNDROME	0.00098912	0.09838305922337501
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 6	0.00098912	0.09838305922337501
VATER-LIKE DEFECTS WITH PULMONARY HYPERTENSION, LARYNGEAL WEBS, AND GROWTH DEFICIENCY	0.00098912	0.09838305922337501
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IK; CDG1K	0.00098912	0.09838305922337501
LARSEN-LIKE SYNDROME	0.00098912	0.09838305922337501
OSSIFICATION ANOMALIES-PSYCHOMOTOR DEVELOPMENTAL DELAY SYNDROME	0.00098912	0.09838305922337501
%608572 BURN-MCKEOWN SYNDROME	0.00098912	0.09838305922337501
ASCHER SYNDROME	0.00098912	0.09838305922337501
MENTAL RETARDATION WITH OPTIC ATROPHY, FACIAL DYSMORPHISM, MICROCEPHALY, AND SHORT STATURE	0.00098912	0.09838305922337501
VICI SYNDROME	0.00098912	0.09838305922337501
PIERPONT SYNDROME	0.00098912	0.09838305922337501
MESOMELIA-SYNOSTOSES SYNDROME	0.00098912	0.09838305922337501
GÓMEZ-LÓPEZ-HERNÁNDEZ SYNDROME	0.00098912	0.09838305922337501
DISTAL MONOSOMY 10P	0.00098912	0.09838305922337501
600460 CLEFT PALATE, CARDIAC DEFECT, GENITAL ANOMALIES, AND ECTRODACTYLY;;CCGE;;ACROCARDIOFACIAL SYNDROME; ACFS	0.00098912	0.09838305922337501
SIMPSON-GOLABI-BEHMEL SYNDROME	0.00098912	0.09838305922337501
DERMOID CYSTS, FAMILIAL FRONTONASAL	0.00098912	0.09838305922337501
600736 VELOFACIOSKELETAL SYNDROME	0.00098912	0.09838305922337501
CRANIOSYNOSTOSIS 4; CRS4	0.00098912	0.09838305922337501
GORLIN SYNDROME	0.00098912	0.09838305922337501
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.00098912	0.09838305922337501
CURRY-JONES SYNDROME	0.00098912	0.09838305922337501
JACKSON-WEISS SYNDROME	0.00098912	0.09838305922337501
CRANIOSYNOSTOSIS-DANDY-WALKER MALFORMATION-HYDROCEPHALUS SYNDROME	0.00098912	0.09838305922337501
FRONTORHINY	0.00098912	0.09838305922337501
OCULOAURICULOFRONTONASAL SYNDROME	0.00098912	0.09838305922337501
DIAPHRAGMATIC DEFECTS, LIMB DEFICIENCIES, AND OSSIFICATION DEFECTS OF SKULL	0.00098912	0.09838305922337501
601165 CLEFT LIP/PALATE WITH CHARACTERISTIC FACIES, INTESTINAL MALROTATION,AND LETHAL CONGENITAL HEART DISEASE	0.00098912	0.09838305922337501
CRANIOFRONTONASAL DYSPLASIA-POLAND ANOMALY SYNDROME	0.00098912	0.09838305922337501
VAN MALDERGEM SYNDROME 1; VMLDS1	0.00098912	0.09838305922337501
CRANIOFRONTONASAL DYSPLASIA	0.00098912	0.09838305922337501
%601499 AXENFELD-RIEGER SYNDROME, TYPE 2; RIEG2;;RIEGER SYNDROME, TYPE 2	0.00098912	0.09838305922337501
MULTIPLE EPIPHYSEAL DYSPLASIA WITH ROBIN PHENOTYPE	0.00098912	0.09838305922337501
DEVELOPMENTAL MALFORMATIONS-DEAFNESS-DYSTONIA SYNDROME	0.00098912	0.09838305922337501
HYPERTELORISM, TEEBI TYPE	0.00098912	0.09838305922337501
CRANIOFACIAL DYSSYNOSTOSIS	0.00098912	0.09838305922337501
GOMEZ-LOPEZ-HERNANDEZ SYNDROME; GLHS	0.00098912	0.09838305922337501
NF1-MICRODELETION SYNDROME	0.00098912	0.09838305922337501
